EOS Med Chem is serving more than 100 Pharma companies, we have the original Drug Discovery Compounds, Like Impurity, small molecule and inhibitor.
Impurity we keep stock more than 80000, most in stock, we are World Sole Original Supplier, Each impurity we could supply: Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA.
EOS Med Chem Quotation include: Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, COA, MSDS.
Contact:
EOS Med Chem, Medicinal Chemical is Big
執大象，天下往，往而無害，安平泰
Ms Nina
Youtube: https://youtu.be/r5cJdXKNXHk
Tel: 0086-531-69905422
SALE OFFICE: 16F, China Overseas Plaza, Jinan City, China
2-Bromo-7-iodo-9H-fluorene, CAS: 123348-27-6, stock: 9.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₈BrI.
2-Bromo-7-nitrofluorene, CAS: 6638-61-5, stock: 7.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₈BrNO₂.
2-Bromo-9,9-bis(4-methylphenyl)-9H-fluorene, CAS: 474918-33-7, stock: 9.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₁Br.
2-Bromo-9,9-dibutylfluorene, CAS: 88223-35-2, stock: 9.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₅Br.
2-Bromo-9,9-diethylfluorene, CAS: 287493-15-6, stock: 6.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₇Br.
2-Bromo-9,9-difluoro-7-iodo-9H-fluorene, CAS: 1499193-60-0, stock: 2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₆BrF₂I.
2-Bromo-9,9-dihexylfluorene, CAS: 226070-05-9, stock: 3.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₃Br.
2-Bromo-9,9-dimethylfluorene, CAS: 28320-31-2, stock: 9.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₃Br.
2-Bromo-9,9-dioctyl Fluorene, CAS: 302554-80-9, stock: 3.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₄₁Br.
2-Bromo-9,9-Diphenylfluorene, CAS: 474918-32-6, stock: 1.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₁₇Br.
2-Bromo-9,9’-spirobi[fluorene], CAS: 171408-76-7, stock: 3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₁₅Br.
2-Bromofluorene, CAS: 1133-80-8, stock: 9.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₉Br.
2-Chloro-7-nitro-9H-fluorene, CAS: 05/05/6939, stock: 7.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₈ClNO₂.
2-Fluorofluorene, CAS: 343-43-1, stock: 6.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₉F.
2-Hydroxy Fluorene, CAS: 2443-58-5, stock: 6.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₀O.
2-Hydroxy Fluorene-d9, CAS: 922510-18-7, stock: 5.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃HD₉O.
2-Iodo-9,9-dimethylfluorene, CAS: 144981-85-1, stock: 8.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₃I.
2-Iodo-9H-fluorene, CAS: 2523-42-4, stock: 3.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₉I.
2-Methylfluorene, CAS: 1430-97-3, stock: 2.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₂.
2-Nitrofluorene, CAS: 607-57-8, stock: 1.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₉NO₂.
2-[(4-Methoxybenzylidene)amino]fluorene, CAS: 5424-78-2, stock: 7.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₇NO.
2’,7’-Dibromo-2-vinylspiro[cyclopropane-1,9’-fluorene], CAS: 951884-03-0, stock: 6.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₂Br₂.
2’,7’-Dibromospiro[cyclopent[3]ene-1,9’-fluorene], CAS: 951884-04-1, stock: 1.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₂Br₂.
2’-Bromo-spiro[1,3-dithiolane-2,9’-[9h]fluorene], CAS: 113425-37-9, stock: 7.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₁S₂Br.
2’-Deoxy-8-(9H-fluoren-2-ylamino)-guanosine, CAS: 73051-69-1, stock: 7.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₂N6O₄.
3,3’-(2,7-Dibromo-9H-fluorene-9,9-diyl)bis(N,N-dimethylpropan-1-amine), CAS: 673474-73-2, stock: 3.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₀Br₂N₂.
3,6-Dibromo-9H-fluoren-9-one, CAS: 216312-73-1, stock: 8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₆Br₂O.
3,6-Dimethyl-fluorene, CAS: 7495-37-6, stock: 6.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₄.
3,6-Dimethyl-fluorene-d5, CAS: /, stock: 9.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₉D₅.
3-Bromo-9,9-dimethyl-9H-fluorene, CAS: 1190360-23-6, stock: 6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₃Br.
3-Bromo-9,9-diphenyl-9H-fluorene, CAS: 1547491-70-2, stock: 2.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₁₇Br.
3-Bromo-9,9-Spirobifluorene, CAS: 1361227-58-8, stock: 6.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₁₅Br.
3-Hydroxy-N-acetyl-2-aminofluorene, CAS: 1838-56-8, stock: 2.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₃NO₂.
3-Methyl-9H-fluorene, CAS: 2523-39-9, stock: 1.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₂.
3-Nitrofluorene, CAS: 5397-37-5, stock: 3.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₉NO₂.
4,4’-(9H-Fluorene-9,9-diyl)dianiline, CAS: 15499-84-0, stock: 4.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₀N₂.
4,5-Diazafluorene-9-one O-(p-Toluenesulfonyl)oxime, CAS: 1655490-79-1, stock: 2.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₃N₃O₃S.
4-Bromo-9,9-dimethyl-9H-fluorene, CAS: 942615-32-9, stock: 4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₃Br.
4-Bromo-9,9-diphenyl-9H-fluorene, CAS: 713125-22-5, stock: 5.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₁₇Br.
4-Bromo-9,9’-spirobi[fluorene], CAS: 1161009-88-6, stock: 7.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₁₅Br.
4-Methylfluorene, CAS: 1556-99-6, stock: 3.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₂.
5,9-Dibromo-7,7-dimethyl-7H-benzo[c]fluorene, CAS: 1056884-35-5, stock: 9.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₄Br₂.
5-Oxiranyl-2,7-dichlorofluorene, CAS: 53221-14-0, stock: 3.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀C₂O.
7,7-Dimethylbenzo[c]fluorene, CAS: 112486-09-6, stock: 7.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₆.
7-Hydroxy-2-acetylaminofluorene, CAS: 363-49-5, stock: 4.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₃NO₂.
7-Nitrofluoren-2-ol, CAS: 6633-40-5, stock: 8.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₉NO₃.
7H-Benzo[c]fluorene, CAS: 205-12-9, stock: 1.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₂.
7H-Dibenzo[c,g]carbazole, CAS: 194-59-2, stock: 1.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₃N.
9,9-Bis(3,4-dihydroxyphenyl)fluorene, CAS: 351521-78-3, stock: 5.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₁₈O₄.
9,9-bis(3-Amino-4-hydroxyphenyl)fluorene, CAS: 20638-07-7, stock: 5.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₀N₂O₂.
9,9-bis(4-Amino-3-chlorophenyl)fluorene, CAS: 107934-68-9, stock: 9.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₁₈N₂Cl₂.
9,9-bis(4-Amino-3-fluorophenyl)fluorene, CAS: 127926-65-2, stock: 2.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₁₈N₂F₂.
9,9-bis(4-Amino-3-methylphenyl)fluorene, CAS: 107934-60-1, stock: 4.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₄N₂.
9,9-Bis(4-hydroxy-3-methylphenyl)fluorene, CAS: 88938-12-9, stock: 2.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₂O₂.
9,9-Bis(4-methoxyphenyl)-9H-fluorene, CAS: 117766-40-2, stock: 2.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₂O₂.
9,9-bis(4-Prop-2-enoxyphenyl)fluorene, CAS: 142494-81-3, stock: 8.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₂₆O₂.
9,9-Bis[4-(pyrenyl)phenyl]-9H-fluorene, CAS: 1174006-47-3, stock: 9.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₇H₃₄.
9,9-Di(p-tolyl)fluorene-2-boronic Acid, CAS: 1193104-83-4, stock: 8.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₃BO₂.
9,9-Di-N-octylfluorene, CAS: 123863-99-0, stock: 4.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₄₂.
9,9-Di-N-octylfluorene-2,7-dicarboxaldehyde, CAS: 380600-91-9, stock: 2.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₄₂O₂.
9,9-Didecyl-2,7-dibromofluorene, CAS: 175922-78-8, stock: 8.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₄₈Br₂.
9,9-Didodecylfluorene-2,7-diboronic acid, CAS: 480424-86-0, stock: 5.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₆₀B₂O₄.
9,9-Dihexyl-2,7-dibromofluorene, CAS: 189367-54-2, stock: 7.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₂Br₂.
9,9-Dihexylfluorene, CAS: 123863-97-8, stock: 4.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₄.
9,9-Dimethyl-9H-9-silafluorene, CAS: 13688-68-1, stock: 4.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₄Si.
9,9-Dimethyl-9H-fluorene, CAS: 4569-45-3, stock: 7.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₄.
9,9-Dimethyl-9H-fluorene-2-carbonitrile, CAS: 890134-27-7, stock: 1.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₃N.
9,9-Dioctyl-2,7-dibromofluorene, CAS: 198964-46-4, stock: 1.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₄₀Br₂.
9,9-Dioctyl-9H-fluorene-2,7-diamine, CAS: 851042-10-9, stock: 9.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₄₄N₂.
(6α,11β,16α)-21-(Acetyloxy)-6,9-difluoro-14,16-dehydro-11,16,17-trihydroxypregna-1,4-diene-3,20-dione, CAS: /, stock: 4.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₆F₂O₇.
9,9-Dioctylfluorene-2,7-bis(trimethylborate), CAS: 317802-08-7, stock: 8.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₅H₅₂B₂O₄.
9,9-Dioctylfluorene-2,7-diboronic acid, CAS: 258865-48-4, stock: 4.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₄₄B₂O₄.
(6α,11β,16α)-6,9-Difluoro-11,21-dihydroxy-21-methoxy-16,17-[(1-methylethylidene)bis(oxy)]-pregna-1,4-diene-3,20-dione, CAS: 62013-83-6, stock: 1.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₂F₂O₇.
9,9-Dioctylfluorene-2,7-diboronic Acid bis(Pinacol) Ester, CAS: 196207-58-6, stock: 2.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₁H₆₄B₂O₄.
9,9-Diphenyl-9H-9-silafluorene, CAS: 03/08/5550, stock: 7.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₁₈Si.
(6α,11β,16α,17α)-6,9-Difluoro-11-hydroxy-16,17-[(1-methylethylidene)bis(oxy)]-3-oxoandrosta-1,4-diene-17-carboxylic Acid, CAS: 65751-34-0, stock: 7.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₈F₂O₆.
(6α,9β,11β,16α)-21-(Acetyloxy)-9,11-epoxy-6-fluoro-16,17-[(1-methylethylidene)bis(oxy)]pregna-1,4-diene-3,20-dione, CAS: 6598-95-4, stock: 5.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₁FO₇.
9,9-Diphenylfluorene, CAS: 20302-14-1, stock: 8.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₁₈.
9,9’-Spirobifluorene, CAS: 159-66-0, stock: 4.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₁₆.
(6α,9β,11β,16α)-9,11-Epoxy-6-fluoro-21-hydroxy-16,17-[(1-methylethylidene)bis(oxy)]pregna-1,4-diene-3,20-dione, CAS: 68352-03-4, stock: 1.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₉FO₆.
14,15-Dehydro Fluocinolone Acetonide, CAS: /, stock: 6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₈F₂O₆.
9,9-Bis(methoxymethyl)-9H-fluorene, CAS: 182121-12-6, stock: 9.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₈O₂.
9-(3-Bromophenyl)-9-phenyl-9H-fluorene, CAS: 1257251-75-4, stock: 1.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₁₇Br.
14,15-Dehydro-21-acetyl Fluocinolone Acetonide, CAS: /, stock: 2.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₀F₂O₇.
9-(4-Bromobutyl)-9H-fluorene-9-carboxylic Acid, CAS: 182438-97-7, stock: 5.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₇O₂Br.
9-(4-Bromobutyl)-N-(2,2,2-trifluoroethyl)-9H-fluorene-9-carboxamide, CAS: 182438-98-8, stock: 4.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₉NOF₃Br.
21-Acetyl-6α-chlorotriamcinolone Acetonide, CAS: 1181-32-4, stock: 4.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₂ClFO₇.
21-Acetyl-6β-fluorotriamcinolone Acetonide, CAS: 67438-37-3, stock: 1.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₂F₂O₇.
9-(4-Bromophenyl)-9-phenyl-9H-fluorene, CAS: 937082-81-0, stock: 2.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₁₇Br.
9-(Acetoxymethyl)fluorene, CAS: 63839-86-1, stock: 5.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₄O₂.
4-Fluorotriamcinolone Acetonide, CAS: /, stock: 1.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₀F₂O₆.
9-(Chloromethyl)-9H-fluorene, CAS: 36375-77-6, stock: 4.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₁Cl.
9-Benzylfluorene, CAS: 1572-46-9, stock: 7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₆.
Ciprocinonide, CAS: 58524-83-7, stock: 9.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₄F₂O₇.
Fluocinolone, CAS: 807-38-5, stock: 8.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₆F₂O₆.
9-Bromo-7,7-dimethyl-7H-benzo[c]fluorene, CAS: 1198396-46-1, stock: 9.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₅Br.
2-Methyl-3-(trifluoromethyl)pivalanilide, CAS: 150783-50-9, stock: 4.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₆F₃NO.
Fluocinolone Acetonide, CAS: 67-73-2, stock: 2.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₀F₂O₆.
Fluocinolone Acetonide Acetate, CAS: 356-12-7, stock: 2.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₂F₂O₇.
9-Bromo-9-phenylfluorene, CAS: 55135-66-5, stock: 6.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₃Br.
9-Bromofluorene, CAS: 1940-57-4, stock: 7.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₉Br.
2-Methyl-d3-3-(trifluoromethyl)pivalanilide, CAS: 1189715-10-3, stock: 1.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₃D₃F₃NO.
3-(Trifluoromethyl)pivalanilide, CAS: 1939-19-1, stock: 4.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₄F₃NO.
Fluocinolone Acetonide Diacetate, CAS: 73327-17-0, stock: 5.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₄F₂O₈.
Fluocinolone Acetonide-13C3, CAS: 1262192-25-5, stock: 8.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁¹³C₃H₃₀F₂O₆.
9-Chlorofluorene, CAS: 6630-65-5, stock: 2.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₉Cl.
9-Chlorofluorene-13C6 (Contain 3% unlabeled), CAS: /, stock: 1.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇¹³C₆H₉Cl.
3-Trifluoromethyl-2-methylaniline-d3, CAS: 1189989-60-3, stock: 2.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₅D₃F₃N.
5-Hydroxy Flunixin (Contain 5% Flunixin), CAS: 75369-61-8, stock: 1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₁F₃N₂O₃.
Fluocinolone Acetonide-21-aldehyde, CAS: 13242-30-3, stock: 3.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₈F₂O₆.
Fluocinolone Acetonide-21-carboxylic Acid, CAS: 106931-78-6, stock: 9.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₈F₂O₇.
9-Ethylfluorene, CAS: 2294-82-8, stock: 8.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₄.
5-Hydroxy Flunixin Glucuronide, CAS: /, stock: 2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₉F₃N₂O₉.
5-Hydroxy Flunixin-d3See H942424, CAS: 1185088-54-3, stock: 1.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₈D₃F₃N₂O₃.
Fluocinolone Acetonide-9,11-epoxy-20-carboxylic acid, CAS: /, stock: 7.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₇FO₆.
Fluocinonide 22 Methyl Homologue, CAS: 51372-50-0, stock: 7.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₀F₂O₇.
9-Fluoren-9-ylidenefluorene, CAS: 746-47-4, stock: 9.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₁₆.
5-Hydroxy Flunixin-d3 (Major), CAS: /, stock: 6.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₈D₃F₃N₂O₃.
6-Methyl-3-(trifluoromethyl)pivalanilide, CAS: 1246819-76-0, stock: 7.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₆F₃NO.
9-Fluorenemethanol, CAS: 24324-17-2, stock: 4.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₂O.
9-Fluorenone-1-carboxylic Acid, CAS: 1573-92-8, stock: 9.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₈O₃.
Flunixin, CAS: 38677-85-9, stock: 9.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₁F₃N₂O₂.
Flunixin Glucuronide, CAS: /, stock: 5.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₉F₃N₂O₈.
9-Fluorenone-2-carboxylic Acid, CAS: 784-50-9, stock: 4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₈O₃.
Flunixin Meglumine, CAS: 42461-84-7, stock: 3.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₈F₃N₃O₇.
Flunixin-d3, CAS: 1015856-60-6, stock: 6.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₈D₃F₃N₂O₂.
9-Fluorenylmethyl tosylate, CAS: 71532-40-6, stock: 2.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₈O₃S.
9-Hydroxyfluorene, CAS: 1689-64-1, stock: 6.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₀O.
9-Methyl-9h-fluorene-9-carboxylic acid, CAS: 3300-17-2, stock: 9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₂O₂.
9-Methylfluorene, CAS: 2523-37-7, stock: 8.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₂.
9-Methylfluorene-9-carbonyl Chloride, CAS: 82102-37-2, stock: 6.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₁OCl.
9-Methylidenefluorene, CAS: 4425-82-5, stock: 1.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₀.
9-N-Butylfluorene, CAS: 3952-42-9, stock: 2.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₈.
9-Oxo-9H-fluorene-4-carboxylic Acid, CAS: 6223-83-2, stock: 8.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₈O₃.
9-Phenyl-9-fluorenol, CAS: 25603-67-2, stock: 6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₄O.
9-Propylfluorene, CAS: 4037-45-0, stock: 6.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₆.
9-[(2-Bromophenyl)methyl]-9H-fluorene, CAS: 187754-47-8, stock: 6.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₅Br.
9-[Bromo(phenyl)methylene]-9H-fluorene, CAS: 33735-95-4, stock: 9.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₃Br.
9H-Fluorene-1-carboxylic Acid Methyl Ester, CAS: 28314-01-4, stock: 5.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₂O₂.
9H-Fluoren-1-amine, CAS: 6344-63-4, stock: 2.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₁N.
9H-Fluorene-1-carbohydrazide, CAS: /, stock: 9.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₂N₂O.
allo-Chrysoketone, CAS: 6051-98-5, stock: 3.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₀O.
Benzo[j]fluoranthene, CAS: 205-82-3, stock: 7.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₂.
Benzo[j]fluoranthene-D12, CAS: /, stock: 4.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀D₁₂.
Benzo[k]fluoranthene, CAS: 207-08-9, stock: 3.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₂.
Benzo[k]fluoranthene-13C6, CAS: 1397194-60-3, stock: 1.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄¹³C₆H₁₂.
Chlorflurenol-methyl, CAS: 2536-31-4, stock: 3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₁ClO₃.
Chlorflurenol-methyl (Technical Grade), CAS: 2536-31-4, stock: 9.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₁ClO₃.
Desbutyl Lumefantrine-d9(E/Z-Mixture), CAS: 1346606-35-6, stock: 9.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₁₅D₉Cl₃NO.
Dinaphtho[2,1-b:1’,2’-d]furan, CAS: 194-63-8, stock: 5.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₂O.
Diphenyldichlorosilane, CAS: 80-10-4, stock: 6.9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₀Cl₂Si.
Fireshield C2, CAS: 58910-85-3, stock: 1.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₂Cl₁₂.
Fireshield C3, CAS: 13560-90-2, stock: 2.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₂Cl₁₂.
Fluoranthene, CAS: 206-44-0, stock: 6.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₀.
Fluoren-1-ol, CAS: 6344-61-2, stock: 7.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₀O.
Fluoren-3-ol, CAS: 6344-67-8, stock: 10g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₀O.
Fluoren-3-ol-d9 (Major), CAS: /, stock: 7.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃HD₉O.
Fluorene-2-carboxaldehyde, CAS: 30084-90-3, stock: 2.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₀O.
Fluorene-9-carboxamide, CAS: 7471-95-6, stock: 8.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₁NO.
Fluorene-1-carbamic Acid Ethyl Ester, CAS: 28314-06-9, stock: 1.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₅NO₂.
Fluorene-D10, CAS: 81103-79-9, stock: 2.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃D₁₀.
Fluorobenzo[c]fluorene, CAS: /, stock: 1.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₁F.
Fluoroene-9-acetic Acid, CAS: 6284-80-6, stock: 6.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₂O₂.
Indecainide Hydrochloride, CAS: 73681-12-6, stock: 9.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₅ClN₂O.
Indecainide-d7 Hydrochloride, CAS: /, stock: 4.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₈D₇ClN₂O.
α-Carboline, CAS: 244-76-8, stock: 2.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₈N₂.
α-Carboline-15N2, CAS: 1189983-12-7, stock: 7.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₈¹⁵N₂.
α-Methyl-9H-fluorene-9-propanoic Acid, CAS: 748152-56-9, stock: 6.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₆O₂.
Lumefantrine, CAS: 82186-77-4, stock: 9.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₃₂Cl₃NO.
Lumefantrine β-D-Glucuronide, CAS: /, stock: 1.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₆H₄₀Cl₃NO₇.
Lumefantrine-d18, CAS: 1185240-53-2, stock: 6.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₁₄D₁₈Cl₃NO.
Methyl 9-Hydroxy-9H-fluorene-9-carboxylate, CAS: 1216-44-0, stock: 8.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₂O₃.
Methyl Fluorene-9-carboxylic Acid Ester, CAS: 3002-30-0, stock: 2.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₂O₂.
N-(1-Hydroxy-9H-fluoren-2-yl)-acetamide, CAS: 2784-86-3, stock: 8.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₃NO₂.
N-(4-Hydroxy-9H-fluoren-2-yl)-acetamide, CAS: 64724-49-8, stock: 3.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₃NO₂.
N-(5-Hydroxy-9H-fluoren-2-yl)-acetamide, CAS: 1147-55-3, stock: 1.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₃NO₂.
N-(8-Hydroxy-9H-fluoren-2-yl)-acetamide, CAS: 101020-76-2, stock: 2.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₃NO₂.
N-(9-Hydroxy-9H-fluoren-2-yl)-acetamide, CAS: 57229-41-1, stock: 5.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₃NO₂.
N-9H-Fluoren-2-yl-N-hydroxy-acetamide, CAS: 53-95-2, stock: 7.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₃NO₂.
N-9H-Fluoren-4-yl-N-hydroxy-acetamide, CAS: 22225-34-9, stock: 9.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₃NO₂.
N-Boc-4-oxo-L-proline, CAS: 84348-37-8, stock: 7.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₅NO₅.
N-Fmoc-glycine, CAS: 29022-11-5, stock: 9.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₅NO₄.
N-Fmoc-glycine-d2, CAS: 284665-11-8, stock: 2.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₃D₂NO₄.
N-Hydroxy-2-aminofluorene, CAS: 53-94-1, stock: 4.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₁NO.
NGB 2904, CAS: 189060-98-8, stock: 7.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₀Cl₃N₃O.
NGB 2904 Hydrochloride, CAS: 189061-11-8, stock: 1.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₀Cl₃N₃O.
NGB 2904-d8 Hydrochloride, CAS: /, stock: 5.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₂₂D₈Cl₃N₃O.
Nor Harmane, CAS: 244-63-3, stock: 7.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₈N₂.
Nor Harmane-d7, CAS: 1216503-21-7, stock: 9.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁HD₇N₂.
NSC 91800, CAS: 13560-91-3, stock: 1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₆Cl₁₂.
Peimisine, CAS: 19773-24-1, stock: 9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₄₁NO₃.
PF8-TAA, CAS: 1178569-78-2, stock: 4.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: (C₄₉H₅₇N)n.
Phenindamine Hydrochloride, CAS: 02/08/5503, stock: 8.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₀ClN.
Phenindamine-d3 Hydrochloride, CAS: 1346603-22-2, stock: 1.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₇D₃ClN.
PIF8-TAA, CAS: 1178569-79-3, stock: 7.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: (C₇₂H₉₃N)n.
SMBA 1, CAS: 906440-37-7, stock: 6.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₃NO₃.
Spiro[fluorene-9,9’-xanthene]-3’,6’-diol, CAS: 4081-00-9, stock: 8.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₁₆O₃.
Verapatuline, CAS: 212968-58-6, stock: 8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₄₁NO₅.
Veratramine, CAS: 60-70-8, stock: 3.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₉NO₂.
[5a-S,10b-R]-2-(2,4,6-Trimethyl-phenyl)-2,5a,6,10b-tetrahydro-4H-5-oxa-2,3-diaza-10c-azonia-cyclopenta[c]fluorene Chloride, CAS: 919102-70-8, stock: 5.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₂ClN₃O • H ₂O.
(E/Z)-Trelnarizine Dihydrochloride(Mixture), CAS: 99661-27-5, stock: 8.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₂Cl₂F₂N₂O₂.
(E/Z)-Trelnarizine-d8 Dihydrochloride(Mixture), CAS: 1287285-71-5, stock: 5.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₂₄D₈Cl₂F₂N₂O₂.
5-(2-Chloroethylidene)-10,11-dihydro-5H-Dibenzo[a,d]cycloheptene, CAS: 40443-01-4, stock: 7.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₅Cl.
Hydroxy Flunarizine, CAS: 87166-81-2, stock: 3.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₆F₂N₂O.
Flumethrin, CAS: 69770-45-2, stock: 4.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₂₂Cl₂FNO₃.
(6α,11β)-6,9-Difluoro-11-hydroxypregna-1,4,16-triene-3,20-dione, CAS: 1027011-66-0, stock: 3.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₄F₂O₃.
(6α,11β,16α,17α)-17-(Acetyloxy)-6,9-difluoro-11-hydroxy-16-methyl-3-oxo-androsta-1,4-diene-17-carbothioic Acid, CAS: 80473-93-4, stock: 1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₈F₂O₅S.
(6α,11β,16α,17α)-17-(Acetyloxy)-6,9-difluoro-11-hydroxy-16-methyl-3-oxo-androsta-1,4-diene-17-carbothioic Acid S-(Iodomethyl) Ester, CAS: 80474-71-1, stock: 2.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₉F₂IO₅S.
(6α,11β,16α,17α)-6,9-Difluoro-11-hydroxy-16-methyl-3-oxo-17-(1-oxopropoxy)-androsta-1,4-diene-17-carbothioic Acid Anhydrosulfide with Propanethioic Acid-d6, CAS: /, stock: 4.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₈D₆F₂O₆S.
(6α,11β,16α,17α)-6,9-Difluoro-11-hydroxy-16-methyl-spiro[androsta-1,4-diene-17,5’-[1,3]oxathiolane]-2’,3,4’-trione, CAS: 219719-95-6, stock: 2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₄F₂O₅S.
(6α,9β,11β)-9,11-Epoxy-6-fluoropregna-1,4,16-triene-3,20-dione, CAS: 1027011-64-8, stock: 6.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₃FO₃.
(6α,11β,16α,17α)-6,9-Difluoro-11-hydroxy-16-methyl-17-(2-methyl-1-oxopropoxy)-3-oxo-androsta-1,4-diene-17-carbothioic Acid, CAS: 884332-14-3, stock: 8.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₂F₂O₅S.
(9β,11β)-9,11-Epoxy-pregna-1,4,16-triene-3,20-dione, CAS: 153469-93-3, stock: 1.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₄O₃.
1,2-Dihydro Fluticasone Propionate, CAS: 105613-90-9, stock: 9.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₃F₃O₅S.
1,2-Dihydro Fluticasone Propionate-d3, CAS: /, stock: 3.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₀D₃F₃O₅S.
11-Oxo Fluticasone Propionate, CAS: 1219174-94-3, stock: 5.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₉F₃O₅S.
11-Oxo Fluticasone Propionate-d3, CAS: /, stock: 2.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₆D₃F₃O₅S.
17-Dehydroxo(propionaldehyde-d5)-20-desmethoxy-S-fluoromethyl Flumethasone, CAS: /, stock: 5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₆D₅ClF₂O₅S.
17-Dehydroxopropionaldehyde-20-desmethoxy-S-fluoromethyl Flumethasone, CAS: /, stock: 6.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₁ClF₂O₅S.
17-Keto Flumethasone, CAS: 25256-97-7, stock: 8.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₄F₂O₃.
17-Keto Flumethasone-d3, CAS: /, stock: 1.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₁D₃F₂O₃.
21-Dehydro Flumethasone, CAS: 65751-65-7, stock: 5.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₆F₂O₅.
6-Defluoro-6-oxo-Fluticasone Acetate, CAS: /, stock: 2.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₈F₂O₆S.
6-Defluoro-6-oxo-fluticasone Propionate, CAS: /, stock: 3.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₀F₂O₆S.
6-Defluro-6-oxo-fluticasone Propionate-d3, CAS: /, stock: 9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₇D₃F₂O₆S.
6β-Fluoro-Flumethasone, CAS: 60895-22-9, stock: 8.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₈F₂O₅.
6β-Fluticasone Propionate, CAS: /, stock: 6.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₁F₃O₅S.
Desfluoromethyl Fluticasone Propionate Disulfide, CAS: 201812-64-8, stock: 8.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₈H₅₈F₄O₁₀S₂.
Flumethasone, CAS: 2135-17-3, stock: 1.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₈F₂O₅.
Flumethasone 21-Glucuronide, CAS: /, stock: 9.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₆F₂O₁₁.
Flumethasone 21-Pivalate, CAS: 2002-29-1, stock: 10g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₆F₂O₆.
Flumethasone 21-Pivalate-d3, CAS: /, stock: 2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₃D₃F₂O₆.
Flumethasone Acetate, CAS: 2823-42-9, stock: 1.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₀F₂O₆.
Flumethasone-∆17,20 21-Aldehyde, CAS: 28400-50-2, stock: 7.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₆F₂O₄.
Flumethasone-d3, CAS: /, stock: 9.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₅D₃F₂O₅.
Flumethasone-d3 Acetate, CAS: /, stock: 5.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₇D₃F₂O₆.
Fluticasone 21-Isobutyrate, CAS: 1648562-63-3, stock: 4.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₃F₃O₅S.
Fluticasone 21-Isobutyrate-d6, CAS: /, stock: 2.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₇D₆F₃O₅S.
Fluticasone Acetate, CAS: 80474-24-4, stock: 6.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₉F₃O₅S.
Fluticasone Propionate, CAS: 80474-14-2, stock: 5.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₁F₃O₅S.
Fluticasone Propionate-13C3, CAS: /, stock: 9.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂¹³C₃H₃₁F₃O₅S.
Fluticasone Propionate-d3, CAS: /, stock: 2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₈D₃F₃O₅S.
Fluticasone Propionate-d5, CAS: 1093258-28-6, stock: 5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₆D₅F₃O₅S.
Halometasone, CAS: 50629-82-8, stock: 7.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₇ClF₂O₅.
S-Chlorofluticasone Acetate, CAS: 80474-07-3, stock: 8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₉ClF₂O₅S.
(R)-Flumequine, CAS: 215178-95-3, stock: 5.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₂FNO₃.
(S)-Flumequine, CAS: 202349-45-9, stock: 5.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₂FNO₃.
Diethyl Ethoxymethylidenemalonate, CAS: 87-13-8, stock: 5.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₆O₅.
Flumequine, CAS: 42835-25-6, stock: 1.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₂FNO₃.
Flumequine-13C3, CAS: 1185049-09-5, stock: 4.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁¹³C₃H₁₂FNO₃.
1-Bis(4-fluorophenyl)methyl Piperazine, CAS: 27469-60-9, stock: 7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₈F₂N₂.
7-Fluoro-3,4-dihydro-4-methyl-1H-1,4-benzodiazepine-2,5-dione, CAS: 78755-80-3, stock: 6.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₉FN₂O₂.
Defluoro 8-Hydroxy Flumazenil (Impurity), CAS: 131666-45-0, stock: 4.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₅N₃O₄.
Defluoro 8-Hydroxy Flumazenil-D3 (Impurity), CAS: /, stock: 8.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₂D₃N₃O₄.
Defluoro Flumazenil Isothiocyanate, CAS: 954107-48-3, stock: 3.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₄N₄O₃S.
Flumazenil, CAS: 78755-81-4, stock: 4.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₄FN₃O₃.
Flumazenil Carbonyl Chloride, CAS: 1420354-30-8, stock: 5.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₉ClFN₃O₂.
Flumazenil Carboxylic Acid, CAS: 84378-44-9, stock: 6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₀FN₃O₃.
Flumazenil Carboxylic Acid-D3, CAS: /, stock: 1.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₇D₃FN₃O₃.
Flumazenil-D5, CAS: 78755-81-4, stock: 3.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₉D₅FN₃O₃.
Fluindione, CAS: 957-56-2, stock: 9.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₉FO₂.
Fluindione-d4, CAS: 1246820-41-6, stock: 4.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₅D₄FO₂.
4-Phenylsulfonylaniline, CAS: 04/01/7019, stock: 7.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₁NO₂S.
Allyl Flufenamic Acid Glucuronide, CAS: /, stock: 7.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₂F₃NO₈.
Flufenamic Acid Glucuronide, CAS: 87816-74-8, stock: 7.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₈F₃NO₈.
Tolfenamic Acid-13C6, CAS: 1420043-61-3, stock: 2.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈¹³C₆H₁₂ClNO₂.
Ufenamate, CAS: 67330-25-0, stock: 4.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₈F₃NO₂.
9-(3,5-Di-O-phosphono-β-D-arabinofuranosyl)-2-fluoro-9H-purin-6-amine, CAS: 548774-53-4, stock: 7.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄FN₅O₁₀P₂.
Fludarabine, CAS: 21679-14-1, stock: 8.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₂FN₅O₄.
Fludarabine-13C2,15N, CAS: /, stock: 1.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈¹³C₂H₁₂FN₄¹⁵NO₄.
(E)-1,1’-[2-(2,4-Difluorophenyl)-1-propene-1,3-diyl]bis-1H-1,2,4-triazole, CAS: 163921-61-7, stock: 8.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₀F₂N₆.
(Z)-1,1’-(2-(2,4-Difluorophenyl)prop-1-ene-1,3-diyl)bis(1H-1,2,4-triazole), CAS: 163921-62-8, stock: 9.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₀F₂N₆.
1,1’-(1,3-Phenylene)bis-1H-1,2,4-triazole, CAS: 514222-44-7, stock: 9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₈N₆.
1,1’-(1,3-Phenylene)bis-1H-1,2,4-triazole-15N4, CAS: 1329836-75-0, stock: 9.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₈N₂¹⁵N₄.
1,3-Bis(1H-1,2,4-triazol-1-yl)-2-propanone, CAS: 98414-56-3, stock: 8.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₈N₆O.
1-(2,4-Difluorophenyl)-2-(4H-1,2,4-triazol-4-yl)ethanone, CAS: 168479-96-7, stock: 1.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₇F₂N₃O.
1-(2-Cyanoethyl)-4-(2-(2,4-difluorophenyl)-2-oxoethyl)-4H-1,2,4-triazol-1-ium Bromide, CAS: /, stock: 3.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₁BrF₂N₄O.
1-(Chloroacetyl)azepane, CAS: 52227-33-5, stock: 6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₄NOCl.
1-[2-(2,4-Difluorophenyl)-2,3-epoxypropyl]-1H-1,2,4-triazole, CAS: 86386-76-7, stock: 6.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₉F₂N₃O.
1-[2-(2,4-Difluorophenyl)-2,3-epoxypropyl]-1H-1,2,4-triazole-d4, CAS: /, stock: 5.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₅D₄F₂N₃O.
2,5-Dichlorothiophen-3-yl Tioconazole Hydrochloride, CAS: 61675-62-5, stock: 3.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₃Cl₅N₂OS.
2-(2,4-Difluorophenyl)-1,2,3-propanetriol, CAS: 173837-65-5, stock: 6.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₀F₂O₃.
2-(2,4-Difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-3-bromopropan-2-ol, CAS: 150194-52-8, stock: 4.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₀BrF₂N₃O.
2-(2,4-Difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)-1,2-propanediol, CAS: 118689-07-9, stock: 2.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₁F₂N₃O₂.
2-(2-Fluorophenyl)thiopene, CAS: 209592-45-0, stock: 6.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₇FS.
2-Deschlorothien-3-yl Tioconazole Hydrochloride, CAS: 61709-33-9, stock: 4.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₅Cl₃N₂OS.
2-Desfluoro Fluconazole, CAS: 81886-51-3, stock: 1.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₃FN₆O.
2H-1,4-Benzoxazin-3-one, CAS: 5466-88-6, stock: 7.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₇NO₂.
3,4-Dihydro-1,4-benzoxazine-3-one 6-oxoacetic Acid, CAS: 1094428-30-4, stock: 2.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₇NO₅.
3-(4H-1,2,4-Triazol-4-yl)propanenitrile, CAS: 173692-85-8, stock: 3.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₆N₄.
4-Amino Fluconazole Bromide, CAS: 150168-54-0, stock: 5.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₄BrF₂N₇O.
4-Defluoro-4-(1H-1,2,4-triazol-1-yl) Fluconazole, CAS: 871550-15-1, stock: 9.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₄FN₉O.
4-Defluoro-4-(1H-1,2,4-triazol-1-yl) Fluconazole-d4, CAS: 1794817-03-0, stock: 2.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀D₄FN₉O.
5-Bromo-2-chlorothien-3-yl Tioconazole Hydrochloride, CAS: /, stock: 3.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₃BrCl₄N₂OS.
Fluconazole, CAS: 86386-73-4, stock: 8.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₂F₂N₆O.
Fluconazole β-D-Glucuronide, CAS: 136134-23-1, stock: 5.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₀F₂N₆O₇.
Fluconazole N-Oxide, CAS: 1997296-62-4, stock: 4.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₂F₂N₆O₂.
Fluconazole-d4, CAS: 1124197-58-5, stock: 8.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₈D₄F₂N₆O.
Fludarabine Phosphate, CAS: 75607-67-9, stock: 8.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₃FN₅O₇P.
Iso Fluconazole, CAS: 89429-59-4, stock: 2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₂F₂N₆O.
α-[2,4-Bis(1H-1,2,4-triazol-1-yl)phenyl]-α-(1H-1,2,4-triazol-1-ylmethyl)-1H-1,2,4-triazole-1-ethanol, CAS: 871550-18-4, stock: 2.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₆N₁₂O.
Tioconazole, CAS: 65899-73-2, stock: 8.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₃Cl₃N₂OS.
2,6-Dichloro-4-(trifluoromethyl)pyridin-3-amine, CAS: 175277-67-5, stock: 6.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃Cl₂F₃N₂.
Deschloro Methoxy Fluazinam, CAS: 79614-91-8, stock: 3.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₇ClF₆N₄O₅.
Fluazinam, CAS: 79622-59-6, stock: 9.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₄Cl₂F₆N₄O₄.
1,2-Distearoyl-sn-glycero-3-phosphorylglycerol, CAS: 4537-78-4, stock: 5.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₂H₈₃O₁₀P.
3,5-Di-O-p-chlorobenzoyl Floxuridine, CAS: 1582-79-2, stock: 4.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₁₇Cl₂FN₂O₇.
3,5-Di-O-p-chlorobenzoyl Floxuridine-13C,15N2, CAS: /, stock: 1.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂¹³CH₁₇Cl₂F¹⁵N₂O₇.
3,5-Di-O-p-chlorobenzoyl α,β-Floxuridine, CAS: /, stock: 1.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₁₇Cl₂FN₂O₇.
3,5-Di-O-p-chlorobenzoyl α,β-Floxuridine-13C,15N2, CAS: /, stock: 6.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂¹³CH₁₇Cl₂F¹⁵N₂O₇.
3,5-Di-O-p-chlorobenzoyl α-Floxuridine, CAS: 110558-30-0, stock: 7.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₁₇Cl₂FN₂O₇.
3,5-Di-O-p-chlorobenzoyl α-Floxuridine-13C,15N2, CAS: /, stock: 1.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂¹³CH₁₇Cl₂F¹⁵N₂O₇.
(4R,5R)-4,5-Dihydro-5-[4-(methylsulfonyl)phenyl]-2-phenyl-4-oxazolemethanol, CAS: 96795-00-5, stock: 8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₇NO₄S.
Floxuridine, CAS: 50-91-9, stock: 7.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₁FN₂O₅.
Floxuridine-13C,15N2, CAS: /, stock: 4.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈¹³CH₁₁F¹⁵N₂O₅.
(4R,5R)-4,5-Dihydro-5-[4-(methylsulfonyl)phenyl]-2-phenyl-4-oxazolemethanol-d3, CAS: 1246814-83-4, stock: 8.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₄D₃NO₄.
N-[N-[(1,1-Dimethylethoxy)carbonyl]-L-leucyl]-glycine, CAS: 32991-17-6, stock: 7.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₂₄N₂O₅.
(4R-5R)-4,5-Dihydro-5-[4-(methylsulfonyl)phenyl]-2-phenyl-4-oxazolecarboxylic Acid Ethyl Ester, CAS: 139059-00-0, stock: 6.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₉NO₅S.
(4S,5R)-4-(Fluoromethyl)-4,5-dihydro-5-[4-(methylsulfonyl)phenyl]-2-phenyloxazole, CAS: 126428-97-5, stock: 8.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₆FNO₃S.
(4S,5R)-4-(Fluoromethyl)-4,5-dihydro-5-[4-(methylsulfonyl)phenyl]-2-phenyloxazole-d3, CAS: 1246818-78-9, stock: 7.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₃D₃FNO₃S.
Deschloro Florfenicol, CAS: 138872-73-8, stock: 4.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₅ClFNO₄S.
Dideschloro Florfenicol, CAS: 138872-76-1, stock: 9.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₆FNO₄S.
Dideschloro Florfenicol-d3, CAS: /, stock: 6.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₃D₃FNO₄S.
ent-Deschloro Florfenicol, CAS: /, stock: 4.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₅ClFNO₄S.
ent-Florfenicol Amine Hydrochloride, CAS: 1391054-08-2, stock: 4.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₅ClFNO₃S.
ent-Florfenicol Amine-d3, CAS: 1217625-88-1, stock: 9.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₁D₃FNO₃S.
ent-Florfenicol-d3, CAS: 1217619-10-7, stock: 2.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₁D₃Cl₂FNO₄S.
Florfenicol, CAS: 73231-34-2, stock: 4.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₄Cl₂FNO₄S.
Florfenicol Amine Hydrochloride, CAS: 108656-33-3, stock: 4.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₅ClFNO₃S.
Florfenicol Chloro Analogue, CAS: 1322625-10-4, stock: 2.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₄Cl₃NO₄S.
Florfenicol Dimer Impurity, CAS: /, stock: 8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₇Cl₂FN₂O₇S₂.
Florfenicol-d3, CAS: /, stock: 8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₁D₃Cl₂FNO₄S.
Florfenicol-d3 Amine, CAS: /, stock: 9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₁D₃FNO₃S.
N-Benzoyl Florfenicol Amine, CAS: 1322626-20-9, stock: 3.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₈FNO₄S.
N-Methyl Florfenicol, CAS: 1322625-61-5, stock: 3.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₆Cl₂FNO₄S.
N-Trichloroacetyl Florfenicol Amine, CAS: 1322623-68-6, stock: 4.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₃Cl₃FNO₄S.
Tilmicosin Phosphate Salt (~80%), CAS: 137330-13-3, stock: 4.6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₆H₈₃N₂O₁₇P.
1,3-Bis(2-(4-(3-(trifluoromethyl)phenyl)piperazin-1-yl)ethyl)-1H-benzo[d]imidazol-2(3H)-one, CAS: /, stock: 2.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₃₆F₆N₆O.
Flibanserin Hydrochloride, CAS: 147359-76-0, stock: 5.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₂ClF₃N₄O.
Flibanserin Hydrochloride, CAS: 147359-76-0, stock: 9.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₁F₃N₄O • HCl.
Flibanserin N-Oxide, CAS: /, stock: 3.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₁F₃N₄O₂.
Flibanserin-d4, CAS: /, stock: 7.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₇D₄F₃N₄O.
1,2-Dihydro-1-[2-[(tetrahydro-2H-pyran-2-yl)oxy]ethyl]-5H-tetrazole-5-thione, CAS: 88570-74-5, stock: 6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₄N₄O₂S.
1,2-Dihydro-1-[2-[(tetrahydro-2H-pyran-2-yl)oxy]ethyl]-5H-tetrazole-5-thione-d4, CAS: /, stock: 9.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₀D₄N₄O₂S.
2-(5-Mercaptotetrazole-1-yl)ethanol, CAS: 56610-81-2, stock: 7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃H₆N₄OS.
2-(5-Mercaptotetrazole-1-yl)ethanol-d4, CAS: /, stock: 9.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃H₂D₄N₄OS.
Flomoxef, CAS: 99665-00-6, stock: 7.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₈F₂N₆O₇S₂.
Flomoxef Benzhydryl Ester, CAS: 949587-46-6, stock: 1.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₂₈F2N₆O₇S₂.
Flomoxef Benzhydryl Ester-d4, CAS: /, stock: 7.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₂₄D₄F₂N₆O₇S₂.
Flomoxef Sodium, CAS: 92823-03-5, stock: 8.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₇F₂N₆NaO₇S₂.
Flomoxef-d4 (90%), CAS: /, stock: 8.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₄D₄F₂N₆O₇S₂.
3-[2,5-bis(2,2,2-trifluoroethoxy)phenyl] -1,5,6,7,8,8a-hexahydroimidazo-[1,5a]pyridine Hydrochloride, CAS: /, stock: 8.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₈F₆N₂O₂.
(-)-8-Prenylnaringenin, CAS: 53846-50-7, stock: 7.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₀O₅.
(-)-Farrerol, CAS: 24211-30-1, stock: 5.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₆O₅.
(-)-Isoxanthohumol, CAS: 70872-29-6, stock: 8.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₂O₅.
(R)-2,3-Dihydro-2-phenyl-4H-1-benzopyran-4-one, CAS: 27439-12-9, stock: 3.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₂O₂.
(R)-Hesperetin, CAS: 24604-97-5, stock: 8.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₄O₆.
(R,E)-7-(Benzyloxy)-2-(3-(benzyloxy)-4-methoxyphenyl)-4-(((S)-1-phenylethyl)imino)chroman-5-ol, CAS: /, stock: 9.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₈H₃₅NO₅.
(R,E)-7-(Benzyloxy)-2-(3-hydroxy-4-methoxyphenyl)-4-(((S)-1-phenylethyl)imino)chroman-5-ol, CAS: /, stock: 1.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₂₉NO₅.
(S)-Isosakuranetin, CAS: 480-43-3, stock: 7.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₄O₅.
(S)-Naringenin, CAS: 480-41-1, stock: 4.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₂O₅.
(S)-Pinocembrin, CAS: 480-39-7, stock: 8.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₂O₄.
(S,E)-7-(Benzyloxy)-2-(3-(benzyloxy)-4-methoxyphenyl)-4-(((S)-1-phenylethyl)imino)chroman-5-ol, CAS: /, stock: 8.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₈H₃₅NO₅.
(S,E)-7-(Benzyloxy)-2-(3-hydroxy-4-methoxyphenyl)-4-(((S)-1-phenylethyl)imino)chroman-5-ol, CAS: /, stock: 5.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₂₉NO₅.
2’-Hydroxyflavanone, CAS: 17348-76-4, stock: 1.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₂O₃.
3,3’,4’,7-Tetrahydroxyflavanone, CAS: 20725-03-5, stock: 9.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₂O₆.
3’,4’,5’,5,7-Pentamethoxyflavanone, CAS: 479672-30-5, stock: 6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₂0₇.
3’-Hydroxyflavanone, CAS: 92496-65-6, stock: 5.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₂O₃.
3’-Hydroxyflavanone, CAS: 1621-55-2, stock: 9.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₂O₃.
4’-Hydroxyflavanone, CAS: 6515-37-3, stock: 8.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₂O₃.
4’-Methoxyflavanone, CAS: 3034-08-0, stock: 9.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₄O₃.
6-Hydroxyflavanone, CAS: 4250-77-5, stock: 7.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₂O₃.
6-Methoxyflavanone, CAS: 06/04/3034, stock: 9.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₄O₃.
7-Hydroxyflavanone, CAS: 6515-36-2, stock: 6.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₂O₃.
alpha-Naphthoflavanone, CAS: 6051-86-1, stock: 3.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₄O₂.
Alpinetin, CAS: 36052-37-6, stock: 10g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₄O₄.
Ampeloptin, CAS: 27200-12-0, stock: 3.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₂O₈.
Bavachin, CAS: 19879-32-4, stock: 1.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₀O₄.
Bavachinin, CAS: 19879-30-2, stock: 4.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₂O₄.
beta-Naphthoflavanone, CAS: 09/03/2860, stock: 1.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₄O₂.
Dihydro Daidzein, CAS: 17238-05-0, stock: 8.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₂O₄.
Dihydro Daidzein-d6, CAS: /, stock: 7.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₆D₆O₄.
Dihydrodatiscetin, CAS: 31477-95-9, stock: 3.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₂O₆.
Dihydrogenistein, CAS: 21554-71-2, stock: 9.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₂O₅.
Eriocitrin, CAS: 13463-28-0, stock: 9.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₂O₁₅.
Eriodictyol, CAS: 4049-38-1, stock: 6.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₂O₆.
Farrerol, CAS: 95403-16-0, stock: 8.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₆O₅.
Flavanone, CAS: 487-26-3, stock: 5.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₂O₂.
Flavanone Azine, CAS: 1692-45-1, stock: 1.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₂₄N₂O₂.
Flavanone Hydrazone, CAS: 1692-46-2, stock: 8.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₄N₂O.
Flavanone-d5, CAS: 146196-91-0, stock: 6.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₇D₅O₂.
Hesperidine, CAS: 520-26-3, stock: 3.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₄O₁₅.
Liquiritigenin, CAS: 578-86-9, stock: 9.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₂O₄.
Liquiritin, CAS: 551-15-5, stock: 7.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₂O₉.
m-Xylene-2,4,6-triol, CAS: 09/02/4463, stock: 2.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₀O₃.
Naringenin 5-β-D-Glucoside, CAS: 23711-00-4, stock: 6.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₂O₁₀.
Neohesperidin, CAS: 13241-33-3, stock: 3.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₄O₁₅.
Neohesperidin Dihydrochalcone, CAS: 20702-77-6, stock: 3.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₆O₁₅.
Neohesperidin Dihydrochalcone-d3, CAS: /, stock: 7.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₃D₃O₁₅.
Neoponcirin, CAS: 14259-47-3, stock: 4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₄O₁₄.
ORM-10962, CAS: 763926-98-3, stock: 2.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₉N₃O₄.
Poncirin, CAS: 14941-08-3, stock: 1.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₄O₁₄.
Prunin, CAS: 529-55-5, stock: 3.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₂O₁₀.
rac Hesperidine-d3, CAS: /, stock: 8.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C28H31D3O15.
rac-Hesperetin, CAS: 69097-99-0, stock: 5.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₄O₆.
rac-Hesperetin 3’,7-Diacetate, CAS: 3316-45-8, stock: 6.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₈O₈.
rac-Hesperetin 3’-O-β-D-Glucuronide 7-O-Sulfate Disodium Salt, CAS: /, stock: 1.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₀Na₂O₁₅S.
rac-Hesperetin 7-O-Sulfate Sodium SaltDISCONTINUED. Please see H289546, CAS: /, stock: 7.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₃NaO₉S.
rac-Hesperetin 7-O-Sulfate Sodium SaltDISCONTINUED. Please see H289546, CAS: /, stock: 8.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₃NaO₉S.
rac-Hesperetin 7-O-Sulfate Sodium Salt-d3, CAS: /, stock: 8.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₀D₃NaO₉S.
rac-Pinobanksin, CAS: /, stock: 7.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₂O₅.
rac-Pinocembrin, CAS: 68745-38-0, stock: 8.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₂O₄.
rac-Vestitone, CAS: 57462-46-1, stock: 5.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₄O₅.
rac-Vestitone-D3, CAS: /, stock: 3.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₁D₃O₅.
Sophoraflavanone G, CAS: 97938-30-2, stock: 1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₈O₆.
3-Hydroxy-5,5-dimethyl-4-[4-(methylsulfonyl)phenyl]-2(5H)-furanone, CAS: 189955-89-3, stock: 6.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₄O₅S.
Firocoxib, CAS: 189954-96-9, stock: 7.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₀O₅S.
Firocoxib-d4, CAS: 1325700-11-5, stock: 7.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₆D₄O₅S.
(4-((4aR)-7-(Benzyloxy)-3,4,4a,5-tetrahydro-2H-chromen-3-yl)phenoxy)(tert-butyl)dimethylsilane, CAS: /, stock: 5.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₄O₃Si.
(R,S)-Equol, CAS: 94105-90-5, stock: 8.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₄O₃.
(R,S)-Equol 4’-Sulfate Sodium Salt (90%), CAS: 1189685-28-6, stock: 4.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₃NaO₆S.
(R,S)-Equol 7-β-D-Glucuronide Sodium Salt, CAS: /, stock: 6.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₁NaO₉.
(R,S)-Equol Hexanoate 3,4-O-Triacetyl-4’-O-β-D-glucuronide Methyl Ester, CAS: /, stock: 5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₄H₄₀O₁₃.
(R,S)-Equol-d4 (Major)(Mixture of Diastereomers), CAS: 1216469-13-4, stock: 2.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀D₄O₃.
(S)-Equol, CAS: 531-95-3, stock: 5.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₄O₃.
(S)-Equol 4’-Sulfate Sodium Salt, CAS: /, stock: 8.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₃NaO₆S.
(S)-Equol 4’-Sulfate-d3 Sodium Salt, CAS: /, stock: 5.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀D₃NaO₆S.
(S)-Equol 7-β-D-Glucuronide Sodium Salt, CAS: /, stock: 7.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₁NaO₉.
(S)-Equol 7-β-D-Glucuronide-d3 Sodium Salt, CAS: /, stock: 8.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₈D₃NaO₉.
1-[4-(Dimethylamino)phenyl]-3-(2-hydroxy-3,4-dimethoxyphenyl)-1,3-propanedione, CAS: 1205548-02-2, stock: 9.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₁NO₅.
2,3-Dihydro-5-hydroxy-2-(4-hydroxyphenyl)-7-(phenylmethoxy)-4H-1-benzopyran-4-one, CAS: 874202-29-6, stock: 4.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₈O₅.
2,3-Dimethylphenol, CAS: 526-75-0, stock: 2.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₀O.
2,3-Dimethylphenol-13C4, CAS: /, stock: 9.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄¹³C₄H₁₀O.
2,3-Dimethylphenol-13C8, CAS: /, stock: 1.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: ¹³C₈H₁₀O.
2-(Chloromethyl)quinazoline, CAS: 6148-18-1, stock: 6.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₇ClN₂.
2-Methyl-4-nitroindole, CAS: 04/10/3484, stock: 6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₈N₂O₂.
2’,3,5,7-Tetrahydroxyflavone, CAS: 480-15-9, stock: 3.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₆.
2’,3’-Dimethoxy-3-hydroxyflavone, CAS: 80710-38-9, stock: 3.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₅.
2’,7-Dihydroxyflavone, CAS: 77298-66-9, stock: 4.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₄.
2’-Hydroxyflavone, CAS: 35244-11-2, stock: 7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₃.
2’-Hydroxyformononetin, CAS: 1890-99-9, stock: 8.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₂O₅.
2’-Methoxy-alpha-naphthoflavone, CAS: 14756-21-9, stock: 8.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₄O₃.
2’-Methoxyflavone, CAS: 19725-47-4, stock: 4.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₂O₃.
2’-Methoxyformononetin, CAS: 1891-01-6, stock: 4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₄O₅.
3,2’-Dihydroxyflavone, CAS: 6068-76-4, stock: 6.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₄.
3,2’-Dimethoxyflavone, CAS: 105827-35-8, stock: 3.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₄O₄.
3,4,5,7-Tetramethoxyflavone, CAS: 855-97-0, stock: 3.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₈O₆.
3,4’-Dihydroxyflavone, CAS: 14919-49-4, stock: 7.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₄.
3,5,7,8,3’,4’-Hexahydroxyflavone, CAS: 489-35-0, stock: 2.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₈.
3,6-Dimethoxyflavone, CAS: 206121-28-0, stock: 7.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₄O₄.
3,7,4’-Trihydroxyflavone, CAS: 2034-65-3, stock: 3.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₅.
3,7,8,4’-Tetrahydroxyflavone, CAS: 1429-28-3, stock: 1.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₆.
3,7-Dihydroxy-3’,4’,5’-trimethoxyflavone, CAS: 132594-09-3, stock: 7.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₆O₇.
3,7-Dihydroxy-3’,4’-dimethoxyflavone, CAS: 93322-61-3, stock: 9.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₄O₆.
3,7-Dimethoxyflavone, CAS: 20950-52-1, stock: 9.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₄O₄.
3-(4-((tert-Butyldimethylsilyl)oxy)phenyl)chroman-7-ol, CAS: /, stock: 5.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₈O₃Si.
3-(4-Bromophenyl)-4-oxo-4H-chromen-7-yl methanesulfonate, CAS: 610753-87-2, stock: 2.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₁BrO₅S.
3-(4-Hydroxyphenyl)chroman-7-yl Hexanoate, CAS: /, stock: 4.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₄O₄.
3-Hydroxy-2’-methoxyflavone, CAS: 29219-03-2, stock: 4.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₂O₄.
3-Hydroxy-7,2’,4’-trimethoxyflavone, CAS: 263365-51-1, stock: 7.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₆O₆.
3-Hydroxy-7,8,3’-trimethoxyflavone, CAS: 1017060-12-6, stock: 8.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₆O₆.
3-Hydroxyflavone, CAS: 577-85-5, stock: 3.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₃.
3-Methoxyphenylacetonitrile, CAS: 19924-43-7, stock: 2.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₉NO.
3-Methyl-3-butenal, CAS: 1118-59-8, stock: 2.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₈O.
3-Methyl-7-methoxy-8-(chloromethyl)flavone, CAS: 25782-05-2, stock: 1.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₅ClO₃.
3-Methylflavone-8-carboxylic Acid, CAS: 07/01/3468, stock: 4.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₂O₄.
3-Methylflavone-8-carboxylic Acid, CAS: 07/01/3468, stock: 5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₂O₄.
3-Methylflavone-8-carboxylic Acid Acyl-β-D-glucuronide, CAS: 60218-13-5, stock: 8.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₀O₁₀.
3-Methylflavone-8-carboxylic Acid-d5, CAS: 1189883-79-1, stock: 1.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₇D₅O₄.
3-O-Methylfisetin, CAS: 20870-06-8, stock: 7.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₂O₆.
3-O-Methylfisetin-d3, CAS: /, stock: 6.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₉D₃O₆.
3’,4’,5,7-Tetra-O-benzylquercetin, CAS: 116973-12-7, stock: 1.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₃H₃₄O₇.
3’,4’,5’,5,6,7-Hexamethoxyflavone, CAS: 29043-07-0, stock: 3.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₂O₈.
3’,4’,5’,6,7,8-Hexamethoxy-5-hydroxyflavone, CAS: 21187-73-5, stock: 4.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₂O₉.
3’,4’,7,8-Tetrahydroxyflavone, CAS: 3440-24-2, stock: 1.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₆.
3’,4’,7,8-Tetramethoxyflavone, CAS: 65548-55-2, stock: 1.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₈O₆.
3’,4’,7- Trihydroxy Flavone, CAS: 2150-11-0, stock: 3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₅.
3’,4’,7-Trihydroxyisoflavone, CAS: 485-63-2, stock: 7.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₅.
3’,4’,7-Tris(benzyloxy)-5-hydroxy-3-methoxy Flavone, CAS: 1486-57-3, stock: 9.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₃₀O₇.
3’,4’-Di-O-Methoxy 3,7-Bis(benzyloxy) Quercetin, CAS: 3306-17-0, stock: 5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₂₆O₇.
3’,4’-Di-O-Methoxy 3,7-Bis(benzyloxy) Quercetin-d6, CAS: /, stock: 5.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₂₀D₆O₇.
3’,4’-Dihydroxyflavone, CAS: 4143-64-0, stock: 10g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₄.
3’,4’-Dimethoxy-α-naphthoflavone, CAS: 14756-24-2, stock: 7.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₆O₄.
3’,4’-Dimethoxyflavone, CAS: 4143-62-8, stock: 8.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₄O₄.
3’,5,7-Tri-O-hexanoyldiosmetin, CAS: 1391052-63-3, stock: 6.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₄H₄₂O₉.
3’-Benzyloxy-4’,5,6,7-tetramethoxyflavone, CAS: 21764-08-9, stock: 2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₄O₇.
3’-Benzyloxy-5,7-dihydroxy-3,4’-dimethoxyflavone, CAS: 62507-01-1, stock: 5.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₀O₇.
3’-Hydroxypuerarin, CAS: 117060-54-5, stock: 3.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₀O₁₀.
3’-Methoxy-3,7,4’-trihydroxyflavone, CAS: 21511-25-1, stock: 9.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₂O₆.
3’-Methoxy-4’-nitroflavone, CAS: 145370-39-4, stock: 3.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₁NO₅.
3’-Methoxyflavonol, CAS: 76666-32-5, stock: 5.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₂O₄.
4-(7-(Benzoyloxy)-5-hydroxy-4-oxochroman-2-yl)phenyl Benzoate, CAS: /, stock: 2.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₂₀O₇.
4-(7-Hydroxychroman-3-yl)phenyl Hexanoate, CAS: /, stock: 9.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₄O₄.
4-Bromo-1-napthaldehyde, CAS: 50672-84-9, stock: 5.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₇BrO.
4-Bromo-3,5-dimethylphenol, CAS: 7463-51-6, stock: 9.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₉BrO.
4-O-Methylfisetin, CAS: 57396-72-2, stock: 1.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₂O₆.
4-O-Methylfisetin-d3, CAS: /, stock: 1.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₉D₃O₆.
4-Oxo-6-propyl-3-(pyridin-2-yl)-4H-chromen-7-yl Acetate, CAS: 299952-11-7, stock: 5.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₇NO₄.
4-[7-(Benzoyloxy)-3,4-dihydro-5-hydroxy-4-oxo-2H-1-benzopyran-2-yl]phenyl-β-D-glucopyranosiduronic Acid Methyl Ester 2,3,4-Triacetate, CAS: 1237479-00-3, stock: 8.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₅H₃₂O₁₅.
4’,5,7-Trihydroxy-flavone 4’,5-Diacetate, CAS: 34331-04-9, stock: 6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₄O₇.
4’,5,7-Trihydroxyisoflavone 4’,5’-Diacetate, CAS: 23050-36-4, stock: 3.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₄O₇.
4’,5,7-Trihydroxyisoflavone 4’,5’-Diacetate 7’-Sulfate Pyridinium Salt, CAS: /, stock: 9.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₁₉NO₁₀S.
4’,5,7-Trihydroxyisoflavone Triacetate, CAS: 5995-97-1, stock: 9.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₆O₈.
4’,5-Dihydroxyflavone, CAS: 6665-67-4, stock: 2.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₄.
4’,7-Bis(benzyloxy)-5-hydroxy-flavone, CAS: 32375-14-7, stock: 8.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₂₂O₅.
4’,7-Dihydroxy-3’-methoxyisoflavone, CAS: 21913-98-4, stock: 8.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₂O₅.
4’,7-Dimethoxyisoflavone, CAS: 1157-39-7, stock: 6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₄O₄.
4’,6,7-Trihydroxyisoflavone, CAS: 17817-31-1, stock: 5.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₅.
4’-Bromoflavone, CAS: 20525-20-6, stock: 5.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₉BrO₂.
4’-Dimethylamino 7,8-Dihydroxyflavone, CAS: 1205548-04-4, stock: 5.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₅NO₄.
4’-Hydroxyflavone, CAS: 4143-63-9, stock: 4.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₃.
4’-Methoxy-5,6-benzoflavone, CAS: 125240-02-0, stock: 1.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₄O₃.
4’-Methoxy-alpha-naphthoflavone, CAS: 14756-22-0, stock: 1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₄O₃.
4’-Methoxyflavone, CAS: 4143-74-2, stock: 2.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₂O₃.
5,2’-Dihydroxyflavone, CAS: 6674-39-1, stock: 2.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₄.
5,3’,4’-Trihydroxyflavone, CAS: 19852-25-6, stock: 8.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₅.
5,4’-Dimethoxyflavone, CAS: 6697-63-8, stock: 6.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₄O₄.
5,6-Dihydroxy-7-methoxyflavone, CAS: 29550-13-8, stock: 4.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₂O₅.
5,7,4’-Trimethoxyisoflavone, CAS: 52796-14-2, stock: 7.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₆O₅.
5,7-Bis-(benzyloxy)-2-(4-(benzyloxy)phenyl)-3-hydroxy-4H-chromen-4-one, CAS: 23405-70-1, stock: 6.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₆H₂₈O₆.
5,7-Bis-(benzyloxy)-2-(4-(benzyloxy)phenyl)-4H-chromen-4-one, CAS: 96333-59-4, stock: 8.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₆H₂₈O₅.
5,7-Dihydroxyisoflavone, CAS: 4044-00-2, stock: 8.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₄.
5,7-Dimethoxyisoflavone, CAS: 26964-35-2, stock: 2.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₄O₄.
5-Hydroxy-3’,3,4’,5’,7-pentamethoxyflavone, CAS: 5084-19-5, stock: 2.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₀O₈.
5-Hydroxy-7,2’,3’,4’,5’-pentamethoxyflavone, CAS: 132923-24-1, stock: 7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₀O₈.
5-Hydroxyflavone, CAS: 491-78-1, stock: 2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₃.
5-Methoxyflavone, CAS: 42079-78-7, stock: 2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₂O₃.
5-Methyl-7-hydroxyisoflavone, CAS: 55338-30-2, stock: 6.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₂O₃.
5-Methyl-7-methoxyisoflavone, CAS: 82517-12-2, stock: 7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₄O₃.
1-(2,6-Dichloro-4-trifluoromethylphenyl)-3-carboxamido-5-aminopyrazole, CAS: 270564-31-3, stock: 9.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₇Cl₂F₃N₄O.
5’-Hydroxyequol, CAS: 65998-44-9, stock: 3.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₄O₄.
6,2’,4’-Trimethoxyflavone, CAS: 720675-74-1, stock: 4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₆O₅.
5-Amino-1-[2-chloro-4-(trifluoromethyl)phenyl]-1H-pyrazole-3-carbonitrile, CAS: 120068-81-7, stock: 2.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₆ClF₃N₄.
5-Amino-3-cyano-4-iodo-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]pyrazole, CAS: 188539-59-5, stock: 6.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₄Cl₂F₃IN₄.
6,2’-Dihydroxyflavone, CAS: 92439-20-8, stock: 3.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₄.
Cyanoacetic Acid-13C 15N, CAS: /, stock: 2.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂¹³CH₃¹⁵NO₂.
Ethyl 2-Cyanoacetate-13C 15N, CAS: 130442-98-7, stock: 7.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄¹³CH₇¹⁵NO₂.
6,2’-Dimethoxyflavone, CAS: 156464-92-5, stock: 6.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₄O₄.
6,3’-Dihydroxyflavone, CAS: 71592-46-6, stock: 8.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₄.
Fipronil, CAS: 120068-37-3, stock: 6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₄Cl₂F₆N₄OS.
6,4’-Dimethoxyflavone, CAS: 54401-47-7, stock: 3.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₄O₄.
6,7-Dihydroxyflavone, CAS: 38183-04-9, stock: 8.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₄.
Fipronil Desulfinyl, CAS: 205650-65-3, stock: 2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₄Cl₂F₆N₄.
6,7-Dimethoxy-3’,4’,5-trihydroxyflavone, CAS: 34334-69-5, stock: 5.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₄O₇.
6-Bromo-3’-nitroflavone, CAS: 187932-50-9, stock: 5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₈BrNO₄.
Fipronil Detrifluoromethylsulfinyl, CAS: 120068-79-3, stock: 9.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₅Cl₂F₃N₄.
6-Bromoflavone, CAS: 1218-80-0, stock: 7.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₉BrO₂.
6-Chloroflavone, CAS: 10420-73-2, stock: 3.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₉O₂Cl.
Fipronil Detrifluoromethylsulfinyl-13C2 15N2, CAS: /, stock: 9.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉¹³C₂H₅Cl₂F₃N₂¹⁵N₂.
Fipronil Sulfide, CAS: 120067-83-6, stock: 6.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₄Cl₂F₆N₄S.
6-Fluoroflavone, CAS: 1218-82-2, stock: 3.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₉O₂F.
Fipronil Sulfone, CAS: 120068-36-2, stock: 1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₄Cl₂F₆N₄O₂S.
Fipronil Sulfone-13C2,15N2, CAS: /, stock: 6.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀¹³C₂H₄Cl₂F₆N₂¹⁵N₂O₂S.
6-Hydroxyflavone, CAS: 6665-83-4, stock: 2.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₃.
6-Hydroxyflavone-beta-D-glucoside, CAS: 20594-05-2, stock: 9.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₀O₈.
Fipronil- 13C2 15N2, CAS: /, stock: 6.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀¹³C₂H₄Cl₂F₆N₂¹⁵N₂OS.
Flupiprole, CAS: 704886-18-0, stock: 6.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₀Cl₂F₆N₄OS.
6-Methoxyflavone, CAS: 26964-24-9, stock: 4.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₂O₃.
6-Methylflavone, CAS: 29976-75-8, stock: 7.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₂O₂.
7,2’-Dimethoxyflavone, CAS: 62536-78-1, stock: 5.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₄O₄.
7,3-Dihydroxyflavone, CAS: 492-00-2, stock: 1.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₄.
7,3’,4’-Trimethoxyisoflavone, CAS: 1621-61-0, stock: 8.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₆O₅.
7,3’-Dimethoxyflavone, CAS: 6802-49-9, stock: 5.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₄O₄.
7,4’-Dimethoxyflavone, CAS: 20979-50-4, stock: 4.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₄O₄.
7,8,3’-Trihydroxyflavone, CAS: 137502-84-2, stock: 5.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₅.
7,8,4’-Trihydroxyflavone, CAS: 147711-26-0, stock: 6.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₅.
7,8-Dihydroxyflavone, CAS: 38183-03-8, stock: 5.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₄.
7,8-Dimethoxyflavone, CAS: 65548-54-1, stock: 4.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₄O₄.
7-(Benzoyloxy)-2,3-dihydro-5-hydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one, CAS: 1237478-96-4, stock: 5.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₆O₆.
7-(Benzyloxy)-4’,5-dihydroxy-flavone, CAS: 20450-81-1, stock: 1.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₆O₅.
7-Hydroxy-3-phenyl-4H-chromen-4-one, CAS: 13057-72-2, stock: 5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₃.
7-Hydroxyflavone, CAS: 6665-86-7, stock: 3.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₃.
7-Hydroxyflavone-beta-D-glucoside, CAS: 71802-05-6, stock: 1.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₀O₈.
7-Methoxy-3-methyl-flavone, CAS: 18651-16-6, stock: 9.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₄O₃.
7-Methoxyisoflavone, CAS: 1621-56-3, stock: 9.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₂O₃.
7-O-Benzyl Luteolin, CAS: 1201808-24-3, stock: 3.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₆O₆.
8-Hydroxy-7-methoxyflavone, CAS: 40316-76-5, stock: 5.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₂O₄.
8-Prenylchrysin, CAS: 34125-75-2, stock: 6.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₈O₄.
8-Prenylquercetin, CAS: 143724-75-8, stock: 3.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₈O₇.
Acacetin, CAS: 480-44-4, stock: 9.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₂O₅.
Amentoflavone, CAS: 1617-53-4, stock: 8.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₁₈O₁₀.
Aminogenistein, CAS: 132018-32-7, stock: 1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₁NO₃.
Apigenin, CAS: 520-36-5, stock: 4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₅.
Apigenin 4’-O-β-D-Glucuronide, CAS: 51771-57-4, stock: 7.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₈O₁₁.
Apigenin 4’-O-β-D-Glucuronide Sodium Salt (~90%), CAS: /, stock: 6.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₇NaO₁₁.
Apigenin 5-O-β-D-Glucopyranoside, CAS: 28757-27-9, stock: 7.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₀O₁₀.
Apigenin 7-Glucoside, CAS: 578-74-5, stock: 4.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₀O₁₀.
Apigenin 7-Sulfate-O-N,N,N-tributyl-1-butanaminium, CAS: /, stock: 3.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₉O₈S⁻ • C₁₆H₃₆N⁺.
Apigenin Triacetate, CAS: 3316-46-9, stock: 1.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₆O₈.
Apigenin Triacetyl-4’-O-β-D-Glucuronide Methyl Ester, CAS: /, stock: 6.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₂₆O₁₄.
Apigenin-4’-O-sulfate Potassium Salt, CAS: 120537-28-2, stock: 6.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₉KO₈S.
Apigenin-7-O-sulfate Potassium Salt, CAS: 120562-19-8, stock: 3.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₉KO₈S.
Apigenin-d5 (Major), CAS: 263711-74-6, stock: 1.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₅D₅O₅.
Apigenin-O-Benzyl Triacetyl-4’-O-β-D-Glucuronide Methyl Ester, CAS: /, stock: 3.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₅H₃₂O₁₄.
B-[3-[[2-Hydroxy-3-[3-(triethoxysilyl)propoxy]propyl]amino]phenyl]boronic acid, CAS: 1817624-37-5, stock: 5.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₄BNO₇Si.
Baicalein, CAS: 491-67-8, stock: 1.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₅.
Baicalein Monohydrate, CAS: 352000-07-8, stock: 3.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₂O₆.
Barbigerone, CAS: 75425-27-3, stock: 8.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₂O₆.
Barbigerone-d3, CAS: /, stock: 3.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₁₉D₃O₆.
(S) FTY720 Phosphate, CAS: 402616-26-6, stock: 2.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₄NO₅P.
beta-Naphthoflavone, CAS: 6051-87-2, stock: 6.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₂O₂.
Biochanin A, CAS: 491-80-5, stock: 1.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₂O₅.
1-(1-iodoethyl)-4-octylbenzene, CAS: /, stock: 9.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₅I.
1-(2-Iodoethyl)-2-octylbenzene, CAS: 162358-96-5, stock: 2.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₅I.
Biochanin A-7-O-β-D-glucuronide, CAS: 38482-76-7, stock: 2.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₀O₁₁.
Calycosin, CAS: 20575-57-9, stock: 6.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₂O₅.
1-Ethyl 3-methyl 2-acetamido-2-(4-octylphenethyl)malonate, CAS: /, stock: 6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₇NO₅.
1-Ethyl 3-methyl 2-acetamido-2-(4-octylphenethyl)malonate-d3, CAS: /, stock: 9.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₄D₃NO₅.
Calycosin 7-O-β-D-glucoside, CAS: 20633-67-4, stock: 9.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₂O₁₀.
Cannflavin A, CAS: 76735-57-4, stock: 4.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₈O₆.
1-Hydroxy Fingolimod, CAS: 162361-49-1, stock: 1.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₃NO₃.
1-Hydroxy-3-nitrodeamino Fingolimod, CAS: 899822-99-2, stock: 3.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₁NO₅.
Cannflavin A-d3, CAS: /, stock: 4.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₅D₃O₆.
Cannflavin B, CAS: 76735-58-5, stock: 3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₀O₆.
2,2’-((4-Octyl-1,3-phenylene)bis(ethane-2,1-diyl))bis(2-aminopropane-1,3-diol) Dihydrochloride, CAS: /, stock: 6.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₄₆Cl₂N₂O₄.
Chrysin, CAS: 480-40-0, stock: 4.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₄.
2-((tert-Butoxycarbonyl)amino)-2-(hydroxymethyl)-4-(4-octylphenyl)butyl Acetate, CAS: /, stock: 3.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₄₃NO₅.
2-(4-Methoxyphenyl)oxazolidine-fingolimod, CAS: /, stock: 2.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₉NO₃.
2-(4-Octylphenethyl)-fingolimod, CAS: 851039-25-3, stock: 4.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₅H₅₇NO₂.
2-Amino-2-[2-(4-decylphenyl)ethyl]-1,3-propanediol, CAS: 780729-32-0, stock: 7.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₇NO₂.
(17β)-N-[2,5-Bis(trifluoromethyl)phenyl]-3-oxo-4-azaandrost-5-ene-17-carboxamide, CAS: 164656-21-7, stock: 2.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₀F₆N₂O₂.
Daidzein, CAS: 486-66-8, stock: 7.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₄.
Daidzein Diacetate, CAS: 07/01/3682, stock: 3.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₄O₆.
2-Amino-2-[2-(4-heptylphenyl)ethyl]propane-1,3-diol, CAS: 745767-97-9, stock: 3.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₁NO₂.
(17β)-N-[2,5-Bis(trifluoromethyl)phenyl]-3-oxo-androst-4-ene-17-carboxamide, CAS: 164656-19-3, stock: 9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₁F₆NO₂.
Daidzein-3’,5’,8-d3, CAS: 220930-96-1, stock: 2.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₇D₃O₄.
Daidzein-d6, CAS: 291759-05-2, stock: 8.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₄D₆O₄.
2-Amino-2-[2-(4-hexylphenyl)ethyl]-1,3-propanediol, CAS: 1201794-93-5, stock: 6.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₉NO₂.
2-Amino-2-[2-(4-nonylphenyl)ethyl]-1,3-propanediol, CAS: 746594-44-5, stock: 4.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₅NO₂.
(3S,3aS,5aS,6R,9aS,9bS)-3-[[[2,5-Bis(trifluoromethyl)phenyl]amino]carbonyl]dodecahydro-3a,6-dimethyl-7-oxo-1H-benz[e]indene-6-propanoic Acid, CAS: 164656-20-6, stock: 7.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₁F₆NO₄.
(3S-3aS,6R)-3-Carboxydodecahydro-3a,6-dimethyl-1-Benz[e]indene-6-propionic Acid, CAS: /, stock: 9.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₀O₄.
Daidzin, CAS: 552-66-9, stock: 4.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₀O₉.
Daidzin 6’’-O-Acetate, CAS: 71385-83-6, stock: 3.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₂O₁₀.
2-Amino-2-[2-(4-pentylphenyl)ethyl]-1,3-propanediol Hydrochloride, CAS: 1201794-92-4, stock: 2.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₇NO₂.
2-Dimethylamino Fingolimod, CAS: 1404433-87-9, stock: 2.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₇NO₂.
(4aR,6aS,7R,9aS,9bS,11aR)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic Acid, CAS: 2124269-84-5, stock: 7.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₇NO₃.
(4aR,6aS,7R,9aS,9bS,11aR)-Methyl 4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylate, CAS: 2124269-75-4, stock: 1.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₉NO₃.
Daidzin 6’’-O-Malonate, CAS: 124590-31-4, stock: 5.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₂O₁₂.
Desmethyl Icaritin, CAS: 28610-31-3, stock: 6.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₈O₆.
2-Nitrodeamino Fingolimod, CAS: 374077-88-0, stock: 7.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₁NO₄.
2-[4-(1-Hydroxyoctyl)phenyl]ethyl Acetate, CAS: /, stock: 2.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₈O₃.
(E)-4-((3-Nitrophenyl)diazenyl)-2,5-bis(trifluoromethyl)phenol, CAS: /, stock: 8.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₇F₆N₃O₃.
Dimefline Hydrochloride, CAS: 07/04/2740, stock: 2.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₂ClNO₃.
2-[4-(Oct-1-en-yl)phenyl]ethyl Acetate, CAS: /, stock: 6.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₆O₂.
3-(4-Octylphenethyl)-fingolimod, CAS: 851039-24-2, stock: 5.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₄H₅₆ClNO₂.
17α-Dutasteride, CAS: 1796930-46-5, stock: 1.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₀F₆N₂O₂.
2-Iodo-3-Oxo-4-aza-5α-androst-17β-carboxylic Acid, CAS: 140700-63-6, stock: 9.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₈INO₃.
Dimefline-d6 Hydrochloride, CAS: /, stock: 9.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₆D₆ClNO₃.
3-Amino-1-(4-octylphenyl)butane-1,4-diol, CAS: /, stock: 4.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₁NO₂.
3-Nitro-1-(4-octylphenyl)-1-propanone, CAS: 899822-97-0, stock: 4.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₅NO₃.
3-Oxo-4-aza-5-androstene-17β-carboxylic Acid, CAS: 103335-54-2, stock: 2.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₇NO₃.
Diosmetin 3’,5-Diacetate, CAS: 1798006-01-5, stock: 4.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₆O₈.
3-Nitro-1-(4-octylphenyl)propan-1-ol, CAS: 899822-98-1, stock: 5.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₇NO₃.
4’-Deoctyl 4’-(1-Hydroxyoctyl) Fingolimod, CAS: 296282-43-4, stock: 9.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₃NO₃.
3-Oxo-4-aza-5α-androst-1-ene-17β-carboxylic Acid Chloride, CAS: 183020-20-4, stock: 7.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₆ClNO₂.
3-Oxo-4-aza-5α-androstan-17β-carboxylic Acid, CAS: 103335-55-3, stock: 5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₉NO₃.
Diosmetin-7-o-β-D-glucopyranoside, CAS: 20126-59-4, stock: 3.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₂O₁₁.
3-Oxo-4-aza-5α-αndrost-1,5-diene-17β-carboxylic Acid Methyl Ester, CAS: 166896-62-4, stock: 8.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₇NO₃.
3-Oxo-4-aza-5α-αndrost-1-ene-17β-carboxylic Acid, CAS: 104239-97-6, stock: 6.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₇NO₃.
Diosmetine Tri-O-benzoyl, CAS: 1797983-90-4, stock: 1.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₂₄O₉.
Diosmetine Triacetate, CAS: 08/05/3162, stock: 8.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₈O₉.
Desethyl Fingolimod Hydrochloride, CAS: /, stock: 5.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₃₀ClNO₂.
Deshydroxymethyl Carboxyethyl N,O-Diacetyl Fingolimod, CAS: /, stock: 2.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₉NO₅.
3-Oxo-4-aza-5α-αndrost-1-ene-17β-carboxylic Acid Methyl Ester, CAS: 103335-41-7, stock: 7.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₉NO₃.
Deshydroxymethyl Fingolimod, CAS: /, stock: 1.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₅NO₃.
Diethyl 2-Acetamido-2-[2-(4-octylphenylethyl)malonate, CAS: 162358-08-9, stock: 1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₉NO₅.
3-Oxo-4-aza-androst-1,5-diene-17-carboxylic Acid, CAS: 1180488-92-9, stock: 6.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₅NO₃.
Ethyl 2-Acetamido-4-(4-octylphenyl)butanoate, CAS: /, stock: 8.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₅NO₃.
Ethyl Fingolimod Hydrochloride, CAS: 162361-23-1, stock: 2.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₈ClNO₂.
4-((tert-Butyldimethylsilyl)oxy)-2,5-bis(trifluoromethyl)aniline, CAS: /, stock: 6.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₉F₆NOSi.
Fisetin, CAS: 528-48-3, stock: 7.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₆.
Fingolimod, CAS: 162359-55-9, stock: 7.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₃NO₂.
Fingolimod Hydrochloride, CAS: 162359-56-0, stock: 7.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₄ClNO₂.
4-Amino-2,5-bis(trifluoromethyl)phenol, CAS: 1805587-94-3, stock: 9.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₅F₆NO.
4’-Hydroxy Dutasteride, CAS: /, stock: 1.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₀F₆N₂O₃.
Flavone, CAS: 525-82-6, stock: 6.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₂.
Flavoxate Hydrochloride, CAS: 3717-88-2, stock: 8.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₆ClNO₄.
Fingolimod N-Oxide, CAS: /, stock: 8.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₁NO₃.
Fingolimod Palmitate Amide, CAS: 1242271-26-6, stock: 1.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₅H₆₃NO₃.
5,6,7,8,9-Dehydro-10-desmethyl Finasteride, CAS: 1346602-40-1, stock: 1.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₈N₂O₂.
Flavoxate-d4 Hydrochloride, CAS: 1189678-43-0, stock: 2.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₂D₄ClNO₄.
Fingolimod Palmitate Amide-d4, CAS: /, stock: 5.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₅H₅₉D₄NO₃.
5,6-Dehydro Finasteride, CAS: 1329611-51-9, stock: 2.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₄N₂O₂.
Galangin, CAS: 548-83-4, stock: 5.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₅.
Genistein, CAS: 446-72-0, stock: 1.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₅.
Fingolimod Stearoate Amide, CAS: 1242271-27-7, stock: 7.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₆₇NO₃.
Fingolimod Stearoate Amide-d4, CAS: /, stock: 7.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₆₃D₄NO₃.
5,6-Dehydro-1,2-dihydro Finasteride Des-N-t-butylformamide Carboxylic Acid Methyl Ester, CAS: 104214-18-8, stock: 8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₉NO₃.
5,6-Dehydro-17α-Dutasteride, CAS: /, stock: 1.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₈F₆N₂O₂.
Genistein 4’-β-D-glucopyranoside, CAS: 152-95-4, stock: 2.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₀O₁₀.
Genistein-2’,3’,5’,6’-d4 (Major), CAS: 187960-08-3, stock: 3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₆D₄O₅.
Fingolimod-D4, CAS: 1346747-38-3, stock: 6.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₉D₄NO₂.
Fingolimod-d4 Hydrochloride, CAS: 1346604-90-7, stock: 7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₀D₄ClNO₂.
5,6-Dehydro-17β-dutasteride, CAS: 1430804-85-5, stock: 7.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₈F₆N₂O₂.
Genistein-2’,6’-d2, CAS: 315204-48-9, stock: 8.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₈D₂O₅.
Genistin 6’’-O-Acetate, CAS: 73566-30-0, stock: 10g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₂O₁₁.
Heptyl Deoctyl Fingolimod Hydrochloride, CAS: 162361-44-6, stock: 1.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₂ClNO₂.
5β-Finasteride, CAS: 140375-22-0, stock: 5.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₆N₂O₂.
6-O-Trimethysilyl Dutasteride, CAS: /, stock: 6.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₃₈F₆N₂O₃Si.
Genistin 6’’-O-Malonate, CAS: 51011-05-3, stock: 4.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₂O₁₃.
β-Nitropropionyl Chloride, CAS: 51834-15-2, stock: 6.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃H₄ClNO₃.
6-Oxo-Dihydrodutasteride, CAS: /, stock: 3.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₀F₆N₂O₃.
6α-Hydroxy Finasteride, CAS: 154387-62-9, stock: 9.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₆N₂O₃.
Glycitin, CAS: 40246-10-4, stock: 1.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₂O₁₀.
Mono-O-acetyl Fingolimod TFA, CAS: /, stock: 1.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₅NO₃ • C₂HF₃O₂.
6β-Hydroxy 1,2-Dihydrodutasteride, CAS: /, stock: 9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₂F₆N₂O₃.
6β-O-Trimethysilyl Dihydrodutasteride, CAS: /, stock: 4.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₄₀F₆N₂O₃Si.
Glycitin 6’’-O-Acetate, CAS: 134859-96-4, stock: 7.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₄O₁₁.
Glycitin 6’’-O-Malonate, CAS: 137705-39-6, stock: 2.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₄O₁₃.
N,O-Diacetyl Fingolimod, CAS: /, stock: 1.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₇NO₄.
N-Acetyl Deshydroxymethyl Fingolimod, CAS: 177259-52-8, stock: 2.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₃NO₂.
Des[[N-(1,1-Dimethylethyl)amino]carbonyl] 17-(Propionyl) Finasteride, CAS: 1346604-11-2, stock: 8.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₁NO₂.
Dihydro Dutasteride β-Dimer, CAS: /, stock: 6.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₆H₅₇F₆N₃O₄.
Gnaphaliin, CAS: 33803-42-8, stock: 8.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₄O₆.
Herbacetin, CAS: 527-95-7, stock: 6.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₇.
N-Formyl Fingolimod, CAS: /, stock: 5.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₃NO₃.
N-Hydroxy Fingolimod, CAS: /, stock: 4.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₃NO₃.
Dihydro Finasteride, CAS: 98319-24-5, stock: 8.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₈N₂O₂.
Dutasteride, CAS: 164656-23-9, stock: 7.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₀F₆N₂O₂.
Hyperoside, CAS: 482-36-0, stock: 8.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₀O₁₂.
N-Methylfingolimod Hydrochloride, CAS: 1404233-80-2, stock: 1.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₆ClNO₂.
Dutasteride α-Dimer, CAS: /, stock: 7.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₆H₅₅F₆N₃O₄.
Dutasteride β-Dimer, CAS: 1648593-70-7, stock: 4.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₆H₅₅F₆N₃O₄.
Irigenin, CAS: 548-76-5, stock: 9.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₆O₈.
Isoflavone, CAS: 574-12-9, stock: 1.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₂.
Nonyl Deoctyl Fingolimod Hydrochloride, CAS: 296282-40-1, stock: 5.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₆ClNO₂.
Dutasteride-13C6, CAS: 1217685-27-2, stock: 1.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁¹³C₆H₃₀F₆N₂O₂.
Dutasteride-13C6 (Contains 2% d0)Discontinued, CAS: 1217685-27-2, stock: 8.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁¹³C₆H₃₀F₆N₂O₂.
Isoquercitroside, CAS: 21637-25-2, stock: 2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₀O₁₂.
Isovitexin, CAS: 38953-85-4, stock: 1.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₀O₁₀.
ortho-Fingolimod, CAS: 767262-51-1, stock: 8.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₃NO₂.
rac FTY720 Phosphate, CAS: 402615-91-2, stock: 8.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₄NO₅P.
Dutasteride-3-phenylselanyl β-Dimer, CAS: /, stock: 9.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₂H₆₁F₆N₃O₄Se.
Dutasteride-d3, CAS: 1131341-46-2, stock: 4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₇D₃F₆N₂O₂.
α-Naphthylflavone, CAS: 604-59-1, stock: 1.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₂O₂.
tert-Butyl (1-Hydroxy-2-(hydroxymethyl)-4-(4-octylphenyl)butan-2-yl)carbamate, CAS: 844496-96-4, stock: 3.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₄₁NO₄.
Finasteride 2-(2-Methylpropanol)amide β-D-Glucuronide, CAS: 1196787-38-8, stock: 6.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₄₄N₂O₉.
Kaempferol, CAS: 520-18-3, stock: 3.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₆.
Finasteride Carboxaldehyde, CAS: 154387-61-8, stock: 8.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₄N₂O₃.
3’’’,5’’’-Dideshydroxy-3’’’,5’’’-dimethoxy Fidaxomicin, CAS: 185248-68-4, stock: 1.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₄H₇₈Cl₂O₁₈.
Kaempferol 3-β-Sophoroside, CAS: 19895-95-5, stock: 3.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₀O₁₆.
Kuwanon A, CAS: 62949-77-3, stock: 7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₄O₆.
Fidaxomicin, CAS: 873857-62-6, stock: 3.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₂H₇₄Cl₂O₁₈.
Fidaxomicin-D7, CAS: 2143934-06-7, stock: 1.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₂H₆₇D₇Cl₂O₁₈.
Ligustroflavone, CAS: 260413-62-5, stock: 5.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₄₀O₁₈.
OP-1118, CAS: 1030825-28-5, stock: 7.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₈H₆₈Cl₂O₁₇.
Linarine, CAS: 480-36-4, stock: 4.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₂O₁₄.
Linarine (1.0 mg/mL in Methanol), CAS: 480-36-4, stock: 9.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₂O₁₄.
Luteolin, CAS: 491-70-3, stock: 7.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₆.
Luteolin 7-Glucoside, CAS: 05/11/5373, stock: 5.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₀O₁₁.
Luteolin 7-O-α-L-Rhamnoside, CAS: 18016-54-1, stock: 2.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₀O₁₀.
Luteolin 7-O-Rutinoside, CAS: 20633-84-5, stock: 9.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₀O₁₅.
Morin, CAS: 480-16-0, stock: 4.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₇.
Myricetin, CAS: 529-44-2, stock: 4.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₈.
Myricetin 3-β-Glucoside, CAS: 19833-12-6, stock: 1.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₂O₁₂.
N-Methylaminogenistein, CAS: 359436-93-4, stock: 2.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₃NO₃.
Naringoside, CAS: 10236-47-2, stock: 1.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₂O₁₄.
Neobavaisoflavone, CAS: 41060-15-5, stock: 1.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₈O₄.
Neodiosmin, CAS: 38665-01-9, stock: 3.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₂O₁₅.
Neodiosmin-d3, CAS: /, stock: 3.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₂₉D₃O₁₅.
Nitrogenistein, CAS: 39679-60-2, stock: 9.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₉NO₅.
Nobiletin, CAS: 478-01-3, stock: 9.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₂O₈.
o-Aminoazotoluene, CAS: 97-56-3, stock: 6.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₅N₃.
O-Desethylpiperidine Flavoxate Ethyl Ester, CAS: 35888-94-9, stock: 4.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₆O₄.
O-Desethylpiperidine Flavoxate Methyl Ester, CAS: 90101-87-4, stock: 8.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₄O₄.
Ononin, CAS: 486-62-4, stock: 9.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₂O₉.
Orientin, CAS: 28608-75-5, stock: 2.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₀O₁₁.
Pratol, CAS: 487-24-1, stock: 5.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₂O₄.
Pseudobabtigen, CAS: 90-29-9, stock: 1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₀O₅.
Quercetin, CAS: 117-39-5, stock: 8.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₇.
Quercetin 3,4’-Diglucoside, CAS: 29125-80-2, stock: 6.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₀O₁₇.
Quercetin 3-O-α-L-Arabinopyranoside, CAS: 22255-13-6, stock: 2.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₀O₁₁.
Quercetin 3-O-β-D Glucoside, CAS: 482-35-9, stock: 2.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₂O₁₂.
Quercetin 3-O-β-xyloside, CAS: 549-32-6, stock: 7.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₈O₁₁.
Quercetin 3-O-β-xyloside-d3, CAS: /, stock: 8.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₅D₃O₁₁.
Quercetin Dihydrate, CAS: 6151-25-3, stock: 9.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₄O₉.
Quercetin Hydrate, CAS: 849061-97-8, stock: 5.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₇ • x(H ₂O).
Quercetin-3-arabinoglucoside, CAS: 23284-18-6, stock: 5.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₈O₁₆.
Quercetin-d3 (Major), CAS: 263711-79-1, stock: 4.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₇D₃O₇.
Quercitrin, CAS: 522-12-3, stock: 8.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₀O₁₁.
Rhoifolin, CAS: 17306-46-6, stock: 1.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₀O₁₄.
Salvigenin, CAS: 19103-54-9, stock: 5.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₆O₆.
Salvigenin-d9, CAS: /, stock: 5.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₇D₉O₆.
Scutellarein, CAS: 529-53-3, stock: 8.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀O₆.
Scutellarein-d4, CAS: /, stock: 1.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₅D₅O₆.
Scutellarin, CAS: 27740-01-8, stock: 4.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₈O₁₂.
Skullcapflavone II, CAS: 55084-08-7, stock: 9.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₈O₈.
Sodium Benzoate, CAS: 532-32-1, stock: 6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₅NaO₂.
Taiwaniaflavone, CAS: 27090-22-8, stock: 9.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₁₈O₁₀.
TAK 778, CAS: 180185-61-9, stock: 1.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₈NO₇PS.
Tangeretin, CAS: 481-53-8, stock: 2.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₀O₇.
Thymonin, CAS: 76844-67-2, stock: 8.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₆O₈.
Vitexin, CAS: 3681-93-4, stock: 9.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₀O₁₀.
Wighteone, CAS: 51225-30-0, stock: 6.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₈O₅.
Wogonin, CAS: 632-85-9, stock: 1.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₂O₅.
(2S)-2-(4-(1-(2-Amino-4-hydroxypteridin-6-yl)pent-4-yn-2-yl)benzamido)pentanedioic Acid, CAS: /, stock: 8.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₂N₆O₆.
1-Dehydroxy-1-dehyro-fexofenadine-d6 Methyl Ester, CAS: 1795031-46-7, stock: 3.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₃₁D₆NO₃.
1-Oxo Fexofenadine-d6 Methyl Ester, CAS: /, stock: 5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₃₃D₆NO₄.
10-Propargyl-10-deazaminopterin Diethyl Ester, CAS: 146464-94-0, stock: 7.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₁N₇O₅.
2-Phenylisobutyric Acid, CAS: 826-55-1, stock: 3.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₂O₂.
4-(4-Chloro-1-oxobutyl)-α,α-dimethylbenzeneacetic Acid Methyl Ester, CAS: 154477-54-0, stock: 4.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₉ClO₃.
4-[4-[4-(Diphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-α,α-dimethylbenzeneacetic Acid, CAS: 1347311-10-7, stock: 3.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₃₉NO₃.
(2E)-2-Butenedioic Acid 1-[[3-[(1R)-3-[Bis(1-methylethyl)amino]-1-phenylpropyl]-4-(2-methyl-1-oxopropoxy)phenyl]methyl] Ester, CAS: 1254942-29-4, stock: 7.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₃₉NO₆.
(R)-2-(3-(Diisopropylamino)-1-phenylpropyl)-4-methylphenyl Isobutyrate Hydrogen Fumarate, CAS: 1428856-56-7, stock: 7.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₇NO₂ • C₄H₄O₄.
(R)-4,4’-[Oxybis(methylene)]bis[2-[(1R)-3-[bis(1-methylethyl)amino]-1-phenylpropyl]-phenol Difumarate, CAS: /, stock: 7.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₂H₆₈N₂O₁₁.
(R)-5-Hydroxymethyl Tolterodine 5-Fumarate Ester, CAS: /, stock: 2.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₃NO₅.
(R)-5-Hydroxymethyl Tolterodine Methacrylate, CAS: 1390644-37-7, stock: 1.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₅NO₃.
Fexofenadine Methyl Ester, CAS: 154825-96-4, stock: 6.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₄₁NO₄.
(R)-5-Isopropylcarbonyloxymethyl Tolterodine, CAS: 1380491-70-2, stock: 9.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₇NO₃.
(R)-5-Isopropylcarbonyloxymethyl Tolterodine-d7, CAS: /, stock: 5.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₀D₇NO₃.
(R)-5-Methoxymethyl Tolterodine, CAS: /, stock: 7.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₃NO₂.
(R)-5-Methoxymethyl Tolterodine Hydrochloride, CAS: /, stock: 6.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₄ClNO₂.
(R)-Fesoterodine Fumarate, CAS: 286930-03-8, stock: 8.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₄₁NO₇.
Fexofenadine-d6 Methyl Ester, CAS: 1286458-00-1, stock: 3.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₃₅D₆NO₄.
(S)-Fesoterodine Fumarate, CAS: 1431511-18-0, stock: 5.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₄₁NO₇.
(S)-Fesoterodine-d7 Fumarate, CAS: /, stock: 9.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₃₄D₇NO₇.
1-[[3-[(1R)-3-[Bis(1-methylethyl)amino]-1-phenylpropyl]4-hydroxyphenyl]methyl 2-Butanedioic Acid Ester, CAS: /, stock: 8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₅NO₅.
1-[[3-[(1R)-3-[Bis(1-methylethyl)amino]-1-phenylpropyl]4-hydroxyphenyl]methyl 2-Butanedioic Acid Ester-d7, CAS: /, stock: 9.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₁D₄NO₅.
α-(4-Piperidyl)benzhydrol, CAS: 115-46-8, stock: 9.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₁NO.
α-(4-Piperidyl)benzhydrol-d10, CAS: /, stock: 9.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₁D₁₀NO.
2-(3-(Diisopropylamino)-1-phenylpropyl)-4-formylphenyl Isobutyrate, CAS: 1333234-71-1, stock: 1.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₅NO₃.
2-Methyl-propanoic Acid 2-[(1R)-3-[Bis(1-methylethyl)amino]-1-phenylpropyl]-4-formylphenyl Ester, CAS: 1435768-96-9, stock: 9.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₅NO₃.
m-Fexofenadine Ethyl Ester, CAS: /, stock: 3.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₄H₄₃NO₄.
meta-Fexofenadine, CAS: 479035-75-1, stock: 7.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₃₉NO₄.
2-Methyl-propanoic Acid 2-[(1R)-3-[Bis(1-methylethyl)amino]-1-phenylpropyl]-4-[[[3-[(1R)-3-[bis(1-methylethyl)amino]-1-phenylpropyl]-4-hydroxyphenyl]methoxy]methyl]phenyl Ester Difumaric Acid Salt (Fesoterodine Impurity) (>85%), CAS: /, stock: 4.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₆H₇₄N₂O₁₂.
2-[1-Phenyl-3-(1-piperidinyl)propyl]phenyl Isobutyrate, CAS: /, stock: 8.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₁NO₂.
meta-Fexofenadine-D6, CAS: /, stock: 4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₃₃D₆NO₄.
N-[4-[2-(2,4-Diamino-7-pteridinyl)ethyl]benzoyl]-L-glutamic Acid, CAS: 2058054-07-0, stock: 2.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₁N₇O₅.
4-(Deshydroxymethyl) 4-(1-Hydroxyethyl) (R)-Fesoterodine, CAS: /, stock: 4.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₉NO₃.
4-Hydroxymethyl-2-benzylphenyl Isobutyrate, CAS: 1309934-15-3, stock: 6.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₀O₃.
6-Bromo-3,4-dihydro-4-phenyl-2H-1-benzopyran-2-one, CAS: 156755-23-6, stock: 1.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₁BrO₂.
Deoxy Fesoterodine, CAS: 895137-81-2, stock: 2.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₇NO₂.
Fesoterodine ((S)-2-Hydroxy-2-phenylacetic Acid), CAS: 1206695-46-6, stock: 5.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₇NO₃ • C ₈H₈O₃.
Fesoterodine 4-Oxo-2-pentenoate Benzylic Ester, CAS: /, stock: 7.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₄₁NO₅.
O-Isobutyryl (R)-Fesoterodine, CAS: 1208313-13-6, stock: 8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₄₃NO₄.
rac 5-Hydroxymethyl Desisopropyl Tolterodine, CAS: 480432-16-4, stock: 8.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₅NO₂.
rac 5-Hydroxymethyl Tolterodine, 90% by HPLC, CAS: 200801-70-3, stock: 9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₁NO₂.
rac Fesoterodine Fumarate, CAS: 1333234-73-3, stock: 5.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₄₁NO₇.
rac Fesoterodine-d14 Fumarate, CAS: 1185237-08-4, stock: 1.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₂₇D₁₄NO₇.
rac-5-Hydroxymethyl Tolterodine Methacrylate-d14, CAS: /, stock: 4.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₁D₁₄NO₃.
rac-5-Isopropylcarbonyloxymethyl Tolterodine, CAS: 250214-66-5, stock: 3.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₇NO₃.
rac-5-Isopropylcarbonyloxymethyl Tolterodine-d7, CAS: /, stock: 9.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₀D₇NO₃.
Tolterodine-4-methylfumaric Acid Hydrochloride (~80%), CAS: /, stock: 2.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₄ClNO₅.
(4-(Chloromethyl)phenyl)(phenyl)sulfane, CAS: 1208-87-3, stock: 4.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₁ClS.
3-[2-(2,4-Dichlorophenyl)-2-hydroxyethyl]-1-[[4-(phenylthio)phenyl]methyl]-1H-imidazolium Chloride, CAS: 80639-93-6, stock: 7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₁Cl₂N₂OS • (Cl).
4-(Phenylthio)benzyl Alcohol, CAS: 6317-56-2, stock: 1.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₂OS.
Fenticonazole Nitrate, CAS: 73151-29-8, stock: 4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₁Cl₂N₃O₄S.
Fenticonazole Nitrate-d9, CAS: 72479-26-6, stock: 9.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₁₂D₉Cl₂N₃O₄S.
Fenticonazole Sulfone Nitric Acid Salt, CAS: 80676-29-5, stock: 2.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₁Cl₂N₃O₆S.
Fenticonazole Sulfoxide Nitric Acid Salt, CAS: 80639-95-8, stock: 8.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₁Cl₂N₃O₅S.
N-(4-Phenylthiobenzyl) Fenticonazole Chloride, CAS: 80639-92-5, stock: 8.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₃₁Cl₃N₂OS₂.
rac-1-(2,4-Dichlorophenyl)-2-(1-imidazolyl)ethanol, CAS: 24155-42-8, stock: 3.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₀Cl₂N₂O.
2-Hydroxy Fenspiride, CAS: 441781-21-1, stock: 1.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₀N₂O₃.
3-Hydroxy Fenspiride, CAS: 441781-23-3, stock: 2.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₀N₂O₃.
4-(Aminomethyl)-1-phenethyl-4-piperidinol, CAS: 23808-42-6, stock: 7.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₂N₂O.
4-(Aminomethyl)-1-phenethyl-4-piperidinol-d5, CAS: /, stock: 7.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₇D₅N₂O.
4-Hydroxy Fenspiride, CAS: 441781-25-5, stock: 5.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₀N₂O₃.
Fenspiride Hydrochloride, CAS: 07/08/5053, stock: 4.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₁ClN₂O₂.
Fenspiride N-Oxide, CAS: 210690-26-9, stock: 8.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₀N₂O₃.
Fenspiride-d5 Hydrochloride, CAS: 1246815-28-0, stock: 9.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₆D₅ClN₂O₂.
Fenspiride-d5 N-Oxide, CAS: /, stock: 8.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₅D₅N₂O₃.
N-(4-Chlorophenyl)-2-methyl-N-[1-(2-phenylethyl)-4-piperidinyl]propanamide, CAS: 244195-34-4, stock: 8.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₉ClN₂O.
N-Despropionyl N-Acetyl Carfentanil Methyl Ester, CAS: 131821-81-3, stock: 1.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₈N₂O₃.
N-Despropionyl N-Acetyl-d3 Carfentanil Methyl Ester, CAS: /, stock: 5.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₅D₃N₂O₃.
13-cis-Fenretinide, CAS: 75686-07-6, stock: 7.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₃NO₂.
13-cis-Fenretinide-d4, CAS: /, stock: 5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₉D₄NO₂.
3-Hydroxy Fenretinide, CAS: 1027233-22-2, stock: 5.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₃NO₃.
3-Hydroxy Fenretinide-d4, CAS: /, stock: 3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₉D₄NO₃.
ABT 751, CAS: 141430-65-1, stock: 5.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₇N₃O₄S.
Fenretinide, CAS: 65646-68-6, stock: 7.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₃NO₂.
Fenretinide Glucuronide Monosodium Salt, CAS: 76177-99-6, stock: 5.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₄₀NNaO₈.
Fenretinide Glucuronide Monosodium Salt-d4, CAS: /, stock: 6.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₃₆D₄NNaO₈.
Fenretinide-d4, CAS: /, stock: 9.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₉D₄NO₂.
(1RS)-1-(3,5-Dihydroxyphenyl)2-[[(1RS)-2-(4-hydroxy-3-methylphenyl)-1-methylethyl]aminoethanol Hydrobromide, CAS: /, stock: 5.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₄BrNO₄.
(R*,S*)-(±)-Fenoterol Hydrobromide, CAS: 38964-10-2, stock: 6.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₂BrNO₄.
(R*,S*)-(±)-Fenoterol Hydrobromide-d6, CAS: /, stock: 7.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₆D₆BrNO₄.
1-(7-Methoxy-1-naphthalenyl)-2-propanone, CAS: 118647-68-0, stock: 4.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₄O₂.
1-[3,5-Bis(phenylmethoxy)phenyl]-2-ethoxy-2-hydroxy-ethanone, CAS: 57730-48-0, stock: 7.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₄O₅.
4-(2-((2-(3,5-Bis(benzyloxy)phenyl)-2-hydroxyethyl)amino)propyl)-2-methylphenol, CAS: /, stock: 1.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₃₅NO₄.
4-Methoxy-α,3-dimethyl-benzeneethanamine Hydrochloride, CAS: 59067-69-5, stock: 7.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₇NO•HCl.
4-Methoxy-N-(phenylmethylene)benzeneethanamine, CAS: 50822-97-4, stock: 6.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₇NO.
5-((S)-1-Hydroxy-2-(((R)-1-(4-hydroxy-3-methylphenyl)propan-2-yl)amino)ethyl)benzene-1,3-diol Hydrobromide, CAS: /, stock: 6.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₃NO₄•HBr.
Fenoterol Hydrobromide, CAS: 03/12/1944, stock: 8.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₂BrNO₄.
Fenoterol O-β-D-Glucuronide, CAS: 61046-78-4, stock: 5.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₉NO₁₀.
Fenoterol Sulfate Sodium Salt, CAS: /, stock: 9.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₀NNaO₇S.
Fenoterol-d6 Hydrobromide, CAS: 1286129-04-1, stock: 4.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₆D₆BrNO₄.
α-[[[2-(4-Methoxyphenyl)-1-methylethyl]amino]methyl]-3,5-bis(phenylmethoxy)-benzenemethanol-d6, CAS: /, stock: 8.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₂₉D₆NO₄.
Methoxy Fenoterol-d6, CAS: 1346599-77-6, stock: 7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₇D₆NO₄.
2-(2,4,5-Trichlorophenoxy)propionic Acid, CAS: 93-72-1, stock: 9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₇Cl₃O₃.
2-(2,4,5-Trichlorophenoxy)propionic Acid-13C6, CAS: /, stock: 6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃¹³C₆H₇Cl₃O₃.
Fenoprofen, CAS: 29679-58-1, stock: 6.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₄O₃.
Fenoprofen Sodium Salt Dihydrate, CAS: 66424-46-2, stock: 3.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₃NaO₃•2H₂O.
(4-Chlorophenyl)[4-(1-methylethoxy)phenyl]methanone(Fenofibrate Impurity), CAS: 154356-96-4, stock: 3.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₅ClO₂.
(4-Chlorophenyl)[4-(1-methylethoxy)phenyl]methanone-D7(Fenofibrate Impurity), CAS: /, stock: 3.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₈D₇ClO₂.
3-[4-(4-Chlorobenzoyl)phenoxy]-2-butanone(Fenofibrate Impurity), CAS: 217636-47-0, stock: 3.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₅ClO₃.
Dihydro Fenofibrate, CAS: 61001-99-8, stock: 3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₃ClO₄.
Dihydro Fenofibrate-d6, CAS: 1189501-82-3, stock: 3.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₇D₆ClO₄.
Fenirofibrate, CAS: 54419-31-7, stock: 4.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₇ClO₄.
Fenirofibrate Acyl-β-D-glucuronide (Mixture of Diastereomers), CAS: 168844-25-5, stock: 3.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₅ClO₁₀.
Fenirofibrate O-β-D-Glucuronide, CAS: 168844-26-6, stock: 7.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₅ClO₁₀.
Fenirofibrate-d6, CAS: 1189423-29-7, stock: 4.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₁D₆ClO₄.
Fenirofibrate-d6 Acyl-β-D-glucuronide (Mixture of Diastereomers), CAS: /, stock: 7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₁₉D₆ClO₁₀.
Fenofibrate, CAS: 49562-28-9, stock: 3.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₁ClO₄.
Fenofibrate-d6, CAS: 1092484-56-4, stock: 9.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₅D₆ClO₄.
Fenofibric Acid, CAS: 42017-89-0, stock: 5.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₅ClO₄.
Fenofibric Acid 1,1-Dimethyl-2-(1-methylethoxy)-2-oxoethyl Ester, CAS: 217636-48-1, stock: 7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₇ClO₆.
Fenofibric Acid 1-Carboxyl-1-methylethyl Ester, CAS: 1797121-54-0, stock: 8.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₁ClO₆.
Fenofibric Acid Acyl-β-D-glucuronide (~90%), CAS: 60318-63-0, stock: 1.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₃ClO₁₀.
Fenofibric-d6 Acid, CAS: 1092484-69-9, stock: 8.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₉D₆ClO₄.
(±)-p-Fenfluramine Hydrochloride, CAS: 54779-55-4, stock: 4.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₆F₃N •HCl.
(R)-Norfenfluramine Hydrochloride, CAS: 41538-52-7, stock: 8.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₃ClF₃N.
(S)-Norfenfluramine Hydrochloride, CAS: 37936-89-3, stock: 2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₃ClF₃N.
DL-Fenfluramine, CAS: 458-24-2, stock: 1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₆F₃N.
DL-Fenfluramine Hydrochloride, CAS: 404-82-0, stock: 6.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₆F₃N • (HCl).
Flucetorex, CAS: 40256-99-3, stock: 1.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₁F₃N₂O₃.
N-Nitrosofenfluramine, CAS: 19023-40-6, stock: 9.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₅F₃N₂O.
rac Fenfluramine-d5 Hydrochloride, CAS: 1216927-29-5, stock: 7.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₂D₅ClF₃N.
rac-Fenfluramine-D11 Hydrochloride, CAS: /, stock: 2.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₅D₁₁F₃N • HCl.
1H-Benzotriazole-1-carboxylic Acid Methyl Ester, CAS: 86298-22-8, stock: 2.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₇N₃O₂.
1H-Benzotriazole-1-carboxylic Acid Methyl Ester-d3, CAS: /, stock: 2.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₄D₃N₃O₂.
Fenbendazole, CAS: 43210-67-9, stock: 9.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₃N₃O₂S.
Fenbendazole Sulfone, CAS: 54029-20-8, stock: 8.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₃N₃O₄S.
Fenbendazole Sulfone-d3, CAS: 1228182-49-7, stock: 6.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀D₃N₃O₄S.
Fenbendazole Sulfoxide, CAS: 53716-50-0, stock: 5.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₃N₃O₃S.
Fenbendazole Sulfoxide-d3, CAS: 1228182-54-4, stock: 6.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀D₃N₃O₃S.
Fenbendazole-amine Hydrochloride, CAS: 1448346-29-9, stock: 4.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₃ClN₄S.
Fenbendazole-Amine Sulfoxide, CAS: 69489-26-5, stock: 3.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₁N₃OS.
Fenbendazole-Amine Sulfoxide N,N’-Urea Dimer, CAS: /, stock: 7.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₀N₆O₃S₂.
Fenbendazole-d3, CAS: 1228182-47-5, stock: 4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀D₃N₃O₂S.
4-(2,3-Dichlorophenyl)-5-(methoxycarbonyl)-2,6-dimethylnicotinic Acid, CAS: 91854-02-3, stock: 7.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₃Cl₂NO₄.
5-Carboxy-6-hydroxymethyl Dehydro Felodipine, CAS: 96558-29-1, stock: 8.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₅Cl₂NO₅.
Dehydro Felodipine, CAS: 96382-71-7, stock: 3.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₇Cl₂NO₄.
Dehydro Felodipine Ester Lactone, CAS: 96558-27-9, stock: 1.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₃Cl₂NO₄.
Dehydro Felodipine-d3, CAS: 1189916-52-6, stock: 5.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₄D₃Cl₂NO₄.
Felodipine Ester Lactone, CAS: 85825-42-9, stock: 1.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₅Cl₂NO₄.
Methyl 4-(2,3-Dichlorophenyl)-2,6-dimethylnicotinate, CAS: 105383-68-4, stock: 3.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₃Cl₂NO₂.
O-Ethyl Felodipine 2-Acetoxymethyl, CAS: /, stock: 6.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₃Cl₂NO₆.
2-Hydroxy Felbamate, CAS: 109482-32-8, stock: 2.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₄N₂O₅.
2-Hydroxy Felbamate-d4, CAS: 1346602-71-8, stock: 4.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₀D₄N₂O₅.
2-Phenyl-1,3-propanediol, CAS: 1570-95-2, stock: 9.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₂O₂.
2-Phenyl-1,3-propanediol-d4, CAS: 98704-00-8, stock: 2.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₈D₄O₂.
3,3’-Carbonylbis(oxy)bis(2-phenylpropane-3,1-diyl) Dicarbamate, CAS: 1796927-91-7, stock: 7.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₄N₂O₇.
3-(Benzyloxy)-2-phenylpropyl morpholine-4-carboxylate, CAS: /, stock: 7.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₅NO₄.
4-Hyrdroxy Felbamate, CAS: 109482-28-2, stock: 3.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₄N₂O₅.
4-Hyrdroxy Felbamate-d4, CAS: /, stock: 5.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₀D₄N₂O₅.
Diethyl 2-(4-Methoxyphenyl)malonate, CAS: 23197-67-3, stock: 9.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₈O₅.
Ethylfelbamate, CAS: 53054-24-3, stock: 2.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₈N₂O₄.
Ethylfelbamate-d5, CAS: /, stock: 6.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₃D₅N₂O₄.
Felbamate, CAS: 25451-15-4, stock: 1.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₄N₂O₄.
Felbamate-d4, CAS: 106817-52-1, stock: 8.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₀D₄N₂O₄.
Felbamate-d5, CAS: /, stock: 5.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₇D₅N₂O₄.
Hydroxy-2-phenylpropyl Carbamate, CAS: 25451-53-0, stock: 8.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₃NO₃.
Isopropylfelbamate, CAS: /, stock: 7.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₀N₂O₄.
Isopropylfelbamate-d5, CAS: /, stock: 2.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₅D₅N₂O₄.
Methylfelbamate, CAS: 22131-25-5, stock: 7.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₆N₂O₄.
Methylfelbamate-d5, CAS: /, stock: 7.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₁D₅N₂O₄.
N-Aminocarbonyl Felbamate, CAS: 1797130-34-7, stock: 9.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₅N₃O₅.
Phenethyl Carbamate, CAS: 6326-19-8, stock: 6.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₁NO₂.
1-Cyclopropyl-2-nitro-naphthalene, CAS: 1802080-61-0, stock: 6.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₁NO₂.
2,2’-[4-(2-Methylpropoxy)-1,3-phenylene]bis[4-methyl-5-thiazolecarboxylic Acid, CAS: 1330632-48-8, stock: 7.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₀N₂O₅S₂.
2,2’-[4-(2-Methylpropoxy)-1,3-phenylene]bis[4-methyl-5-thiazolecarboxylic Acid 5,5’-Dimethyl Ester, CAS: 1330632-47-7, stock: 6.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₄N₂O₅S₂.
2-(3,5-Diformyl-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylic Acid, CAS: /, stock: 3.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₇NO₅S.
2-(3-Cyano-4-hydroxyphenyl)-4-methyl-1,3-thiazole-5-carboxylic Acid Ethyl Ester, CAS: 161798-02-3, stock: 9.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₂N₂O₃S.
2-Cyclopropyl-1-nitro-naphthalene, CAS: 52331-35-8, stock: 5.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₁NO₂.
2-[3-(Aminocarbonyl)-4-(2-methylpropoxy)phenyl]-4-methyl-5-thiazolecarboxylic Acid, CAS: 1239233-86-3, stock: 3.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₈N₂O₄S.
2-[3-Carboxy-4-(2-methylpropoxy)phenyl]-4-methyl-5-thiazolecarboxylic Acid, CAS: 1239233-87-4, stock: 3.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₇NO₅S.
2-[3-Carboxy-4-(2-methylpropoxy)phenyl]-4-methyl-5-thiazolecarboxylic Acid-d9, CAS: /, stock: 4.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₈D₉NO₅S.
2-[3-Cyano-4-(3-hydroxy-2-methylpropoxy)phenyl]-4-methyl-5-thiazolecarboxylic Acid Ethyl Ester, CAS: 1572503-72-0, stock: 1.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₀N₂O₄S.
2-[4-(2-Carboxypropoxy)-3-cyanophenyl]-4-methyl-5-thiazolecarboxylic Acid 5-Ethyl Ester, CAS: 1572503-76-4, stock: 9.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₈N₂O₅S.
2-[[4-(1-Naphthalenyl)-4H-1,2,4-triazol-3-yl]thio]-acetic Acid, CAS: 1038366-57-2, stock: 7.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₁N₃O₂S.
2-[[5-Bromo-4-(1-cyclopropyl-2-naphthalenyl)-4H-1,2,4-triazol-3-yl]thio]-acetic Acid, CAS: 1533519-94-6, stock: 6.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₄BrN₃O₂S.
2-[[5-Bromo-4-(4-propyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]thio]-acetic Acid, CAS: 1533519-96-8, stock: 3.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₆BrN₃O₂S.
2-[[5-Bromo-4-(5-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]thio]-acetic Acid, CAS: 1533519-97-9, stock: 4.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₄BrN₃O₂S.
2-[[5-Bromo-4-(naphthalen-1-yl)-4H-1,2,4-triazol-3-yl]thio]-acetic Acid, CAS: 1210330-64-5, stock: 8.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₀BrN₃O₂S.
3-Cyano-4-isobutyloxythiobenzamide, CAS: 163597-57-7, stock: 9.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₄N₂OS.
3-Bromo-2-methylpropan-1-ol, CAS: 40145-08-2, stock: 7.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₉BrO.
3-Descyano 3-Bromo-febuxostat, CAS: 144060-40-2, stock: 6.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₆BrNO₃S.
3-Descyano 3-Bromo-febuxostat-d9, CAS: /, stock: 3.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₇D₉BrNO₃S.
3-Descyano Febuxostat, CAS: 1206550-99-3, stock: 6.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₇NO₃S.
3-Descyano Febuxostat Ethyl Ester, CAS: 144060-97-9, stock: 6.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₁NO₃S.
3-Descyano Febuxostat-d9, CAS: /, stock: 8.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₈D₉NO₃S.
3-Descyano Febuxostat-d9 Ethyl Ester, CAS: /, stock: 8.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₂D₉NO₃S.
3-Descyano-3-((hydroxyimino)methyl) Febuxostat, CAS: 1350352-70-3, stock: 4.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₈N₂O₄S.
3-Descyano-3-formyl Febuxostat, CAS: 144060-62-8, stock: 5.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₇NO₄S.
3-Descyano-3-formyl Febuxostat Isobutyl Ester, CAS: 1312815-36-3, stock: 6.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₅NO₄S.
4-(2-Methylpropoxy)-1,3-benzenedicarbothioamide, CAS: 1330632-46-6, stock: 4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₆N₂OS₂.
4-Hydroxy-1,3-benzenedicarbonitrile, CAS: 34133-58-9, stock: 7.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₄N₂O.
4-Isobutyloxy-1,3-benzenedicarbonitrile, CAS: 161718-81-6, stock: 1.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₂N₂O.
5-Amino-4-(4-cyclopropyl-1-naphthalenyl)-2,4-dihydro-3H-1,2,4-Triazol-3-one, CAS: 1847413-14-2, stock: 4.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₄N₄O.
5-Amino-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazole-3-thiol, CAS: 878671-96-6, stock: 9.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₄N₄S.
Butyl 2-[3-Cyano-4-(2-methylpropoxy)phenyl]-4-methyl-5-thiazolecarboxylic Acid Ester, CAS: 1619982-02-3, stock: 9.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₄N₂O₃S.
Descarboxyl Febuxostat, CAS: 1335202-60-2, stock: 8.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₆N₂OS.
Descarboxyl Febuxostat-d9, CAS: /, stock: 4.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₇D₉N₂OS.
Desisobutyl Febuxostat, CAS: 407582-48-3, stock: 3.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₈N₂O₃S.
Ethyl 2-(3-Cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate, CAS: 160844-75-7, stock: 3.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₀N₂O₃S.
Ethyl 2-(3-Cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate-d9, CAS: /, stock: 2.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₁D₉N₂O₃S.
Ethyl 2-(3-formyl-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate, CAS: 161798-03-4, stock: 5.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₁NO₄S.
Ethyl 2-(4-Butoxy-3-cyanophenyl)-4-methylthiazole-5-carboxylate, CAS: /, stock: 2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₀N₂O₃S.
Ethyl 2-(4-Hydroxyphenyl)-4-methylthiazole-5-carboxylate, CAS: 161797-99-5, stock: 5.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₃NO₃S.
Febuxostat, CAS: 144060-53-7, stock: 5.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₆N₂O₃S.
Febuxostat 2-Butyl Isomer, CAS: 1335202-59-9, stock: 3.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₆N₂O₃S.
Febuxostat 2-Butyl Isomer Ethyl Ester, CAS: /, stock: 8.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₈N₄O₂.
Febuxostat 67M-1, CAS: 887945-96-2, stock: 8.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₆N₂O₄S.
Febuxostat 67M-2, CAS: 407582-47-2, stock: 3.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₆N₂O₄S.
Febuxostat 67M-4, CAS: 407582-49-4, stock: 7.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₄N₂O₅S.
Febuxostat Acyl-β-D-glucuronide, CAS: 1351692-92-6, stock: 10g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₄N₂O₉S.
Febuxostat Acyl-β-D-glucuronide-O-(1-propene), CAS: /, stock: 6.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₈N₂O₉S.
1-Nitro Febantel, CAS: 63470-85-9, stock: 8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₄N₂O₄S.
Febuxostat Isopropyl Ester, CAS: 1346238-10-5, stock: 5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₂N₂O₃S.
Febuxostat Isopropyl Isomer, CAS: 144060-52-6, stock: 5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₄N₂O₃S.
2-(Methoxymethyl)-5-(phenylthio)-1H-benzimidazole, CAS: 92114-71-1, stock: 9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₄N₂OS.
Febuxostat n-Butyl Isomer, CAS: 1657014-33-9, stock: 7.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₆N₂O₃S.
Febuxostat-d7, CAS: 1285539-74-3, stock: 7.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₉D₇N₂O₃S.
Des(methoxycarbonyl) Febantel, CAS: 92088-58-9, stock: 2.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₀N₄O₄S.
Febantel, CAS: 58306-30-2, stock: 2.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₂N₄O₆S.
Febuxostat-d9, CAS: 1246819-50-0, stock: 8.6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₇D₉N₂O₃S.
Lesinurad, CAS: 878672-00-5, stock: 5.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₄BrN₃O₂S.
Methyl 2-[3-Cyano-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylate, CAS: 923942-34-1, stock: 4.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₈N₂O₃S.
O-Desisobutyl-O-n-propyl Febuxostat, CAS: 1530308-87-2, stock: 9.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₄N₂O₃S.
O-Desisobutyl-O-N-propyl O-Ethyl Febuxostat, CAS: /, stock: 3.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₈N₂O₃S.
Fasudil, CAS: 103745-39-7, stock: 7.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₇N₃O₂S.
Fasudil Monohydrochloride Salt, CAS: 105628-07-7, stock: 4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₇N₃O₂S • (HCl).
Hydroxy Fasudil Hydrochloride, CAS: 155558-32-0, stock: 1.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₈ClN₃O₃S.
N-(3-Hydroxypropyl)ethylenediamine, CAS: 56344-32-2, stock: 8.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₁₄N₂O.
Ripasudil Monohydrochloride Dihydrate, CAS: 887375-67-9, stock: 8.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₃ClFN₃O₄S.
6-Dehydroxy 6-Oxo Faropenem-d4, CAS: /, stock: 6.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₉D₄NO₅S.
Faropenem, CAS: 106560-14-9, stock: 1.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₅NO₅S.
Faropenem Daloxate, CAS: 141702-36-5, stock: 9.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₉NO₈S.
Faropenem Related Compound 3, CAS: 120705-67-1, stock: 7.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₃NO₅SSi.
Faropenem Sodium Salt Hemipentahydrate, CAS: 158365-51-6, stock: 9.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₄NNaO₅S•5/2H₂O.
Faropenem-d5, CAS: /, stock: 4.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₀D₅NO₅S.
(+/-)12-HpETE, CAS: 71030-35-8, stock: 6.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₂O₄.
(10E)-10-Heptadecenoic Acid, CAS: 126761-43-1, stock: 8.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₃₂O₂.
(10E)-10-Pentadecenoic Acid, CAS: 321744-58-5, stock: 2.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₈O₂.
(10E,12Z)-Methyl Ester 10,12-Octadecadienoate, CAS: 21870-97-3, stock: 8.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₄O₂.
(10Z,12E)-Linoleic Acid Methyl Ester, CAS: 13058-53-2, stock: 6.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₄O₂.
(11E)-11-Hexadecenoic Acid Methyl Ester, CAS: 132170-71-9, stock: 8.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₃₂O₂.
(11Z)-11-Eicosenoic Acid, CAS: 5561-99-9, stock: 2.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₈O₂.
(12Z,15Z)-12,15-Heneicosadienoic Acid, CAS: 191545-08-1, stock: 5.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₈O₂.
(13E)-13-Docosenoic Acid, CAS: 506-33-2, stock: 8.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₄₂O₂.
(13Z,16Z,19Z)-13,16,19-Docosatrienoic Acid, CAS: 28845-86-5, stock: 4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₈O₂.
(14Z)-14-Eicosenoic Acid, CAS: 17735-95-4, stock: 7.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₈O₂.
(1E,3R)-1-Iodo-1-penten-3-ol, CAS: 126641-06-3, stock: 5.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₉IO.
(21E/Z,36Z)-2-Docosyl-3-hydroxy-21,36-pentapentacontadienoic Acid, CAS: 958726-09-5, stock: 7.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇₇H₁₅₀O₃.
(2E)-3-(4-Phenoxyphenyl)-2-propenoic Acid Ethyl Ester, CAS: 945414-28-8, stock: 2.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₆O₃.
(2R)- 2-[[(1,1-Dimethylethyl)diphenylsilyl]oxy]-5-(trimethylsilyl)-4-pentynal, CAS: 1220354-17-5, stock: 5.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₂O₂Si₂.
(2R)-1-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-5-(trimethylsilyl)-4-pentyn-2-ol, CAS: 380909-90-0, stock: 7.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₃₀O₂Si₂.
(2E,6E)-3,7,11-Trimethyldodeca-2,6,10-trien-1-yl Acetate, CAS: 4128-17-0, stock: 9.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₈O₂.
(2R)-2-[[(1,1-Dimethylethyl)diphenylsilyl]oxy]-5-(trimethylsilyl)-4-pentyn-1-ol, CAS: 1251537-18-4, stock: 8.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₄O₂Si₂.
(2R)-2-[[(1,1-Dimethylethyl)diphenylsilyl]oxy]butanal, CAS: 1309610-38-5, stock: 3.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₆O₂Si.
(E)-3,7,11-Trimethyldodeca-6,10-dien-1-ol, CAS: 51411-24-6, stock: 7.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₈O.
(E,E)-Farnesol, CAS: 106-28-5, stock: 7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₆O.
(E,E)-Farnesol 11,11,11,12,12,12-d6, CAS: 166447-71-8, stock: 3.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₀D₆O.
(4Z,6E)-4,6-Octadienal, CAS: 95404-20-9, stock: 5.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₂O.
(E,E)-Farnesol-13C3, CAS: /, stock: 2.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂¹³C₃H₂₆O.
(E,E)-Farnesyl Bromide, CAS: 28290-41-7, stock: 9.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₅Br.
(4Z,6E)-4,6-Octadienoic Acid Ethyl Ester, CAS: 1173170-10-9, stock: 8.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₆O₂.
(4Z,7Z,10Z,13Z,16Z) 4,7,10,13,16-Docosapentaenoic Acid Methyl Ester, CAS: 31930-67-3, stock: 2.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₆O₂.
(E,E)-Farnesyl Bromide (~90% purity), CAS: 28290-41-7, stock: 3.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₅Br.
(5R)-2,2,8,8,9,9-Hexamethyl-3,3-diphenyl-5-[3-(trimethylsilyl)-2-propyn-1-yl]-4,7-ddioxa-3,8-disiladecane, CAS: 1251537-17-3, stock: 8.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₄₈O₂Si₃.
(5S)-5-Hydroxy-6-heptynoic Acid 1-Methylethyl Ester, CAS: 1251537-14-0, stock: 4.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₆O₃.
(5S,6E,8Z)-5,18-Dihydroxy-6,8-octadecadienoic Acid, CAS: 1021188-24-8, stock: 7.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₂O₄.
(5S,6E,8Z)-5-Hydroxy-6,8-octadecadienoic Acid, CAS: 1021188-23-7, stock: 6.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₂O₃.
(5S,8E,10E,12R)-12-[[(1,1-Dimethylethyl)diphenylsilyl]oxy]-5-hydroxy-15-(trimethylsilyl)-8,10-Pentadecadiene-6,14-diynoic acid 1-Methylethyl Ester, CAS: 1251537-19-5, stock: 1.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₅₀O₄Si₂.
(5S,8E,10E,12R)-5,12-Dihydroxy-8,10-pentadecadiene-6,14-diynoic Acid 1-Methylethyl Ester, CAS: 1251537-11-7, stock: 3.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₄O₄.
Farnesol (Mixture of Isomers), CAS: 4602-84-0, stock: 7.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₆O.
(5S,8E,10E,12R,16E,18R)-5,12,18-Trihydroxy-8,10,16-Elcosatriene-6,14-diynoic Acid 1-Methylethyl Ester, CAS: 1309610-40-9, stock: 6.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₂O₅.
(5Z)-5-Dodecenoic acid, CAS: 2430-94-6, stock: 9.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₂O₂.
Solanesol (~90%), CAS: 13190-97-1, stock: 3.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₅H₇₄O.
trans-2,3-Epoxyfarnesol, CAS: 83680-00-6, stock: 6.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₆O₂.
(6E,8Z)-18-Hydroxy-5-oxo-6,8-octadecadienoic Acid, CAS: 1021188-26-0, stock: 1.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₀O₄.
(6E,8Z)-5-Oxo-6,8-octadecadienoic Acid, CAS: 1021188-25-9, stock: 4.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₀O₃.
(7Z)-7-Hexadecenoic Acid Methyl Ester, CAS: 56875-67-3, stock: 4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₃₂O₂.
(7Z)-7-Hexadecenoic acid, CAS: 2416-19-5, stock: 9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₃₀O₂.
(7Z,10Z,13Z,16Z,19Z)-1-(Oleoyloxy)-3-(palmitoyloxy)propan-2-yl docosa-7,10,13,16,19-pentaenoate, CAS: /, stock: 6.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₉H₁₀₂O₆.
(7Z,10Z,13Z,16Z,19Z)-1-(Oleoyloxy)-3-(palmitoyloxy)propan-2-yl docosa-7,10,13,16,19-pentaenoate-D5, CAS: /, stock: 6.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₉H₉₇D₅O₆.
(8-Carboxyoctyl)triphenylphosphonium Bromide, CAS: 88462-46-8, stock: 9.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₂BrO₂P.
(9E)-12-Hydroxy-9-octadecenoic Acid, CAS: 82188-83-8, stock: 2.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₄O₃.
(9E,11E,13E)-9,11,13-Octadecatrienoic Acid, CAS: 544-73-0, stock: 4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₀O₂.
(9E,11E)-9,11-Octadecadienoic Acid, CAS: 544-71-8, stock: 9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₂O₂.
(9Z,11E)-Methyl Ester 9,11-Octadecadienoate, CAS: 13058-52-1, stock: 6.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₄O₂.
(9Z,11R,12S,13S)-11,12,13-Trihydroxy-9-octadecenoic Acid, CAS: 874393-58-5, stock: 2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₄O₅.
(9Z,12S)-Methyl 12-Bromo-9-octadecenoic Acid Ester, CAS: 474302-44-8, stock: 3.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₅BrO₂.
(9Z,12Z)-9,12-Octadecadienoic Acid 1-[[(1-Oxohexadecyl)oxy]methyl]-2-[[(9Z)-1-oxo-9-octadecenyl]oxy]ethyl Ester, CAS: 2579-00-2, stock: 4.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₅H₁₀₀O₆.
(9Z,12Z)-9,12-Octadecadienoic Acid 1-[[(1-Oxohexadecyl)oxy]methyl]-2-[[(9Z)-1-oxo-9-octadecenyl]oxy]ethyl Ester-D5, CAS: /, stock: 4.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₅H₉₅D₅O₆.
(9Z,12Z)-9,12-Octadecadien-1-ol, CAS: 506-43-4, stock: 7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₄O.
(9Z,9’Z)-1,1’-[1-(Chloromethyl)-1,2-ethanediyl] Ester 9-Hexadecenoic Acid, CAS: 1613232-85-1, stock: 5.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₅H₆₃ClO₄.
(all-cis)-7,10,13,16,19-Docosapentaenoic Acid, CAS: 24880-45-3, stock: 7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₄O₂.
(all-cis)-7,10,13,16,19-Docosapentaenoic Acid N-Hydroxysuccinimidyl Ester, CAS: 1798422-32-8, stock: 1.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₇NO₄.
(all-cis)-7,10,13,16,19-Docosapentaenoic-d5 Acid, CAS: 1215168-70-9, stock: 1.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₉D₅O₂.
(all-Z)-5,8,11,14-Eicosatetraenylphosphonofluoridic Acid Methyl Ester, CAS: 188404-10-6, stock: 6.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₆FO₂P.
(all-Z)-6,9,12,15,18-Heneicosapentaenoic Acid, CAS: 24257-10-1, stock: 8.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₂O₂.
(all-Z)-6,9,12,15,18-Heneicosapentaenoic Acid Methyl Ester, CAS: 65919-53-1, stock: 3.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₄O₂.
(all-Z)-6,9,12,15,18-Heneicosapentaenoic Acid Methyl Ester-d3, CAS: /, stock: 8.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₁D₃O₂.
(all-Z)-6,9,12,15,18-Heneicosapentaenoic Acid N-Succinimide, CAS: 1798431-50-1, stock: 2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₅NO₄.
(all-Z)-6,9,12,15,18-Heneicosapentaenoic-d5 Acid, CAS: /, stock: 5.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₇D₅O₂.
(All-Z)-7,10,13,16,19-Docosapentaenoic Acid Ethyl Ester, CAS: 119818-40-5, stock: 3.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₈O₂.
(All-Z)-7,10,13,16,19-Docosapentaenoic Acid Ethyl Ester-d5, CAS: /, stock: 8.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₃D₅O₂.
(All-Z)-7,10,13,16,19-Docosapentaenoic Acid Methyl Ester, CAS: 108698-02-8, stock: 9.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₆O₂.
(All-Z)-7,10,13,16,19-Docosapentaenoic Acid Methyl Ester-d3, CAS: /, stock: 8.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₃D₃O₂.
(all-Z)-9,12,15-Octadecatrienoic Acid 1-[[(1-Oxohexadecyl)oxy]methyl]-2-[(1-oxo-9-octadecenyl)oxy]ethyl Ester, CAS: 20929-69-5, stock: 3.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₅H₉₈O₆.
(all-Z)-9,12,15-Octadecatrienoic Acid 1-[[(1-Oxohexadecyl)oxy]methyl]-2-[(1-oxo-9-octadecenyl)oxy]ethyl Ester-D5, CAS: /, stock: 6.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₅H₉₃D₅O₆.
(±)-2-Hydroxydodecanoic Acid, CAS: 2984-55-6, stock: 4.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₄O₃.
(±)-trans-9,10-Epoxystearic Acid Methyl Ester, CAS: 6084-76-0, stock: 5.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₆O₃.
(±)-trans-9,10-Epoxystearic Acid Methyl Ester-d3, CAS: /, stock: 1.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₃D₃O₃.
(±)-12,13-DIHOME, CAS: 263399-35-5, stock: 6.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₄O₄.
(±)-7-Hydroxy-4Z,8E,10Z,13Z,16Z,19Z-docosahexaenoic Acid, CAS: 90780-55-5, stock: 6.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₂O₃.
(cis-9)-2-Hydroxy-17-oxo-octadecenoic Acid, CAS: 1159977-44-2, stock: 9.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₂O₄.
(cis-9)-2-Hydroxy-2-methyl-octadecenoic Acid, CAS: 1159977-39-5, stock: 7.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₆O₃.
(cis-9)-2-Hydroxyoctadecen-17-ynoic Acid, CAS: 1159977-43-1, stock: 3.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₀O₃.
(E)-4-Hydroxy Hexenal-d3, CAS: 148706-05-2, stock: 3.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₇D₃O₂.
(E)-5-Tetradecenoic Acid Methyl Ester, CAS: 105967-88-2, stock: 1.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₈O₂.
(E)-9-Tetradecenoic Acid, CAS: 50286-30-1, stock: 5.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₆O₂.
(R)-(+)-2-(4-Hydroxyphenoxy)propionic Acid, CAS: 94050-90-5, stock: 4.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₀O₄.
(R)-(+)-Docosahexaenyl-1’-Hydroxy-2’-Propylamide, CAS: 1282618-08-9, stock: 7.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₉NO₂.
(R,E)-4-((tert-Butyldiphenylsilyl)oxy)-7-(trimethylsilyl)hept-2-en-6-ynal, CAS: /, stock: 9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₄O₂Si₂.
(S)-1-tert-butyl 5-(2,5-dioxopyrrolidin-1-yl) 2-palmitamidopentanedioate, CAS: /, stock: 2.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₅₀N₂O₇.
(S)-2-Amino-1-[4-(trifluoromethoxy)phenyl]ethanol, CAS: 1567908-96-6, stock: 2.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₀F₃NO₂.
(S)-3-Chloro(propane-d5)-1,2-diyl Ditetradecanoate, CAS: /, stock: 7.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₅₄D₅ClO₄.
(S)-α-Methylbenzyl Ricinoleamide, CAS: 1246776-22-6, stock: 5.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₄₃NO₂.
(tert-Butoxycarbonylmethylene)triphenylphosphorane, CAS: 35000-38-5, stock: 6.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₅O₂P.
(Z)-11-Hexadecenoic Acid, CAS: 2416-20-8, stock: 2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₃₀O₂.
(Z)-11-Octadecenoic Acid, CAS: 506-17-2, stock: 2.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₄O₂.
(Z)-18-Fluoro-9-octadecenoic Acid, CAS: 1478-37-1, stock: 2.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₃FO₂.
(Z)-2-Eicosenoic Acid, CAS: 93772-82-8, stock: 4.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₈O₂.
(Z,Z,Z)-17-Bromo-3,6,9-Heptadecatriene, CAS: 156559-07-8, stock: 7.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₉Br.
(Z,Z,Z)-9,12,15-Octadecatrienenitrile-13C1, CAS: /, stock: 7.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇¹³CH₂₉N.
1,13-Tetradecadien-4-ol, CAS: 114837-51-3, stock: 3.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₆O.
1,1’-[(1,1-Dimethylethyl)[[(1R,2E)-1-ethyl-3-iodo-2-propen-1-yl]oxy]silylene]bis-benzene, CAS: 1309610-39-6, stock: 4.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₇IOSi.
1,1’-[(1,1-Dimethylethyl)[[(1R,2E,4E)-5-iodo-1-[3-(trimethylsilyl)-2-propyn-1-yl]-2,4-pentadien-1-yl]oxy]silylene]bis-benzene, CAS: 1220354-19-7, stock: 2.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₅IOSi₂.
1,2-Dioleoyl-sn-glycero-3-phosphatidylethanolamine (DOPE), CAS: 01/05/4004, stock: 5.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₁H₇₈NO₈P.
1,2-Dioleoyl-sn-glycero-3-phosphatidylethanolamine-d4, CAS: /, stock: 3.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₁H₇₄D₄NO₈P.
1,2-Dipalmitoyl-rac-glycero-3-phosphoethanolamine, CAS: 5681-36-7, stock: 2.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₇₄NO₈P.
1,7-Octadien-4-ol, CAS: 58728-81-7, stock: 9.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₄O.
1,7-Octadien-4-ol 4-Acetate, CAS: 212008-62-3, stock: 7.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₆O₂.
1,8-Bis(dimethylamino)naphthalene, CAS: 20734-58-1, stock: 4.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₈N₂.
1-(7Z,10Z,13Z,16Z-Docosatetraenoyl)-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-glycero-3-phosphate, CAS: /, stock: 7.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₅H₇₃O₈P.
1-(7Z,10Z,13Z,16Z-Docosatetraenoyl)-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-glycero-3-phosphate-d8, CAS: /, stock: 7.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₅H₆₅D₈O₈P.
1-(Chloromethyl)-2-[(tert-butyldimethylsilyl)oxy]ethyl Ester Hexadecanoic Acid, CAS: /, stock: 5.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₅₁ClO₃Si.
1-(Chloromethyl)-2-[(trimethylsilyl)oxy]ethyl Ester Hexadecanoic Acid, CAS: /, stock: 9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₄₅ClO₃Si.
1-Acetylcyclododecene, CAS: 65938-08-1, stock: 5.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₄O.
1-Bromo-2,5,8,11-tetradecatetrayne, CAS: 07/06/5871, stock: 7.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₃Br.
1-Bromo-2,5,8-undecatriyne, CAS: 34498-25-4, stock: 1.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₁Br.
1-Decanoyl-2-lauroyl-3-chloropropanediol, CAS: /, stock: 6.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₄₇ClO₄.
1-Decanoyl-2-octanoyl-3-chloropropanediol, CAS: /, stock: 8.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₉ClO₄.
1-Fluoro-2-iodoethane, CAS: 762-51-6, stock: 9.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂H₄FI.
1-Iodo-3,7-dimethyloctane, CAS: 124186-79-4, stock: 6.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₂₁I.
1-Isopropyl-1H-pyrazolo[3,4-b]pyridin-5-amine, CAS: 872103-27-0, stock: 8.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₂N₄.
1-Lauroyl-2-myristoyl-3-chloropropanediol, CAS: /, stock: 1.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₅₅ClO₄.
1-Lauroyl-2-myristoyl-3-chloropropanediol-13C3, CAS: /, stock: 2.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆¹³C₃H₅₅ClO₄.
1-Lauroyl-2-myristoyl-3-chloropropanediol-d5, CAS: /, stock: 2.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₅₀D₅ClO₄.
1-Linoleoyl-(2S)-glycerol, CAS: 67968-46-1, stock: 9.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₈O₄.
1-Linoleoyl-3-palmitoyl-rac-glycerol, CAS: 99032-71-0, stock: 4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₆₈O₅.
1-Linoleoyl-3-palmitoyl-rac-glycerol-d5, CAS: /, stock: 7.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₆₃D₅O₅.
1-Nonanol, CAS: 143-08-8, stock: 6.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₂₀O.
1-Octanol, CAS: 111-87-5, stock: 1.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₈O.
1-Octanol-d17, CAS: 153336-13-1, stock: 7.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈HD₁₇O.
1-Octanoyl-2-decanoyl-3-chloropropanediol, CAS: /, stock: 9.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₉ClO₄.
1-Palmitoyl-2-linoleoyl-rac-glycerol, CAS: 73649-99-7, stock: 2.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₆₈O₅.
1-Palmitoyl-2-linoleoyl-rac-glycerol-d5, CAS: /, stock: 8.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₆₃D₅O₅.
1-Pyrenedodecanoic acid, CAS: 69168-45-2, stock: 7.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₂O₂.
1-Stearoyl-sn-glycerol, CAS: 22610-61-3, stock: 8.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₄₂O₄.
1-Tetratriacontanamine, CAS: 66214-29-7, stock: 7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₄H₇₁N.
1-[[(1-Oxohexadecyl)oxy]methyl]-2-[[(9Z)-1-oxo-9-octadecen-1-yl]oxy]ethyl (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,16,19-docosahexaenoate, CAS: 1428732-77-7, stock: 6.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₉H₁₀₀O₆.
1-[[(1-Oxohexadecyl)oxy]methyl]-2-[[(9Z)-1-oxo-9-octadecen-1-yl]oxy]ethyl (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,16,19-docosahexaenoate-D5, CAS: /, stock: 5.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₉H₉₅D₅O₆.
1-[[(1-Oxohexadecyl)oxy]methyl]-2-[[(9Z)-1-oxo-9-octadecen-1-yl]oxy]ethyl (5Z,8Z,11Z,14Z)-5,8,11,14-eicosatetraenoate, CAS: 828253-85-6, stock: 2.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₇H₁₀₀O₆.
1-[[(1-Oxohexadecyl)oxy]methyl]-2-[[(9Z)-1-oxo-9-octadecen-1-yl]oxy]ethyl (5Z,8Z,11Z,14Z)-5,8,11,14-eicosatetraenoate-D5, CAS: /, stock: 8.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₇H₉₅D₅O₆.
1-[[(1-Oxohexadecyl)oxy]methyl]-2-[[(9Z)-1-oxo-9-octadecen-1-yl]oxy]ethyl (5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-eicosapentaenoate, CAS: 148691-16-1, stock: 9.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₇H₉₈O₆.
1-[[(1-Oxohexadecyl)oxy]methyl]-2-[[(9Z)-1-oxo-9-octadecen-1-yl]oxy]ethyl (5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-eicosapentaenoate-D5, CAS: /, stock: 5.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₇H₉₃D₅O₆.
10(S),17(S)-DiHDoHE, CAS: 871826-47-0, stock: 9.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₂O₄.
10-cis,12-trans-Linoleic Acid, CAS: 2420-44-2, stock: 5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₂O₂.
10-Doxyl Stearic Acid, CAS: 50613-98-4, stock: 7.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₄₂NO₄.
10-trans,12-cis-Linoleic Acid, CAS: 2420-56-6, stock: 8.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₂O₂.
10-Undecynoic Acid, CAS: 2777-65-3, stock: 3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₈O₂.
11-Hydroxyundecanoic acid, CAS: 3669-80-5, stock: 5.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₂₂O₃.
12(S)-HEPE, CAS: 116180-17-7, stock: 6.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₀O₃.
12(S)-HPETE, CAS: 71774-10-2, stock: 5.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₂O₄.
12-(7-Nitrobenzofurazan-4-ylamino)dodecanoic acid, CAS: 96801-39-7, stock: 5.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₆N₄O₅.
12-BODIPY-dodecanoic Acid, CAS: 158757-79-0, stock: 7.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₃BF₂N₂O₂.
12-Methyltetradecanoic Acid, CAS: 5502-94-3, stock: 4.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₃₀O₂.
12-Methyltridecanol, CAS: 21987-21-3, stock: 5.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₃₀O.
12-Methyltridecanol-d7, CAS: 1794885-54-3, stock: 5.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₃D₇O.
12-SAHSA, CAS: 51350-61-9, stock: 2.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₆H₇₀O₄.
13(Z),16(Z)-Docosadienoic Acid, CAS: 17735-98-7, stock: 8.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₄₀O₂.
14-Doxylstearic Acid, CAS: 50614-00-1, stock: 3.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₄₂NO₄.
14-Methylpentadecanoic Acid, CAS: 07/02/4669, stock: 9.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₃₂O₂.
15-epi-Lipoxin A4 Sodium Salt, CAS: /, stock: 4.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₁NaO₅.
15-Hydroxypentadecanoic Acid, CAS: 4617-33-8, stock: 8.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₃₀O₃.
16-DOXYL-stearic acid, free radical, CAS: 53034-38-1, stock: 7.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₄₂NO₄.
16-Heptadecyn-1-ol, CAS: 62873-30-7, stock: 2.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₃₂O.
16-Heptadecynoic Acid, CAS: 93813-16-2, stock: 6.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₃₀O₂.
17-Hydroxyheptadecanoic Acid, CAS: 13099-34-8, stock: 10g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₃₄O₃.
3,4-Diaminopyridine, CAS: 54-96-6, stock: 7.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₇N₃.
2,2,2-Trichloroethyl Chloroformate, CAS: 17341-93-4, stock: 2.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃H₂Cl₄O₂.
3,4-Diaminopyridine-d3, CAS: /, stock: 8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₄D₃N₃.
4-Amino-3-hydroxypyridine, CAS: 52334-53-9, stock: 6.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₆N₂O.
2,3-Dimethyl-1-butene, CAS: 563-78-0, stock: 4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₂.
Dalfampridine, CAS: 504-24-5, stock: 7.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₆N₂.
Dalfampridine-d4, CAS: /, stock: 9.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₂D₄N₂.
2,5,8,11-Tetradecatetrayn-1-ol, CAS: 03/10/5871, stock: 1.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₄O.
2,5,8-Undecatriyn-1-ol, CAS: 35378-82-6, stock: 7.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₂O.
Dalfampridine-d6, CAS: 45498-20-2, stock: 6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅D₆N₂.
N,N’-Bis(4-pyridyl)urea, CAS: 39642-87-0, stock: 9.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₀N₄O.
2,6-Dimethylheptanoic Acid, CAS: 04/12/7494, stock: 8.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₈O₂.
2,6-Dimethylheptanoic Anhydride Ethyl Carbonic, CAS: /, stock: 9.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₂O₄.
2-(4-Heptyn-1-yloxy)tetrahydro-2H-pyran, CAS: 1420074-18-5, stock: 5.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₀O₂.
2-(Tributylstannyl)oxazole, CAS: 145214-05-7, stock: 3.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₉NOSn.
2-Acetoxy-3-((trimethylsilyl)oxy)propyl Nonadecanoate, CAS: /, stock: 8.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₅₄O₅Si.
2-Amino-1-(4-phenoxyphenyl)ethanol, CAS: 153285-74-6, stock: 1.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₅NO₂.
2-Amino-1-[4-(trifluoromethoxy)phenyl]ethanol, CAS: 1038262-63-3, stock: 9.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₀F₃NO₂.
2-Amino-3-(trifluoromethyl)pyridine, CAS: 183610-70-0, stock: 2.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₅F₃N₂.
2-Benzyloxypyridine-4-boronic Acid, Pinacol Ester, CAS: 1256359-03-1, stock: 2.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₂BNO₃.
2-Carboxyethylboronic Acid, Pinacol Ester, CAS: 1191063-90-7, stock: 7.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₇BO₄.
2-Ethylphenol, CAS: 90-00-6, stock: 8.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₀O.
2-Fluoropropionic Acid, CAS: 6087-13-4, stock: 4.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃H₅FO₂.
2-Heptadecyn-1-ol, CAS: 2833-98-9, stock: 7.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₃₂O.
2-Hexadecyl-octadecanoic Acid, CAS: 89547-15-9, stock: 2.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₄H₆₈O₂.
2-Hexadecyl-octadecanoic Acid Ethyl Ester, CAS: 1082676-11-6, stock: 6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₆H₇₂O₂.
2-Hexadecyl-octadecanoic Acid Ethyl-d5 Ester, CAS: /, stock: 4.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₆H₆₇D₅O₂.
2-Hexadecyl-octadecanoic Acid Methyl Ester, CAS: 17658-53-6, stock: 7.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₅H₇₀O₂.
2-Hexadecyl-octadecanoic Acid Methyl-d3 Ester, CAS: /, stock: 3.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₅H₆₇D₃O₂.
2-Hydroxyhexadecanoic Acid, CAS: 764-67-0, stock: 1.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₃₂O₃.
2-Hydroxytricosanoic Acid, CAS: 2718-37-8, stock: 4.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₄₆O₃.
2-Iodo-m-xylene, CAS: 608-28-6, stock: 4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₉I.
2-Linoleoyl-rac-glycerol, CAS: 3443-82-1, stock: 7.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₈O₄.
2-Linoleoyl-rac-glycerol-d5, CAS: /, stock: 1.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₃D₅O₄.
2-Octyldodecyl Oleate, CAS: 22801-45-2, stock: 8.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₈H₇₄O₂.
2-Propyl-2-heptenal, CAS: 34880-43-8, stock: 3.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₈O.
3,12-Dihydroxyhexadecanoic Acid, CAS: 66675-73-8, stock: 8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₃₂O₄.
3,4-Dimethyl-2(5H)-furanone, CAS: 1575-46-8, stock: 6.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₈O₂.
3,4-Dimethyl-2-pentylfuran, CAS: 71041-47-9, stock: 1.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₈O.
3,4-Dimethyl-5-pentyl-2-furannonanoic Acid, CAS: 57818-40-3, stock: 7.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₄O₃.
3,4-Dimethyl-5-pentyl-2-furannonanoic Acid Methyl Ester, CAS: 81144-79-8, stock: 6.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₆O₃.
3,4-Dimethyl-5-pentyl-2-furantridecanoic Acid, CAS: 57818-43-6, stock: 7.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₄₂O₃.
3,4-Dimethyl-5-pentyl-2-furanundecanoic Acid, CAS: 57818-36-7, stock: 6.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₈O₃.
3,4-Dimethyl-5-propyl-2-furannonanoic Acid, CAS: 57818-38-9, stock: 2.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₀O₃.
3,4-Dimethyl-5-propyl-2-furanundecanoic Acid, CAS: 57818-41-4, stock: 9.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₄O₃.
3,7-Dimethyl-1-octene, CAS: 04/01/4984, stock: 8.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₂₀.
3-(Acetyloxy)hexanedioic Acid, CAS: 938447-36-0, stock: 6.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₂O₆.
3-(Phenylsulfonyl)-N-(4-(trifluoromethyl)phenyl)-8-azabicyclo[3.2.1]octane-8-carboxamide, CAS: 1170321-78-4, stock: 9.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₁F₃N₂O₃S.
3-(Trifluoromethyl)phenyl Chloroformate, CAS: 95668-29-4, stock: 7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₄ClF₃O₂.
3-Hydroxy-hexadecanoic Acid, CAS: 2398-34-7, stock: 6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₃₂O₃.
3-Chloro-1,2-propanediol, CAS: 96-24-2, stock: 7.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃H₇ClO₂.
3-Cyanophenylboronic acid, CAS: 150255-96-2, stock: 8.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆BNO₂.
3-Hydroxydodecanedioic Acid, CAS: 34574-69-1, stock: 7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₂O₅.
3-Hydroxydodecanoic Acid Methyl Ester, CAS: 72864-23-4, stock: 5.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₂₆O₃.
3-Hydroxyheptadecanoic Acid Methyl Ester, CAS: 112538-92-8, stock: 8.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₆O₃.
3-Hydroxyhexadecanoic Acid Methyl Ester, CAS: 51883-36-4, stock: 2.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₃₄O₃.
3-Hydroxyhexanoic Acid, CAS: 10191-24-9, stock: 1.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₂O₃.
3-Hydroxyoctadecanoic Acid Methyl Ester, CAS: 2420-36-2, stock: 8.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₈O₃.
3-Hydroxyundecanoic Acid Methyl Ester, CAS: 129758-71-0, stock: 6.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₄O₃.
3-Methyl-5-pentyl-2-furannonanoic Acid, CAS: 57818-39-0, stock: 1.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₂O₃.
3-Methyl-5-pentyl-2-furantridecanoic Acid, CAS: 57818-42-5, stock: 1.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₄₀O₃.
3-Methyl-5-pentyl-2-furanundecanal, CAS: 202146-74-5, stock: 8.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₆O₂.
3-Methyl-5-pentyl-2-furanundecanoic Acid, CAS: 57818-37-8, stock: 4.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₆O₃.
3-Octenoic Acid, CAS: 1577-19-1, stock: 7.9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₄O₂.
4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-Heptadecafluoroundecanoic Acid, CAS: 34598-33-9, stock: 3.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₅F₁₇O₂.
4-(Chloromethyl)-2,2,7,7-tetramethyl-3,6-dioxa-2,7-disilaoctane, CAS: 73639-52-8, stock: 2.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₂₃ClO₂Si₂.
1-(1-Ethoxyethoxy)-3,7,11-trimethyl-2,6,10-dodecatriene, CAS: /, stock: 1.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₄O₂.
4-Amino-2-chloro-3-nitropyridine, CAS: 2789-25-5, stock: 6.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₄ClN₃O₂.
2,6,10-Trimethyl-2,6,10-dodecatriene, CAS: 7681-88-1, stock: 3.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₆.
Farnesane, CAS: 3891-98-3, stock: 5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₃₂.
4-Fluoropyridin-3-yl Boronic Acid, CAS: 860626-80-8, stock: 4.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₅BFNO₂.
4-Methyl-2-oxazolidinone, CAS: 16112-59-7, stock: 5.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₇NO₂.
4-Nitrophenyl Myristate, CAS: 14617-85-7, stock: 8.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₁NO₄.
4-Oxo-2-Nonenal Alkyne, CAS: 1680193-58-1, stock: 7.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₀O₂.
4-Pentynoic Acid Methyl Ester, CAS: 21565-82-2, stock: 7.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₈O₂.
4-Pentynoic Acid Methyl Ester-d3, CAS: /, stock: 4.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₅D₃O₂.
4-Phenoxy-benzenepropanoic Acid Ethyl Ester, CAS: 861856-61-3, stock: 5.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₈O₃.
4-Pyridinecarbonyl Azide, CAS: 4013-73-4, stock: 1.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄N₄O.
4-[2-(N-BOC-N-Methyl)aminoethyl]phenylboronic acid, CAS: 1191062-03-9, stock: 6.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₂BNO₄.
5-Aminomethyl-2-chloropyridine, CAS: 97004-04-1, stock: 6.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₇ClN₂.
5-(Oleoyloxy)octadecanoic Acid, CAS: /, stock: 7.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₆H₆₈O₄.
5-Methyloctanoic Acid, CAS: 60218-42-0, stock: 1.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₈O₂.
5-Oxo-7-(trimethylsilyl)-6-heptynoic Acid 1-Methylethyl Ester, CAS: 1251537-12-8, stock: 8.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₂₂O₃Si.
6,9,12,15,18-Heneicosapentayn-1-ol, CAS: 84456-77-9, stock: 2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₄O.
6-Bromo Nicotinic Acid, CAS: 6311-35-9, stock: 1.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄BrNO₂.
6-Bromo Nicotinic Acid Ethyl Ester, CAS: 132334-98-6Lab 9 <lab9@lab-9>, stock: 5.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₈BrNO₂.
6-Heptynoic Acid, CAS: 30964-00-2, stock: 5.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₀O₂.
7(S),17(S)-Resolvin D5, CAS: 578008-43-2, stock: 4.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₂O₄.
7,11-Hexadecadien-1-yl Acetate, CAS: 50933-33-0, stock: 6.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₂O₂.
7-Doxyl Stearic Acid, CAS: 40951-82-4, stock: 8.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₄₂NO₄.
7-Hydroxy Myristic Acid, CAS: 70393-63-4, stock: 4.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₈O₃.
7-Oxooctadecanoic Acid Methyl Ester, CAS: 2380-22-5, stock: 5.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₆O₃.
8(S)-HETE, CAS: 98462-03-4, stock: 10g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₂O₃.
9,10-Epoxystearic Acid-d17, CAS: /, stock: 3.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₇D₁₇O₃.
9,9’-(Hydrazine-1,2-diylidene)bis(9-(3,4-dimethyl-5-pentylfuran-2-yl)nonanoic Acid), CAS: /, stock: 8.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₀H₆₄N₂O₆.
9-(3,4-Dimethyl-5-pentylfuran-2-yl)-9-hydroxynonanoic Acid Methyl Ester, CAS: /, stock: 6.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₆O₄.
9-(3,4-Dimethyl-5-pentylfuran-2-yl)-9-oxononanoic Acid Methyl Ester, CAS: 99290-31-0, stock: 7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₄O₄.
9-Bromononanoic Acid, CAS: 41059-02-3, stock: 9.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₇BrO₂.
9-cis-Retinyl Linoleate, CAS: 79299-81-3, stock: 1.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₈H₆₀O₂.
9-cis-Retinyl Oleate, CAS: 79433-57-1, stock: 9.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₈H₆₂O₂.
9-cis-Retinyl Oleate-d17, CAS: 1795134-64-3, stock: 2.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₈H₄₅D₁₇O₂.
9-cis-Retinyl Palmitate, CAS: 34356-29-1, stock: 9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₆H₆₀O₂.
9-cis-Retinyl Palmitate-d5, CAS: 1331666-45-5, stock: 2.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₆H₅₅D₅O₂.
9-cis-Retinyl Stearate, CAS: 79299-77-7, stock: 6.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₈H₆₄O₂.
9-cis-Retinyl Stearate-d5, CAS: 1331643-11-8, stock: 3.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₈H₅₉D₅O₂.
9-cis-Retinyl Stearate-d5, CAS: /, stock: 4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₈H₅₉D₅O₂.
9-cis-Retinyl-d5 Linoleate, CAS: /, stock: 4.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₈H₅₅D₅O₂.
9-Decenoic Acid, CAS: 14436-32-9, stock: 8.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₈O₂.
9-Nitro Oleic Acid, CAS: 875685-44-2, stock: 1.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₃NO₄.
9-Phenyl-nonanoic Acid, CAS: 16269-06-0, stock: 6.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₂O₂.
9Z,11E,13E-Octadecatrienoic Acid Ethyl Ester, CAS: 42021-86-3, stock: 2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₄O₂.
AM 374, CAS: 86855-26-7, stock: 7.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₃₃FO₂S.
AM 404, CAS: 183718-77-6, stock: 2.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₇NO₂.
AM 404-d4, CAS: 1185244-71-6, stock: 1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₃D₄NO₂.
AR 420626, CAS: 1798310-55-0, stock: 1.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₈Cl₂N₂O₃.
Arachidic Acid, CAS: 506-30-9, stock: 1.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₄₀O₂.
Arachidic Acid N-Hydroxysuccinimide Ester, CAS: 69888-87-5, stock: 4.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₄₃NO₄.
Avenoleic Acid, CAS: 177931-23-6, stock: 3.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₂O₃.
Azelaic Acid Monoethyl Ester, CAS: 1593-55-1, stock: 9.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₂₀O₄.
Behenamide, CAS: /, stock: 6.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₄₅NO.
Behenamide (Technical Grade), CAS: 3061-75-4, stock: 1.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₄₅NO.
Benzhydryl Bromide, CAS: 776-74-9, stock: 3.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₁Br.
Bischloroanthrabenzoxocinone, CAS: 866022-28-8, stock: 2.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₂₄Cl₂O₇.
BML-275, CAS: 866405-64-3, stock: 8.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₅N₅O.
Bongkrekic Acid, Triammonium Salt, CAS: /, stock: 9.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₈O₇ • 3NH ₃.
Bovine Ifabp(Intestinal Fatty Acid Binding Protein) ELISA Kit (96T), CAS: /, stock: 7.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Bovine L-FABP(Liver Fatty acid Binding Protein) ELISA Kit (96T), CAS: /, stock: 6.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Bovine SLC27A1 (Long-chain fatty acid transport protein 1) ELISA Kit (96T), CAS: /, stock: 6.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Butyl Ricinoleate, CAS: 151-13-3, stock: 8.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₄₂O₃.
3-[2-(Diaminomethyleneamino)-1,3-thiazol-4-ylmethylsulphinyl]-N-sulphamoylpropanamide (Famotidine Metabolite), CAS: 1020719-36-1, stock: 4.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₄N₆O₄S₃.
3-[2-(Diaminomethyleneamino)-1,3-thiazol-4-ylmethylsulphinyl]-N-sulphamoylpropanamidineFamotidine Sulfoxide, CAS: 90237-03-9, stock: 2.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₅N₇O₃S₃.
3-[[[2-[(Aminoiminomethyl)amino]-4-thiazolyl]methyl]thio]propanamide, CAS: 76824-16-3, stock: 9.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₃N₅OS₂.
3-[[[2-[(Diaminomethylene)amino]-4-thiazolyl]methyl]thio]propanimidamide Hydrochloride, CAS: 76833-47-1, stock: 2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₄N₆S₂ • HCl.
3-[[[2-[(Diaminomethylene]amino-4-thiazolyl]thio]propionitrile, CAS: 76823-93-3, stock: 2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₁N₅S₂.
Bis[(2-guanidino-4-thiazolyl)methyl]disulfide (85%)(Famotidine Impurity), CAS: 129083-44-9, stock: 6.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄N₈S₄.
Dediaminosulfonyl Hydroxymethyl Famotidine, CAS: 76823-94-4, stock: 2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₅N₅OS₂.
CDDO Imidazolide, CAS: 443104-02-7, stock: 2.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₄H₄₃N₃O₃.
Cerulenin (Synthetic), CAS: 17397-89-6, stock: 3.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₇NO₃.
Famotidine, CAS: 76824-35-6, stock: 7.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₅N₇O₂S₃.
Cetyl Stearate, CAS: 1190-63-2, stock: 6.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₄H₆₈O₂.
Famotidine Acid Impurity, CAS: 107880-74-0, stock: 3.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₂N₄O₂S₂.
Famotidine Acid Methyl Ester Acetic Acid Salt(Famotidine Impurity), CAS: /, stock: 2.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₈N₄O₄S₂.
Famotidine Acid Methyl Ester Hydrochloride (Famotidine Impurity), CAS: 1798006-30-0, stock: 7.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₅ClN₄O₂S₂.
Famotidine Amide Impurity Hydrochloride, CAS: /, stock: 7.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₄ClN₅OS₂.
Famotidine Related Compound A Dihydrochloride, CAS: 88061-72-7, stock: 2.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₆Cl₂N₆S₂.
Famotidine Related Compound B, CAS: 89268-62-2, stock: 4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₃N₁₁O₂S₅.
Famotidine-13C,d4 Acid Impurity, CAS: 1324230-60-5, stock: 6.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇¹³CH₈D₄N₄O₂S₂.
Chloroborane Methyl Sulfide Complex (Technical Grade), CAS: 63348-81-2, stock: 7.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂H₈BClS.
Famotidine-13C,d4 Amide Impurity, CAS: 1327321-45-8, stock: 3.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇¹³CH₉D₄N₅S₂.
Famotidine-13C3, CAS: 1185241-48-8, stock: 1.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅¹³C₃H₁₅N₇O₂S₃.
Famotidine-d4 (Major), CAS: /, stock: 7.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₁D₄N₇O₂S₃.
N-(Aminosulfonyl)-3-chloropropanamide, CAS: 88068-99-9, stock: 4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃H₇ClN₂O₃S.
cis-10-Heptadecenoic Acid, CAS: 29743-97-3, stock: 2.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₃₂O₂.
cis-10-Pentadecenoic Acid, CAS: 84743-29-3, stock: 7.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₈O₂.
N-Desaminosulfonyl-N-cyano Famotidine, CAS: 76823-97-7, stock: 2.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₃N₇S₂.
S-(2-Guanidino-4-thiazolyl)methylisothiourea Dihydrochloride, CAS: 88046-01-9, stock: 7.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₂Cl₂N₆S₂.
cis-11,14,17-Eicosatrienoic Acid Methyl Ester, CAS: 62472-96-2, stock: 3.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₆O₂.
cis-2,17-Dihydroxy-9-octadecenedioic Acid, CAS: /, stock: 8.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₂O₆.
[3-[[[2-(Diaminomethyleneamino)-4-thiazolyl]methyl]thio]propionyl]sulfamide Hydrochloride(Famotidine Impurity), CAS: 76824-17-4, stock: 5.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₅ClN₆O₃S₃.
cis-5-Tetradecenoic Acid, CAS: 5684-70-8, stock: 1.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₆O₂.
cis-5-Tetradecenoic Acid Methyl Ester, CAS: 28369-26-8, stock: 5.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₈O₂.
cis-7,10,13,16-Docosatetraenoic Acid Methyl Ester, CAS: 13487-42-8, stock: 2.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₈O₂.
cis-7,10,13,16-Docosatetraenoic Acid Methyl Ester-d3, CAS: /, stock: 7.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₅D₃O₂.
cis-8,11,14-Eicosatrienoic Acid, CAS: 1783-84-2, stock: 1.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₄O₂.
cis-8,11,14-Eicosatrienoic Acid Ethyl Ester, CAS: 55968-21-3, stock: 6.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₈O₂.
cis-8,11,14-Eicosatrienoic Acid Ethyl Ester-d5, CAS: /, stock: 9.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₃D₅O₂.
cis-8,11,14-Eicosatrienoic Acid Methyl Ester, CAS: 21061-10-9, stock: 5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₆O₂.
cis-8,11,14-Eicosatrienoic Acid Methyl Ester-d3, CAS: /, stock: 2.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₃D₃O₂.
cis-8,11,14-Eicosatrienoic Acid N-Hydroxysuccinimide, CAS: 1798419-12-1, stock: 2.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₇NO₄.
cis-8,11,14-Eicosatrienoic Acid N-Hydroxysuccinimide-d6, CAS: /, stock: 7.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₁D₆NO₄.
cis-8,11,14-Eicosatrienoic Acid-d6, CAS: 81540-86-5, stock: 4.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₈D₆O₂.
Cyhalofop-butyl, CAS: 122008-85-9, stock: 6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₀FNO₄.
D,L-α-Hydroxy Myristic Acid, CAS: 2507-55-3, stock: 2.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₈O₃.
Decanoic-d19 Acid, CAS: 88170-22-3, stock: 3.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀HD₁₉O₂.
Decanoyl Chloride, CAS: 112-13-0, stock: 8.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₉ClO.
DHA-Paclitaxel, CAS: 199796-52-6, stock: 2.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆₉H₈₁NO₁₅.
Diethyl Malonate-1,2-13C2, CAS: 53051-82-4, stock: 2.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅¹³C₂H₁₂O₄.
Diethyl Malonate-13C2, CAS: 77386-82-4, stock: 7.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅¹³C₂H₁₂O₄.
Dimethyl Octadecanedioate, CAS: 1472-93-1, stock: 8.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₈O₄.
Dioctyldilauryltin, CAS: 3648-18-8, stock: 4.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₀H₈₀O₄Sn.
DL-Alaninol, CAS: 6168-72-5, stock: 3.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃H₉NO.
Docosahexaenoic Acid, CAS: 6217-54-5, stock: 5.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₂O₂.
Docosahexaenoic Acid Ethyl Ester, CAS: 81926-94-5, stock: 4.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₆O₂.
Docosahexaenoic Acid Ethyl-d5 Ester, CAS: /, stock: 6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₁D₅O₂.
Docosahexaenoic Acid N-Succinimide, CAS: 160801-26-3, stock: 2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₅NO₄.
Docosahexaenoic Acid-13C, CAS: /, stock: 4.6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁¹³CH₃₂O₂.
Docosahexaenoic Acid-13C22, CAS: /, stock: 7.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: ¹³C₂₂H₃₂O₂.
Docosahexaenoic Acid-d5, CAS: 1197205-71-2, stock: 2.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₇D₅O₂.
Docosahexaenoic Acid-d5 (>80%), CAS: /, stock: 5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₇D₅O₂.
Docosahexaenoic Acid-d5 Ethyl Ester, CAS: 159146-01-7, stock: 9.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₁D₅O₂.
Docosanoic Acid Methyl Ester, CAS: 929-77-1, stock: 3.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₄₆O.
Docosanoic Acid Methyl-d3 Ester, CAS: 77502-87-5, stock: 1.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₄₃D₃O₂.
Dodec-10-en-1-ol, CAS: 35237-63-9, stock: 6.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₄O.
Eicosanedioic Acid, CAS: 2424-92-2, stock: 6.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₈O₄.
Eicosanedioic Acid-d4, CAS: /, stock: 6.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₄D₄O₄.
Eicosapentaenoic Acid Ethyl-d5 Ester, CAS: 1392217-44-5, stock: 5.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₉D₅O₂.
Eicosapentaenoyl Serotonin, CAS: 199875-71-3, stock: 6.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₄₀N₂O₂.
Elaidamide, CAS: 4303-70-2, stock: 7.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₅NO.
Epicoccamide, CAS: 606139-26-8, stock: 6.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₅₁NO₉.
Erucic Acid, CAS: 112-86-7, stock: 8.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₄₂O₂.
Erucic Acid Ethyl Ester, CAS: 37910-77-3, stock: 9.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₄₆O₂.
Erucic Acid Ethyl-d5 Ester, CAS: /, stock: 5.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₄₁D₅O₂.
Erucic Acid Methyl Ester, CAS: 1120-34-9, stock: 7.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₄₄O₂.
Erucic Acid Methyl-d3 Ester, CAS: /, stock: 7.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₄₁D₃O₂.
Ethyl 2-(E)-Decenoate, CAS: 7367-88-6, stock: 8.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₂O₂.
Ethyl 4-Decenoate, CAS: 6142-44-5, stock: 6.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₂O₂.
1-(9-(2-(2,2-Dimethyl-1,3-dioxan-5-yl)ethyl)-2-(((4-methoxyphenyl)diphenylmethyl)amino)-9H-purin-8-yl)ethanol, CAS: /, stock: 4.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₅H₃₉N₅O₄.
Ethyl Decanoate, CAS: 110-38-3, stock: 3.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₄O₂.
1-(9-(2-(2,2-Dimethyl-1,3-dioxan-5-yl)ethyl)-2-(((4-methoxyphenyl)diphenylmethyl)amino)-9H-purin-8-yl)ethanone, CAS: /, stock: 3.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₅H₃₇N₅O₄.
2-(2-(2-Amino-8-(1-aminoethyl)-9H-purin-9-yl)ethyl)propane-1,3-diol, CAS: /, stock: 2.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₀N₆O₂.
Ethyl Decanoate-d5, CAS: /, stock: 4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₉D₅O₂.
Ethyl Laurate(Ethyl Dodecanoate), CAS: 106-33-2, stock: 1.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₈O₂.
2-(Acetoxymethyl)-4-bromobutyl Acetate, CAS: 126589-82-0, stock: 6.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₅BrO₄.
2-(Acetoxymethyl)-4-iodobutyl Acetate, CAS: 127047-77-2, stock: 1.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₅IO₄.
Ethyl Linoleate, CAS: 544-35-4, stock: 5.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₆O₂.
Ethyl Linoleate-d5, CAS: 1331665-14-5, stock: 6.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₁D₅O₂.
2-Amino-6-chloropurine, CAS: 10310-21-1, stock: 8.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₄ClN₅.
4-(2-Amino-9H-purin-9-yl)-2-(((methylsulfonyl)oxy)methyl)butyl acetate, CAS: /, stock: 1.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₉N₅O₅S.
4’-Desacetyloxy 4’Chloro Famciclovir, CAS: /, stock: 5.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₆ClN₅O₂.
6-Alkylamino Famciclovir, CAS: /, stock: 6.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₄N₆O₈.
Ethyl Stearate, CAS: 111-61-5, stock: 1.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₄₀O₂.
6-Chloro Desacetyl Famciclovir, CAS: /, stock: 3.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₆ClN₅O₃.
6-Chloro Didesacetyl Famciclovir, CAS: 172529-94-1, stock: 6.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄ClN₅O₂.
Ethyl Stearate-d5, CAS: 1216808-22-8, stock: 6.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₅D₅O₂.
Ethyl-d5 Dodecanoate, CAS: /, stock: 1.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₃D₅O₂.
6-Deoxypenciclovir, CAS: 104227-86-3, stock: 5.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₅N₅O₂.
6-Deoxypenciclovir hydrochloride, CAS: 246021-75-0, stock: 2.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₆ClN₅O₂.
6-Deoxypenciclovir-d4 Hydrochloride, CAS: /, stock: 6.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₂D₄ClN₅O₂.
6-Methoxy Famciclovir, CAS: 131266-11-0, stock: 1.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₁N₅O₅.
Glycerol 1,3-Dipalmitate, CAS: 502-52-3, stock: 2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₅H₆₈O₅.
Glycerol Trilinoleate, CAS: 537-40-6, stock: 1.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₇H₉₈O₆.
6-[4-Acetoxy-3-(acetoxymethyl)butyl] Famciclovir, CAS: /, stock: 9.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₃N₅O₈.
9-(2-(2,2-Dimethyl-1,3-dioxan-5-yl)ethyl)-N-((4-methoxyphenyl)diphenylmethyl)-9H-purin-2-amine, CAS: /, stock: 8.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₃₅N₅O₃.
Glycerol Trilinoleate-d5, CAS: /, stock: 6.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₇H₉₃D₅O₆.
Glycerol-d5 1,3-Dipalmitate, CAS: 65615-82-9, stock: 3.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₅H₆₃D₅O₅.
9-(4-Acetoxy-2-acetoxymethyl-but-1-yl)-2-aminopurine, CAS: 126589-69-3, stock: 9.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₉N₅O₄.
9-[2-(2,2-Dimethyl-1,3-dioxan-5-yl)ethyl]-9H-purin-2-amine, CAS: 104227-89-6, stock: 3.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₉N₅O₂.
Glycidyl Docosahexaenoate, CAS: /, stock: 4.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₆O₃.
Glycidyl Docosahexaenoate-d5, CAS: /, stock: 9.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₁D₅O₃.
9-[4-Acetoxy-3-(acetoxymethyl)butyl]-2-amino-6-chloropurine, CAS: 97845-60-8, stock: 7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₈ClN₅O₄.
Acetoxybutyl Aminopurin, CAS: /, stock: 9.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₅N₅O₂.
Glycidyl Eicosapentaenoate, CAS: /, stock: 3.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₄O₃.
Glycidyl Eicosapentaenoate-d5, CAS: 1795143-63-3, stock: 3.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₉D₅O₃.
Acetoxybutyl Aminopurin-d8, CAS: /, stock: 5.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₇D₈N₅O₂.
Arabin, CAS: 75272-82-1, stock: 5.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₂₁NOS₂.
Glycidyl Gondolenate, CAS: /, stock: 1.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₈O₃.
Glycidyl Gondolenate-d5, CAS: /, stock: 5.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₃D₅O₃.
Desacetoxy Chloro Famciclovir, CAS: /, stock: 9.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₆ClN₅O₂.
Glycidyl Laurate, CAS: 1984-77-6, stock: 1.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₈O₃.
Glycidyl Laurate (1.0 mg/mL in isopropanol), CAS: 1984-77-6, stock: 1.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₈O₃.
Desacetyl Famciclovir, CAS: 104227-88-5, stock: 2.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₇N₅O₃.
Desdiacetyl-8-oxo Famciclovir, CAS: 166197-79-1, stock: 4.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₅N₅O₃.
Glycidyl Laurate-d5, CAS: 1329563-35-0, stock: 4.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₃D₅O₃.
Desdiacetyl-8-oxo Famciclovir-d4, CAS: 1346603-55-1, stock: 8.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₁D₄N₅O₃.
Famciclovir, CAS: 104227-87-4, stock: 2.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₉N₅O₄.
Glycidyl Laurate-d5 (1.0 mg/mL in isopropanol), CAS: 1329563-35-0, stock: 1.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₃D₅O₃.
Glycidyl Linolenate, CAS: 51554-07-5, stock: 2.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₄O₃.
Famciclovir 8,N2-dimer, CAS: /, stock: 2.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₆N₁₀O₈.
Glycidyl Linolenate (1.0 mg/mL in isopropanol), CAS: 51554-07-5, stock: 1.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₄O₃.
Glycidyl Linolenate-d5, CAS: 1287393-54-7, stock: 5.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₉D₅O₃.
Famciclovir Malonate, CAS: 122497-20-5, stock: 9.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₅N₅O₄.
Famciclovir Methoxycarbonyl Analog, CAS: /, stock: 1.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₅N₅O₄.
Glycidyl Linolenate-d5 (1.0 mg/mL in isopropanol), CAS: 1287393-54-7, stock: 8.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₉D₅O₃.
Famciclovir-d4, CAS: 1020719-42-9, stock: 4.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₅D₄N₅O₄.
Hydroxy Famciclovir, CAS: 172645-79-3, stock: 3.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₉N₅O₅.
Glycidyl Palmitoleate, CAS: 213738-77-3, stock: 6.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₄O₃.
Glycidyl Palmitoleate-d5, CAS: /, stock: 9.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₉D₅O₃.
Hydroxy Famciclovir-d4, CAS: /, stock: 8.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₅D₄N₅O₅.
N-Acetyl Famciclovir, CAS: /, stock: 3.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₁N₅O₅.
Guinea pig IFABP/FABP2(Intestinal Fatty Acid Binding Protein) ELISA Kit (96T), CAS: /, stock: 2.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
N-Acetyl Famciclovir-d4, CAS: /, stock: 4.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₇D₄N₅O₅.
N7-Acetyl Famciclovir, CAS: /, stock: 7.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₃N₅O₅.
Heneicosanoic Acid, CAS: 2363-71-5, stock: 5.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₄₂O₂.
(2Z)-1-Chloro-2-decene, CAS: 135457-18-0, stock: 4.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₉Cl.
N9-Des(4-acetoxy-3-(acetoxymethyl)but-1-yl) N7-[4-acetoxy-3-(acetoxymethyl)but-1-yl] Famciclovir, CAS: 131266-15-4, stock: 1.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₉N₅O₄.
O-Desacetyl O-Propionyl Famciclovir, CAS: /, stock: 2.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₁N₅O₄.
Hentriacontanoic Acid, CAS: 38232-01-8, stock: 3.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₆₂O₂.
Heptadecanoic Acid, CAS: 506-12-7, stock: 2.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₃₄O₂.
(3E,13Z)-Octadecadien-1-ol, CAS: 66410-28-4, stock: 5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₄O.
(9Z)-Dodecen-1-ol, CAS: 35148-18-6, stock: 3.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₄O.
Penciclovir Diacetate, CAS: 97845-72-2, stock: 9.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₉N₅O₅.
Penciclovir Triphosphate, CAS: 120082-86-2, stock: 1.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₈N₅O₁₂P₃.
Heptadecanoic Acid N-Hydroxysuccinimide Ester, CAS: 201472-73-3, stock: 5.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₇NO₄.
Heptadecanoyl Chloride, CAS: 40480-10-2, stock: 4.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₃₃ClO.
(9Z)-Dodecen-1-ol Acetate, CAS: 16974-11-1, stock: 7.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₆O₂.
(R)-(-)-Falcarinol, CAS: 21852-80-2, stock: 7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₄O.
Hexacosanoic Acid-d4, CAS: 1194984-85-4, stock: 5.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₄₈D₄O₂.
Hexadecanal, CAS: 629-80-1, stock: 4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₃₂O.
(Z)-1-Chloro-2-nonene, CAS: 67242-75-5, stock: 9.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₇Cl.
(Z)-2-Nonen-1-ol, CAS: 41453-56-9, stock: 4.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₈O.
2-Decyn-1-ol, CAS: 4117-14-0, stock: 6.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₈O.
cis-2-Decen-1-ol, CAS: 4194-71-2, stock: 10g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₂₀O.
Human ELOVL1 (Elongation of very long chain fatty acids protein 1) ELISA Kit (96T), CAS: /, stock: 1.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Human ELOVL1(Elongation of very long chain fatty acids protein 1) ELISA Kit (96T), CAS: /, stock: 4.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Panaxynol, CAS: 81203-57-8, stock: 3.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₄O.
rac-Falcarinol, CAS: 08/12/4117, stock: 7.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₄O.
Human FABP1(Fatty acid-binding protein, liver) ELISA Kit (96T), CAS: /, stock: 6.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Human FABP12 (Fatty acid-binding protein 12) ELISA Kit (96T), CAS: /, stock: 4.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Human FABP3(Fatty Acid Binding Protein 3, Muscle and Heart) ELISA Kit (96T), CAS: /, stock: 6.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Human FABP4(Fatty acid-binding protein, adipocyte) ELISA Kit (96T), CAS: /, stock: 4.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Human FABP5(Fatty acid-binding protein, epidermal) ELISA Kit (96T), CAS: /, stock: 2.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Human FABP7(Fatty Acid Binding Protein 7, Brain) ELISA Kit (96T), CAS: /, stock: 3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Human FABP8(Fatty Acid Binding Protein 8, Myelin) ELISA Kit (96T), CAS: /, stock: 7.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Human FABP9 (Fatty acid-binding protein 9) ELISA Kit (96T), CAS: /, stock: 4.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Human FADS2(Fatty acid desaturase 2) ELISA Kit (96T), CAS: /, stock: 7.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Human FASN(Fatty acid synthase) ELISA Kit (96T), CAS: /, stock: 7.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Human Fatty Acid desaturase 1(delta-5-desaturase) ELISA Kit (96T), CAS: /, stock: 1.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Human FFAR1 (Free fatty acid receptor 1) ELISA Kit (96T), CAS: /, stock: 3.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Human IFABP/FABP2(Intestinal Fatty Acid Binding Protein) ELISA Kit (96T), CAS: /, stock: 9.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Human SLC27A1 (Long-chain fatty acid transport protein 1) ELISA Kit (96T), CAS: /, stock: 1.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Iodine Monochloride, CAS: 7790-99-0, stock: 3.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: ClI.
Isocapric Acid, CAS: 5963-14-4, stock: 6.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₂₀O₂.
Isocapric Acid Ethyl Ester, CAS: 905589-94-8, stock: 1.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₄O₂.
Isocapric Acid Ethyl-d5 Ester, CAS: /, stock: 7.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₉D₅O₂.
Isocapric Acid Methyl Ester, CAS: 5129-54-4, stock: 3.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₂₂O₂.
Isocapric Acid Methyl-d3 Ester, CAS: /, stock: 6.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₉D₃O₂.
IWP 12, CAS: 688353-45-9, stock: 9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₈N₄O₂S₃.
ω-Hydroxy FTY720 Hydrochloride, CAS: 1346599-82-3, stock: 8.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₄ClNO₃.
ω-Pentadecenoic Acid, CAS: 17351-34-7, stock: 6.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₈O₂.
ω-Tridecenoic Acid, CAS: 6006-06-0, stock: 7.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₂₄O₂.
α-(Aminomethyl)-2-(trifluoromethoxy)benzenemethanol, CAS: 1042605-24-2, stock: 1.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₀F₃NO₂.
α-(Aminomethyl)-3-(trifluoromethoxy)benzenemethanol, CAS: 852392-18-8, stock: 2.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₀F₃NO₂.
α-Eleostearic Acid, CAS: 506-23-0, stock: 7.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₀O₂.
β-Dimorphecolic Acid, CAS: 18104-44-4, stock: 6.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₂O₃.
γ-Linolenic Acid, CAS: 506-26-3, stock: 6.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₀O₂.
γ-Linolenic Acid Methyl Ester, CAS: 16326-32-2, stock: 2.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₂O₂.
γ-Linolenic Acid Methyl Ester-d3, CAS: /, stock: 2.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₉D₃O₂.
γ-Linolenic Acid N-Hydroxysuccinimidyl Ester, CAS: 216447-57-3, stock: 9.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₃NO₄.
Jacaric Acid, CAS: 28872-28-8, stock: 5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₀O₂.
L-γ-Glutamyl-S-[(1R,2E,4E,6Z,9Z)-12-carboxy-1-[(1S,3Z,6Z)-1-hydroxy-3,6-nonadien-1-yl]-2,4,6,9-dodecatetraen-1-yl]-L-cysteinylglycine, CAS: 1784701-61-6, stock: 9.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₄₇N₃O₉S.
Lauric Acid-d3, CAS: 79050-22-9, stock: 4.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₁D₃O₂.
Linoleic Acid-1-13C, CAS: 98353-71-0, stock: 8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇¹³CH₃₂O₂.
Linolenic Acid, CAS: 463-40-1, stock: 9.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₀O₂.
Linolenic Acid Ethyl Ester, CAS: 1191-41-9, stock: 2.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₄O₂.
Linolenic Acid Ethyl Ester- 13C18, CAS: /, stock: 2.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂¹³C₁₈H₃₄O₂.
Linolenic Acid Ethyl Ester-d5, CAS: /, stock: 1.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₉D₅O₂.
Linolenic Acid N-Hydroxysuccinimide, CAS: 359847-18-0, stock: 9.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₃NO₄.
Linolenic Acid-13C18CURRENTLY UNAVAILABLE, CAS: 287111-28-8, stock: 10g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: ¹³C₁₈H₃₀O₂.
Linolenic-1-13C Acid, CAS: 224568-13-2, stock: 2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇¹³CH₃₀O₂.
Lipoxin A4 Sodium Salt, CAS: 99095-28-0, stock: 4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₁NaO₅.
Lipoxin A4-d5 Sodium Salt, CAS: /, stock: 8.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₆D₅NaO₅.
Lubiprostone, CAS: 136790-76-6, stock: 2.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₂F₂O₅.
Lubiprostone Impurity 2, CAS: /, stock: 2.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₀F₂O₄.
Lubiprostone Impurity 4, CAS: /, stock: 7.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₂F₂O₄.
Lubiprostone Impurity 5, CAS: /, stock: 2.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₃FO₅.
Lubiprostone-d7, CAS: 1217675-13-2, stock: 4.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₅D₇F₂O₅.
Menhaden Oil, CAS: 8002-50-4, stock: 3.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: N/A.
Methanolic Hydrochloride (3N), CAS: 7647-01-0, stock: 7.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: HCl.
Methyl 11-Bromoundecanoate, CAS: 6287-90-7, stock: 4.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₃O₂Br.
Methyl 12-Hydroxystearate, CAS: 141-23-1, stock: 8.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₈O₃.
Methyl 12-Oxo-12-phenyldodecanoate, CAS: 104828-35-5, stock: 1.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₈O₃.
Methyl 3-Hydroxyheptanoate, CAS: 15889-95-9, stock: 7.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₆O₃.
Methyl 3-Oxohexadecanoate, CAS: 14427-53-3, stock: 5.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₃₂O₃.
Methyl Heneicosanoate, CAS: 6064-90-0, stock: 7.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₄₄O₂.
Methyl Nervonate, CAS: 2733-88-2, stock: 1.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₄₈O₂.
Methyl Palmitate, CAS: 112-39-0, stock: 2.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₃₄O₂.
Methyl Palmitate-d3, CAS: 60443-57-4, stock: 1.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₃₁D₃O₂.
Methyl Palmoxirate, CAS: 69207-52-9, stock: 7.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₄O₃.
Methyl Tetracosanoate, CAS: 2442-49-1, stock: 5.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₅₀O₂.
Methyl Tricosanoate, CAS: 2433-97-8, stock: 4.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₄₈O₂.
MK 1903, CAS: 1268882-43-4, stock: 7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₈N₂O₂.
Monkey IFABP/FABP2(Intestinal Fatty Acid Binding Protein) ELISA Kit (96T), CAS: /, stock: 8.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mono(3-methylpentyl) Phthalate, CAS: 106636-65-1, stock: 8.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₈O₄.
Mono(3-methylpentyl) Phthalate-d4, CAS: /, stock: 2.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₄D₄O₄.
Mouse Elovl1 (Elongation of very long chain fatty acids protein 1) ELISA Kit (96T), CAS: /, stock: 4.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse ELOVL7(Elongation of very long chain fatty acids protein 7) ELISA Kit (96T), CAS: /, stock: 8.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse Fa2h (Fatty acid 2-hydroxylase) ELISA Kit (96T), CAS: /, stock: 6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse Fabp12 (Fatty acid-binding protein 12) ELISA Kit (96T), CAS: /, stock: 1.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse Fabp3(Fatty acid-binding protein, heart) ELISA Kit (96T), CAS: /, stock: 3.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse Fabp4(Fatty acid-binding protein, adipocyte) ELISA Kit (96T), CAS: /, stock: 4.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse Fabp5(Fatty acid-binding protein, epidermal) ELISA Kit (96T), CAS: /, stock: 2.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse Fabp7(Fatty acid-binding protein, brain) ELISA Kit (96T), CAS: /, stock: 8.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse Fabp9 (Fatty acid-binding protein 9) ELISA Kit (96T), CAS: /, stock: 7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse FABPL(Fatty acid-binding protein) ELISA Kit (96T), CAS: /, stock: 8.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse Fads1 (Fatty acid desaturase 1) ELISA Kit (96T), CAS: /, stock: 8.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse Fads2(Fatty acid desaturase 2) ELISA Kit (96T), CAS: /, stock: 3.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse Fads3(Fatty acid desaturase 3) ELISA Kit (96T), CAS: /, stock: 2.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse Fasn(Fatty acid synthase) ELISA Kit (96T), CAS: /, stock: 6.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse Ffar1 (Free fatty acid receptor 1) ELISA Kit (96T), CAS: /, stock: 7.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse IFABP/FABP2(Intestinal Fatty Acid Binding Protein) ELISA Kit (96T), CAS: /, stock: 8.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse O3far1(Omega-3 fatty acid receptor 1) ELISA Kit (96T), CAS: /, stock: 4.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Mouse Slc27a1 (Long-chain fatty acid transport protein 1) ELISA Kit (96T), CAS: /, stock: 9.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Myristic Acid, CAS: 544-63-8, stock: 7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₈O₂.
Myristic Acid N-Hydroxysuccinimide Ester-13C14, CAS: /, stock: 8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄¹³C₁₄H₃₁NO₄.
Myristic Acid-13C14, CAS: 287111-05-1, stock: 1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: ¹³C₁₄H₂₈O₂.
Myristyl Palmitate, CAS: 4536-26-9, stock: 7.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₆₀O₂.
N-(2-Hydroxyethyl)erucamide, CAS: 18190-74-4, stock: 7.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₄₇NO₂.
N-(2-Hydroxyethyl)tricosanamide, CAS: 171022-15-4, stock: 9.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₅₁NO₂.
N-(3-Phenylpropionyl)glycine, CAS: 56613-60-6, stock: 5.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₃NO₃.
N-(3-Phenylpropionyl)glycine-3C2,15N, CAS: /, stock: 2.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉¹³C₂H₁₃¹⁵NO₃.
N-(NBD-Aminolauroyl)safingol, CAS: 474943-07-2, stock: 6.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₆H₆₃N₅O₆.
N-Boc-N-methylpiperazine, CAS: 53788-49-1, stock: 8.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₂₀N₂O₂.
N-Boc-N-methylpiperazine-d3, CAS: 1459230-58-0, stock: 2.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₇D₃N₂O₂.
N-Carbamoylimidazole, CAS: 2578-41-8, stock: 7.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₅N₃O.
N-Cyclohexyl-N-methyl-4-(1-oxido-3-pyridinyl)-1H-imidazole-1-carboxamide, CAS: 1233855-46-3, stock: 8.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₀N₄O₂.
N-Cyclohexyl-N-methyl-4-(1-oxido-3-pyridinyl)-1H-imidazole-1-carboxamide-d3, CAS: /, stock: 3.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₇D₃N₄O₂.
N-Decanoylglycine, CAS: 14305-32-9, stock: 8.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₃NO₃.
N-Iso Valerylglycine, CAS: 16284-60-9, stock: 5.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₃NO₃.
N-Iso Valerylglycine-d9, CAS: 1330037-21-2, stock: 2.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄D₉NO₃.
N-Isobutyryl-d7-glycine, CAS: 1330037-23-4, stock: 8.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄D₇NO₃.
N-Isobutyrylglycine, CAS: 15926-18-8, stock: 4.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₁NO₃.
N-Myristoylglycine, CAS: 14246-55-0, stock: 8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₃₁NO₃.
n-Nonadecanoic Acid, CAS: 646-30-0, stock: 6.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₈O₂.
N-Valerylglycine, CAS: 24003-66-5, stock: 7.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₃NO₃.
Nervonic Acid, CAS: 506-37-6, stock: 3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₄₆O₂.
Nervonic Acid-d18, CAS: /, stock: 2.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₈D₁₈O₂.
Nervonic Acid-d45, CAS: /, stock: 5.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃D₄₃O₂.
Nonadecanoic Acid 3-(Acetyloxy)-2-hydroxypropyl Ester, CAS: 120602-61-1, stock: 4.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₄₆O₅.
Nonadecanoic Acid 3-(Acetyloxy)-2-hydroxypropyl Ester-d5, CAS: /, stock: 7.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₄₁D₅O₅.
Oleic Acid, CAS: 112-80-1, stock: 6.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₄O₂.
Oleic Acid-d17, CAS: 223487-44-3, stock: 5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₇D₁₇O₂.
PALDA, CAS: 136181-87-8, stock: 3.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₄₁NO₃.
Palmitelaidic Acid, CAS: 10030-73-6, stock: 5.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₃₀O₂.
Palmitic Acid, CAS: 57-10-3, stock: 9.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₃₂O₂.
Palmitic Acid-d3, CAS: 75736-53-7, stock: 1.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₉D₃O₂.
Palmitic Acid-d31, CAS: 39756-30-4, stock: 4.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆HD₃₁O₂.
Palmitic Acid-d4, CAS: 75736-47-9, stock: 6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₈D₄O₂.
Palmitoleic Acid, CAS: 373-49-9, stock: 8.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₃₀O₂.
Palmitoylisopropylamide, CAS: 189939-61-5, stock: 7.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₉NO.
Pamitoyl Meldrum’s Acid, CAS: /, stock: 1.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₈O₅.
Pentacosanoic Acid, CAS: 506-38-7, stock: 7.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₅₀O₂.
Pentacosanoic Acid-d3, CAS: /, stock: 1.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₄₇D₃O₂.
Pentadecafluorooctanoic Acid Ammonium Salt, CAS: 3825-26-1, stock: 9.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₄F₁₅NO₂.
Pentadecanoic Acid, CAS: 1002-84-2, stock: 4.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₃₀O₂.
Pentadecanoic Acid N-Hydroxysuccinimide Ester, CAS: 823780-38-7, stock: 4.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₃NO₄.
Pentadecanoyl Chloride, CAS: 17746-08-6, stock: 1.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₉ClO.
PF 3845, CAS: 1196109-52-0, stock: 7.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₃F₃N₄O₂.
PF 750, CAS: 959151-50-9, stock: 3.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₃N₃O.
POBN, CAS: 66893-81-0, stock: 1.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄N₂O₂.
Porcine FABP1(Fatty Acid Binding Protein 1, Liver) ELISA Kit (96T), CAS: /, stock: 9.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Porcine FABP3(Fatty Acid Binding Protein 3, Muscle and Heart) ELISA Kit (96T), CAS: /, stock: 2.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Porcine FABP4(Fatty acid-binding protein, adipocyte) ELISA Kit (96T), CAS: /, stock: 1.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Porcine IFABP/FABP2(Intestinal Fatty Acid Binding Protein) ELISA Kit (96T), CAS: /, stock: 6.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Potassium Phosphate (Tribasic), CAS: 7778-53-2, stock: 6.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: K₃O₄P.
Pristanic Acid-2,2,2,3,3-d5, CAS: /, stock: 1.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₃D₅O₂.
Prostaglandin D2, CAS: 41598-07-6, stock: 4.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₂O₅.
Pyridoxine Dipalmitate, CAS: 635-38-1, stock: 9.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₀H₇₁NO₅.
Pyroxasulfone, CAS: 447399-55-5, stock: 1.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₄F₅N₃O₄S.
Rabbit FABP3(Fatty Acid Binding Protein 3, Muscle and Heart) ELISA Kit (96T), CAS: /, stock: 2.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Rabbit IFABP/FABP2(Intestinal Fatty Acid Binding Protein) ELISA Kit (96T), CAS: /, stock: 6.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
rac 1,2-Bis-palmitoyl-3-chloropropanediol, CAS: 51930-97-3, stock: 1.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₅H₆₇ClO₄.
rac 1,2-Bis-palmitoyl-3-chloropropanediol-13C3, CAS: /, stock: 6.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂¹³C₃H₆₇ClO₄.
rac 1,2-Bis-palmitoyl-3-chloropropanediol-13C5, CAS: 1246815-94-0, stock: 9.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀¹³C₅H₆₇ClO₄.
rac 1,2-Bis-palmitoyl-3-chloropropanediol-D5, CAS: 1185057-55-9, stock: 3.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₅H₆₂D₅ClO₄.
rac 1,2-Bislauroyl-3-chloropropanediol, CAS: 1051389-99-1, stock: 4.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₅₁ClO₄.
rac 1,2-Bislauroyl-3-chloropropanediol-13C3, CAS: /, stock: 3.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄¹³C₃H₅₁ClO₄.
rac 1,2-Bislauroyl-3-chloropropanediol-d5, CAS: /, stock: 1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₄₆D₅ClO₄.
rac 1,2-Dioleoyl-3-chloropropanediol, CAS: 69161-73-5, stock: 3.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₉H₇₁ClO₄.
rac 1,2-Dioleoyl-3-chloropropanediol-13C36, CAS: /, stock: 4.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃¹³C₃₆H₇₁ClO₄.
rac 1,2-Dioleoyl-3-chloropropanediol-d5, CAS: 1246833-00-0, stock: 6.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₉H₆₆D₅ClO₄.
rac 1-Heptandecanoyl-3-chloropropanediol, CAS: 87505-04-2, stock: 6.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₉ClO₃.
rac 1-Heptandecanoyl-3-chloropropanediol-13C3, CAS: /, stock: 6.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇¹³C₃H₃₉ClO₃.
rac 1-Heptandecanoyl-3-chloropropanediol-d5, CAS: /, stock: 3.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₄D₅ClO₃.
rac 1-Lauroyl-2-linoleoyl-3-chloropropanediol, CAS: 2134114-60-4, stock: 9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₅₉ClO₄.
rac 1-Lauroyl-2-linoleoyl-3-chloropropanediol-13C3, CAS: /, stock: 9.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀¹³C₃H₅₉ClO₄.
rac 1-Lauroyl-2-linoleoyl-3-chloropropanediol-d5, CAS: /, stock: 2.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₅₄D₅ClO₄.
rac 1-Lauroyl-2-oleoyl-3-chloropropanediol, CAS: /, stock: 3.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₆₁ClO₄.
rac 1-Lauroyl-2-oleoyl-3-chloropropanediol-13C3, CAS: /, stock: 6.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀¹³C₃H₆₁ClO₄.
rac 1-Lauroyl-2-oleoyl-3-chloropropanediol-d5, CAS: /, stock: 2.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₅₆D₅ClO₄.
rac 1-Lauroyl-3-chloropropanediol, CAS: 20542-96-5, stock: 2.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₉ClO₃.
rac 1-Lauroyl-3-chloropropanediol-13C3, CAS: /, stock: 9.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂¹³C₃H₂₉ClO₃.
rac 1-Lauroyl-3-chloropropanediol-d5, CAS: /, stock: 6.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₄D₅ClO₃.
rac 1-Linoleoyl-2-linolenoyl-3-chloropropanediol-13C3, CAS: /, stock: 7.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₆¹³C₃H₆₅ClO₄.
rac 1-Myristoyl-3-chloropropanediol, CAS: 30557-03-0, stock: 7.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₃₃ClO₃.
rac 1-Myristoyl-3-chloropropanediol-13C3, CAS: /, stock: 5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄¹³C₃H₃₃ClO₃.
rac 1-Myristoyl-3-chloropropanediol-d5, CAS: /, stock: 7.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₈D₅ClO₃.
rac 1-Oleoyl Glycerol, CAS: 111-03-5, stock: 1.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₄₀O₄.
rac 1-Oleoyl Glycerol-d5, CAS: 565183-24-6, stock: 5.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₅D₅O₄.
rac 1-Oleoyl-2,3-dipalmitoyl Glycerol, CAS: 1867-91-0, stock: 7.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₃H₁₀₀O₆.
rac 1-Oleoyl-2,3-dipalmitoyl Glycerol-d5, CAS: /, stock: 1.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₃H₉₅D₅O₆.
rac 1-Oleoyl-2-palmitoylglycerol, CAS: 3331-34-8, stock: 1.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₇₀O₅.
rac 1-Oleoyl-2-palmitoylglycerol-d5, CAS: /, stock: 4.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₆₅D₅O₅.
rac 1-Oleoyl-3-palmitoylglycerol, CAS: 3343-30-4, stock: 6.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₇₀O₅.
rac 1-Oleoyl-3-palmitoylglycerol-d5, CAS: /, stock: 6.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₆₅D₅O₅.
rac 1-Palmitoyl-2-chloropropanediol, CAS: 63326-63-6, stock: 4.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₇ClO₃.
rac 1-Palmitoyl-2-chloropropanediol-d5, CAS: /, stock: 9.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₂D₅ClO₃.
rac 1-Palmitoyl-2-oleoyl-3-chloropropanediol, CAS: 1363153-60-9, stock: 2.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₆₉ClO₄.
rac 1-Palmitoyl-2-oleoyl-3-chloropropanediol-13C3, CAS: /, stock: 4.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₄¹³C₃H₆₉ClO₄.
rac 1-Palmitoyl-2-oleoyl-3-chloropropanediol-d5, CAS: /, stock: 2.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₆₄D₅ClO₄.
rac 1-Palmitoyl-2-stearoyl-3-chloropropanediol, CAS: /, stock: 9.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₇₁ClO₄.
rac 1-Palmitoyl-2-stearoyl-3-chloropropanediol-13C3, CAS: /, stock: 10g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₄¹³C₃H₇₁ClO₄.
rac 1-Palmitoyl-2-stearoyl-3-chloropropanediol-d5, CAS: /, stock: 2.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₆₆D₅ClO₄.
rac 1-Palmitoyl-3-chloropropanediol, CAS: 30557-04-1, stock: 5.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₇ClO₃.
rac 1-Palmitoyl-3-chloropropanediol-d5, CAS: 1346599-60-7, stock: 4.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₂D₅ClO₃.
(4R)-3-[(2S,5R)-5-(4-Fluorophenyl)-2-[(R)-[(4-fluorophenyl)amino][4-[(trimethylsilyl)oxy]phenyl]methyl]-1-oxo-5-[(trimethylsilyl)oxy]pentyl]-4-phenyl-2-oxazolidinone, CAS: /, stock: 7.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₉H₄₆F₂N₂O₅Si₂.
rac 2-Oleoyl-3-chloropropanediol, 95%, CAS: 915297-48-2, stock: 4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₉ClO₃.
(4R)-4-Phenyl-3-[(5R)-5-(4-fluorophenyl)-5-hydroxypentanoyl]-1,3-oxazolidin-2-one, CAS: 1612153-32-8, stock: 3.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₀FNO₄.
rac 2-Oleoyl-3-chloropropanediol-13C3, CAS: /, stock: 3.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈¹³C₃H₃₉ClO₃.
(4S)-3-[(2R,5S)-5-(4-Fluorophenyl)-2-[(R)-[(3-fluorophenyl)amino][4-[(trimethylsilyl)oxy]phenyl]methyl]-1-oxo-5-[(trimethylsilyl)oxy]pentyl]-4-phenyl-2-oxazolidinone, CAS: /, stock: 8.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₉H₄₆F₂N₂O₅Si₂.
rac 2-Palmitoyl-3-chloropropanediol, CAS: 20618-92-2, stock: 5.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₇ClO₃.
rac 2-Palmitoyl-3-chloropropanediol-13C3, CAS: /, stock: 3.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆¹³C₃H₃₇ClO₃.
(4S)-3-[(2R,5S)-5-(4-Fluorophenyl)-2-[(S)-[(3-fluorophenyl)amino][4-[(trimethylsilyl)oxy]phenyl]methyl]-1-oxo-5-[(trimethylsilyl)oxy]pentyl]-4-phenyl-2-oxazolidinone, CAS: /, stock: 5.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₉H₄₆F₂N₂O₅Si₂.
rac 2-Palmitoyl-3-chloropropanediol-d5, CAS: 1329614-79-0, stock: 1.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₂D₅ClO₃.
rac 3-Hydroxydecanoic Acid Methyl Ester, CAS: 62675-82-5, stock: 2.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₂₂O₃.
rac cis-9,10-Epoxystearic Acid, CAS: 24560-98-3, stock: 2.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₄O₃.
rac threo-9,10-Dihydroxystearic Acid, CAS: 01/05/2391, stock: 8.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₆O₄.
(1,2-α),(6,2’)-Diepoxy Exemestane, CAS: /, stock: 3.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₄O₄.
rac trans-9,10-Epoxystearic Acid, CAS: 13980-07-9, stock: 2.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₄O₃.
rac-1, 2-Didecanoyl-3-chloropropanediol, CAS: /, stock: 5.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₄₃ClO₄.
1,2-Dihydro Exemestane, CAS: 19457-55-7, stock: 4.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₆O₂.
rac-1-Decanoyl-3-Chloropropanediol, CAS: 3537-37-9, stock: 8.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₂₅ClO₃.
rac-1-Lauroyl-2-decanoyl-3-chloropropanediol, CAS: /, stock: 7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₄₇ClO₄.
1,2-α-Epoxy Exemestane, CAS: 159354-61-7, stock: 6.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₄O₃.
rac-1-Linoleoyl-2,3-dilinolenoylglycerol, CAS: 79925-48-7, stock: 10g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₇H₉₄O₆.
rac-1-Linoleoyl-2,3-dilinolenoylglycerol-d5, CAS: /, stock: 8.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₇H₈₉D₅O₆.
16-Methylene Exemestane, CAS: /, stock: 5.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₄O₂.
(R)-4-Ethynyl-2,2-dimethyl-1,3-dioxolane, CAS: 186521-82-4, stock: 5.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₀O₂.
(S)-1-(3-fluorophenyl)-5-(2-oxo-4-phenyloxazolidin-3-yl)pentane-1,5-dione, CAS: /, stock: 9.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₈FNO₄.
rac-1-Linoleoyl-2-stearoyl-3-chloropropanediol-13C3, CAS: /, stock: 8.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₆¹³C₃H₇₁ClO₄.
rac-1-Octanoyl-3-Chloropropanediol, CAS: 3478-18-0, stock: 6.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₂₁ClO₃.
16-Methyleneandrost-4-ene-3,17-dione, CAS: 80108-48-1, stock: 4.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₆O₂.
16α,17α-Epoxy Exemestane, CAS: /, stock: 7.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₄O₂.
rac-13-Hydroxydocosapentaenoic Acid, CAS: 887752-29-6, stock: 3.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₄O₃.
rac-2-Decanoyl-3-Chloropropanediol, CAS: /, stock: 5.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₂₅ClO₃.
17-Hydroxy-6β-(Formyl)androsta-1,4-dien-3,17-dione, CAS: /, stock: 7.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₆O₃.
17β-Hydroxy Exemestane, CAS: 122370-91-6, stock: 2.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₆O₂.
rac-2-Octanoyl-3-Chloropropanediol, CAS: 619329-48-5, stock: 1.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₂₁ClO₃.
rac-2-Palmitoyl-1-oleoyl-3-chloropropanediol, CAS: 1429655-90-2, stock: 7.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₆₉ClO₄.
17β-Hydroxy Exemestane 17-O-β-D-Glucuronide, CAS: /, stock: 1.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₄O₈.
17β-Hydroxy Exemestane 17-O-[2,3,4-Tri-O-acetyl-β-D-Glucuronide Methyl Ester], CAS: /, stock: 2.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₄₂O₁₁.
1,2-Seco-ezetimibe-δ-lactone, CAS: /, stock: 4.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₁F₂NO₃.
rac-2-Palmitoyl-1-oleoyl-3-chloropropanediol-13C3, CAS: /, stock: 5.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₄¹³C₃H₆₉ClO₄.
17β-Hydroxy Exemestane Sulfamate, CAS: /, stock: 3.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₇NO₄S.
17β-Hydroxy Exemestane-d3, CAS: /, stock: 1.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₃D₃O₂.
rac-2-Palmitoyl-1-oleoyl-3-chloropropanediol-d5, CAS: /, stock: 8.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₆₄D₅ClO₄.
rac-3-Hydroxyheptadecanoic Acid, CAS: 40165-89-7, stock: 5.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₃₄O₃.
17β-Hydroxy Exemestane-d3 17-O-β-D-Glucuronide, CAS: /, stock: 5.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₁D₃O₈.
17β-Hydroxy Exemestane-d3 17-O-β-D-Glucuronide 2,3,4-Triacetate Methyl Ester, CAS: /, stock: 1.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₃₉D₃O₁₁.
2-(4-Hydroxybenzyl)-N,5-bis-(4-fluorophenyl)-5-hydroxypentanamide, CAS: 1197811-72-5, stock: 1.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₃F₂NO₃.
rac-3-Hydroxyheptanoic Acid, CAS: 17587-29-0, stock: 7.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₄O₃.
rac-3-Hydroxyoctadecanoic Acid, CAS: 17773-30-7, stock: 6.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₆O₃.
6,16-Dimethyleneandrost-4-ene-3,17-dione, CAS: /, stock: 3.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₆O₂.
6-Formyl-17α-hydroxy-androstan-1,4,6-trien-3-one, CAS: /, stock: 9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₄O₃.
rac-3-Hydroxypentadecanoic Acid, CAS: 32602-70-3, stock: 4.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₃₀O₃.
Rat Fa2h (Fatty acid 2-hydroxylase) ELISA Kit (96T), CAS: /, stock: 1.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
6-Hydroxy-6-(hydroxymethyl)-androsta-1,4-diene-3,17-dione(Mixture of Diastereomers), CAS: 184972-11-0, stock: 1.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₆O₄.
6-Hydroxy-6-(methoxymethyl)-androsta-1,4-diene-3,17-dione, CAS: /, stock: 3.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₈O₄.
3-O-Acetyl Ezetimibe, CAS: 1044664-24-5, stock: 8.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₃F₂NO₄.
Rat Fabp1(Fatty acid-binding protein, liver) ELISA Kit (96T), CAS: /, stock: 8.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Rat FABP12 (Fatty acid-binding protein 12) ELISA Kit (96T), CAS: /, stock: 5.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
6-Hydroxymethyl Exemestane, CAS: 152764-26-6, stock: 3.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₄O₃.
6-Hydroxymethyl Exemestane-d3, CAS: /, stock: 4.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₁D₃O₃.
3-O-Acetyl Ezetimibe-d4, CAS: 1217642-08-4, stock: 3.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₁₉D₄F₂NO₄.
Rat Fabp3(Fatty acid-binding protein, heart) ELISA Kit (96T), CAS: /, stock: 3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Rat Fabp4(Fatty acid-binding protein, adipocyte) ELISA Kit (96T), CAS: /, stock: 5.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
6-Methyleneandrost-4-ene-3,17-dione-19-d3, CAS: /, stock: 1.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₃D₃O₂.
Rat Fabp9 (Fatty acid-binding protein 9) ELISA Kit (96T), CAS: /, stock: 9.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Rat Fads1 (Fatty acid desaturase 1) ELISA Kit (96T), CAS: /, stock: 3.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
6-Oxirane Boldenone(Mixture of Diastereomers), CAS: 1331732-05-8, stock: 1.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₆O₃.
6-Oxo Boldione, CAS: 72648-46-5, stock: 1.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₂O₃.
Rat Fads1(Fatty acid desaturase 1) ELISA Kit (96T), CAS: /, stock: 2.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Rat Fads2(Fatty acid desaturase 2) ELISA Kit (96T), CAS: /, stock: 2.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
6α-(Methoxymethyl)androsta-1,4-dien-3,17-dione, CAS: 881896-95-3, stock: 9.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₈O₃.
6α-Spiro[androsta-1,4-diene-6,2’-oxiran]-3,17-dione, CAS: 152764-24-4, stock: 5.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₄O₃.
3’-(3-Fluorophenyl) Ezetimibe, CAS: /, stock: 7.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₁F₂NO₃.
Rat FASN(Fatty Acid Synthase) ELISA Kit (96T), CAS: /, stock: 3.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Rat Ffar1 (Free fatty acid receptor 1) ELISA Kit (96T), CAS: /, stock: 4.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
6α-Spiro[androsta-1,4-diene-6,2’-oxiran]-3,17-dione-d3, CAS: /, stock: 1.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₁D₃O₃.
Rat IFABP/FABP2(Intestinal Fatty Acid Binding Protein) ELISA Kit (96T), CAS: /, stock: 2.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
Rat Slc27a1 (Long-chain fatty acid transport protein 1) ELISA Kit (96T), CAS: /, stock: 1.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
6β-(Formyl)androsta-1,4-dien-3,17-dione, CAS: /, stock: 2.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₄O₃.
6β-Hydroxymethylandrosta-1,4-diene-3,17-dione, CAS: 121021-51-0, stock: 5.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₆O₃.
3’-Anhydro-Z-1,2-seco Ezetimibe Sodium Salt, CAS: /, stock: 4.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₀F₂NNaO₃.
Rat Slc27a1(Long-chain fatty acid transport protein 1) ELISA Kit (96T), CAS: /, stock: 5.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: /.
6β-Spiro[androsta-1,4-diene-6,2’-oxiran]-3,17-dione, CAS: 152764-31-3, stock: 2.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₄O₃.
Resolvin E1, CAS: 552830-51-0, stock: 2.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₀O₅.
Resolvin E1 Sodium Salt, CAS: 1309610-43-2, stock: 8.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₉NaO₅.
6β-Spiro[androsta-1,4-diene-6,2’-oxiran]-3,17-dione-d3, CAS: /, stock: 9.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₁D₃O₃.
Resolvin E2, CAS: 865532-70-3, stock: 7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₀O₄.
Rhodium(III) Chloride Hydrate, CAS: 20765-98-4, stock: 5.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: Cl₃Rh•xH₂O.
Exemestane, CAS: 107868-30-4, stock: 9.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₄O₂.
4-Fluoroaniline, CAS: 371-40-4, stock: 6.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆FN.
4-Fluoroaniline-2,3,5,6-d4, CAS: 1093659-81-4, stock: 5.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₂D₄FN.
Ricinic Acid Methyl Ester, CAS: 141-24-2, stock: 4.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₆O₃.
Exemestane-13C,D3, CAS: /, stock: 6.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉¹³CH₂₁D₃O₂.
Exemestane-19-d3, CAS: /, stock: 6.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₁D₃O₂.
4-tert-Butyldiphenylsilyl ent-Ezetimibe, CAS: /, stock: 1.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₀H₃₉F₂NO₃Si.
Rumenic Acid (~80%), CAS: 2540-56-9, stock: 9.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₂O₂.
S-[(1R,2E,4E,6Z,9Z)-12-Carboxy-1-[(1S,3Z,6Z)-1-hydroxy-3,6-nonadien-1-yl]-2,4,6,9-dodecatetraen-1-yl]-L-cysteinyl-glycine, CAS: 1784701-62-7, stock: 2.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₄₀N₂O₆S.
Exemestane-D2, CAS: /, stock: 2.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₂D₂O₂.
Spiro[androsta-1,4-diene-6,2’-oxirane]-3,17-dione(Mixture of Diastereomers), CAS: 184972-12-1, stock: 5.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₄O₃.
4-tert-Butyldiphenylsilyl ent-Ezetimibe 3-O-Nitrobenzoate, CAS: /, stock: 4.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₇H₄₂F₂N₂O₆Si.
4-[(Z)-[(4-Fluorophenyl)oxidoimino]methyl]phenol, CAS: 1240816-04-9, stock: 3.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₀FNO₂.
Sebaleic Acid, CAS: 22733-46-6, stock: 8.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₂O₂.
4-[[(3-Fluorophenyl)imino]methyl]phenol, CAS: /, stock: 5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₀FNO.
Sebaleic Acid-d19, CAS: /, stock: 7.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₃D₁₉O₂.
Sebaleic Acid-d4, CAS: /, stock: 7.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₈D₄O₂.
4’-O-Benzyloxy (3S,4S)-Ezetimibe, CAS: 1683564-73-9, stock: 5.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₂₇F₂NO₃.
4’-O-Benzyloxy Ezetimibe, CAS: 163222-32-0, stock: 6.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₂₇F₂NO₃.
Sodium Ethoxide, CAS: 141-52-6, stock: 6.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂H₅NaO.
Sorbitan, CAS: 1338-41-6, stock: 8.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₆O₂ •C₆H₁₄O₆.
Sphingomyelins (eggs), CAS: 383907-87-7, stock: 9.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₉H7₉N₂O₆P (for palmitoyl).
Spilanthol A mixture of (2E, 6Z, 8E) >80%; (2E, 6E, 8E); and (2E, 6Z, 8Z), CAS: 25394-57-4, stock: 3.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₃NO.
Stearic Acid, CAS: 57-11-4, stock: 9.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₆O₂.
Stearic Acid Lithium Salt, CAS: 05/12/4485, stock: 4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₅LiO₂.
Stearic Acid-d35 Lithium Salt, CAS: 126317-77-9, stock: 2.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈D₃₅LiO₂.
Stearic-D35 Acid, CAS: 17660-51-4, stock: 5.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈HD₃₅O₂.
Stearidonic Acid, CAS: 20290-75-9, stock: 3.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₈O₂.
Stearidonic Acid Ethyl Ester, CAS: 119798-44-6, stock: 1.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₂O₂.
ent-Ezetimibe, CAS: 1376614-99-1, stock: 4.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₁F₂NO₃.
Stearidonic Acid Ethyl Ester-d5, CAS: /, stock: 3.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₇D₅O₂.
Stearidonic Acid N-Succinimide, CAS: 1798396-63-0, stock: 9.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₁NO₄.
Ezetimibe Azetidinone Ring-opened Sodium Salt Impurity (Technical Grade, >75%), CAS: /, stock: 7.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₂F₂NNaO₄.
Ezetimibe Diacetate, CAS: 163380-20-9, stock: 5.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₂₅F₂NO₅.
Stearoyl Ethanolamide, CAS: 111-57-9, stock: 6.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₄₁NO₂.
Stearoyl-NTA, CAS: 581064-76-8, stock: 9.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₅₂N₂O₇.
Ezetimibe Diacid Impurity, CAS: 1013025-04-1, stock: 5.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₄FNO₅.
Sulfosuccinimidyl Oleate Sodium, CAS: /, stock: 6.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₆NNaO₇S.
Ezetimibe Hydroxy β-D-Glucuronide, CAS: 536709-33-8, stock: 9.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₂₉F₂NO₉.
Synaptamide, CAS: 162758-94-3, stock: 3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₇NO₂.
Synaptamide-d4, CAS: 946524-43-2, stock: 6.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₃D₄NO₂.
Ezetimibe Hydroxy-d4 β-D-Glucuronide, CAS: /, stock: 7.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₂₅D₄F₂NO₉.
Ezetimibe Ketone, CAS: 191330-56-0, stock: 2.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₁₉F₂NO₃.
TAK 21d, CAS: 1143578-94-2, stock: 9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₇F₂N₇O.
Ezetimibe Tetrahydropyran Impurity, CAS: 1296129-15-1, stock: 1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₁F₂NO₃.
Ezetimibe Tetrahydropyran-d4 Impurity, CAS: /, stock: 7.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₁₇D₄F₂NO₃.
tert-Butyl 8-Hydroxyoctanoate, CAS: 401901-41-5, stock: 10g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₄O₃.
tert-Butyl Phenyl Carbonate, CAS: 6627-89-0, stock: 2.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₄O₃.
Ezetimibe-d4 Diacetate, CAS: 1217861-13-6, stock: 5.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₂₁D₄F₂NO₅.
Tetracosanoic Acid, CAS: 557-59-5, stock: 1.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₄₈O₂.
Tetracosanoic acid D5-2,3-epoxypropyl ester, CAS: /, stock: 3.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₄₇D₅O₃.
Tetracosanoic Acid Ethyl Ester, CAS: 24634-95-5, stock: 5.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₅₂O₂.
Tetracosanoic Acid Ethyl-d5 Ester, CAS: 24634-95-5, stock: 1.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₄₇D₅O₂.
Tetracosanoic-d47 Acid, CAS: 68060-00-4, stock: 5.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄HD₄₇O₂.
Tetradeca-1,13-dien-3-yl Acetate, CAS: /, stock: 3.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₈O₂.
Tetradecylthioacetic Acid, CAS: 2921-20-2, stock: 9.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₃₂O₂S.
Tetrahydro-2-(10-tetradecyn-1-yloxy)-2H-pyran, CAS: 86252-54-2, stock: 6.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₄O₂.
Tetrahydro-2-(7-octyn-1-yloxy)-2H-pyran, CAS: 16695-31-1, stock: 1.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₂₂O₂.
trans-2-Nonenal, CAS: 18829-56-6, stock: 3.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₆O.
trans-2-Nonenal-D2, CAS: 213595-54-1, stock: 3.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₄D₂O.
trans-2-Nonenal-D4, CAS: 221681-22-7, stock: 8.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₂D₄O.
trans-Tetrahydro-4-methylene-2-octyl-5-oxo-3-furancarboxylic Acid, CAS: 191282-48-1, stock: 9.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₂O₄.
Traumatic Acid, CAS: 6402-36-4, stock: 6.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₀O₄.
Traumatin, CAS: 65410-38-0, stock: 3.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₀O₃.
Trehalose 6-Phosphate Potassium Salt, CAS: 136632-28-5, stock: 7.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₁K₂O₁₄P.
Tri-n-octylchlorotin, CAS: 2587-76-0, stock: 6.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₅₁ClSn.
Tricosanoic Acid, CAS: 2433-96-7, stock: 4.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₄₆O₂.
Tricosanoic Acid-13C3, CAS: /, stock: 5.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀¹³C₃H₄₆O₂.
Tricosanoic Acid-d16, CAS: /, stock: 4.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₀D₁₆O₂.
Tricosanoic Acid-d3, CAS: /, stock: 3.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₄₃D₃O₂.
Trifluoroboron, CAS: 02/07/7637, stock: 5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: BF₃.
(19E/Z)-seco-[4-O-(2-Hydroxyethyl)] Rapamycin, CAS: 1062122-63-7, stock: 2.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₃H₈₃NO₁₄.
Trimethyltin Hydroxide, CAS: 56-24-6, stock: 6.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃H₁₀OSn.
Tripalmitin, CAS: 555-44-2, stock: 1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₁H₉₈O₆.
(19E/Z)-seco-[4-O-(2-Hydroxyethyl)] Rapamycin Sodium Salt, ~70%, CAS: /, stock: 3.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₃H₈₂NNaO₁₄.
Tripalmitin-d5, CAS: /, stock: 7.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₁H₉₃D₅O₆.
Tuberculostearic Acid, CAS: 542-47-2, stock: 3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₈O₂.
(19E/Z)-seco-[4-O-[2-Hydroxy(ethyl)-d4]] Rapamycin Sodium Salt, CAS: /, stock: 8.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₃H₇₈D₄NNaO₁₄.
Tuberculostearic Acid Ethyl Ester, CAS: 158648-65-8, stock: 1.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₄₂O₂.
Tuberculostearic Acid Ethyl-d5 Ester, CAS: /, stock: 5.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₇D₅O₂.
2-((tert-Butyldimethylsilyl)oxy)ethyl 2,2,2-trichloroacetimidate, CAS: /, stock: 8.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₂₀Cl₃NO₂Si.
28-Ethyl-d4-hydroxy Rapamycin, CAS: /, stock: 3.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₃H₇₉D₄NO₁₄.
Tuberculostearic Acid Methyl Ester, CAS: 2490-19-9, stock: 6.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₄₀O₂.
Tuberculostearic Acid Methyl-d3 Ester, CAS: /, stock: 2.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₇D₃O₂.
28-Ethylhydroxy Everolimus Impurity, CAS: /, stock: 6.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₅H₈₇NO₁₅.
28-Ethylhydroxy Everolimus-d4 Impurity, CAS: /, stock: 6.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₅H₈₃D₄NO₁₅.
Undecanoic Acid, CAS: 112-37-8, stock: 6.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₂₂O₂.
31-Oxo Everolimus (~80%), CAS: /, stock: 3.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₃H₈₁NO₁₄.
31-Oxo-13-tert-Butyldimethylsilyloxyethyl Everolimus, CAS: /, stock: 4.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆₀H₉₅NO₁₄.
42-O-tert-Butyldimethylsilyl Rapamycin, CAS: /, stock: 8.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₇H₉₃NO₁₃Si.
Vaccenic Acid, CAS: 693-72-1, stock: 10g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₄O₂.
Vaccenic Acid Chloride, CAS: 117485-96-8, stock: 4.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₃ClO.
Vaccenic Acid Ethyl Ester, CAS: 89296-48-0, stock: 2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₈O₂.
Vaccenic Acid Ethyl-d5 Ester, CAS: /, stock: 8.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₃D₅O₂.
Everolimus, CAS: 159351-69-6, stock: 4.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₃H₈₃NO₁₄.
Everolimus Isomer C (>60%, contains everolimus), CAS: 908340-97-6, stock: 8.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₃H₈₃NO₁₄.
Vaccenic Acid Methyl Ester, CAS: 6198-58-9, stock: 8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₆O₂.
Vaccenic Acid Methyl-d3 Ester, CAS: /, stock: 6.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₃D₃O₂.
Everolimus NHS-carbonate, CAS: /, stock: 9.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₈H₈₆N₂O₁₈.
Everolimus Retroaldol Degradation Product, CAS: 1708118-13-1, stock: 8.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₃H₈₃NO₁₄.
Everolimus-13C2,D4 (~90%), CAS: 1661009-29-5, stock: 5.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₁¹³C₂H₇₉D₄NO₁₄.
Ximeninic Acid, CAS: 557-58-4, stock: 3.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₀O₂.
Everolimus-d4 (~90%), CAS: 1338452-54-2, stock: 8.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₃H₇₉D₄NO₁₄.
LY 2584702, CAS: 1082949-67-4, stock: 1.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₉F₄N₇.
O-Desmethyl Everolimus (>80%), CAS: 745779-75-3, stock: 8.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₂H₈₁NO₁₄.
seco Everolimus B, CAS: 769905-89-7, stock: 8.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₃H₈₅NO₁₅.
[3-Hexadecanoyloxy-5-(hydroxymethyl)-2-methylpyridin-4-yl]methyl Hexadecanoate, CAS: 992-42-7, stock: 8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₀H₇₁NO₅.
[N-[(1S,2S)-2-(Amino-κN)-1,2-diphenylethyl]-4-methylbenzenesulfonamidato(2-)-κN][(1,2,3,4,5,6-η)-1-methyl-4-(1-methylethyl)benzene]rutheniumNoyori Catalyst, CAS: 188444-42-0, stock: 2.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₃₄N₂O₂RuS.
1-(4-Hydroxy-3-methoxyphenyl)-1-propanone, CAS: 1835-14-9, stock: 2.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₂O₃.
1-(4-Hydroxy-3-methoxyphenyl)-1-propanone-d3, CAS: /, stock: 5.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₉D₃O₃.
4-(2-Propen-1-yl)-1,2-benzenediol 1-Methanesulfonate, CAS: 115234-25-8, stock: 4.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₂O₄S.
4-Allyl-2,6-dimethoxyphenol, CAS: 6627-88-9, stock: 1.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₄O₃.
4-Allyl-2-methoxyphenyl Methanesulfonate, CAS: 91971-63-0, stock: 7.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₄O₄S.
Eugenol Acetate, CAS: 93-28-7, stock: 1.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₄O₃.
Eugenol-d3 Methanesulfonate, CAS: /, stock: 6.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₁D₃O₄S.
Eugenol-glucuronide, CAS: 95480-61-8, stock: 8.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₀O₈.
Guaiacol Propionate, CAS: 7598-60-9, stock: 4.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₂O₃.
Isoeugenol, CAS: 97-54-1, stock: 1.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₂O₂.
Isoeugenyl acetate, CAS: 93-29-8, stock: 8.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₄O₃.
(E)-2-Chloro-3-imino-N,N-dimethylprop-1-en-1-amine Hydrochloride, CAS: 1352804-27-3, stock: 8.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₁₀Cl₂N₂.
1,4-bis(6-Methylpyridin-3-yl)-2,3-bis(4-(methylsulfonyl)phenyl)butane-1,4-dione, CAS: /, stock: 9.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₂₈N₂O₆S₂.
2-(4-Methanesulfonyl-phenyl)-1-(6-methyl-pyridin-3-yl)-ethanone, CAS: 221615-75-4, stock: 7.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₅NO₃S.
2-(4-Methanesulfonylphenyl)-1-pyridin-3-ylethanone, CAS: 40061-50-5, stock: 2.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₃NO₃S.
2-Chloro-3-(dimethylamino)-N,N-dimethyl-2-propen-1-aminium Hexafluorophosphate(1-), CAS: 291756-76-8, stock: 8.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₄ClN₂F₆P.
6-Chloro-2-(6-methyl-3-pyridinyl)-3-[4-(methylsulfonyl)phenyl]-1,8-naphthyridine, CAS: 646459-41-8, stock: 8.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₆ClN₃O₂S.
6’-Desmethyl-6’-carboxy Etoricoxib, CAS: 349536-39-6, stock: 8.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₃ClN₂O₄S.
6’-Desmethyl-6’-methylhydroxy Etoricoxib, CAS: 349536-41-0, stock: 8.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₅ClN₂O₃S.
6’-Desmethyl-6’-methylhydroxy Etoricoxib N1’-Oxide, CAS: 570394-08-0, stock: 6.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₅ClN₂O₄S.
6’-Desmethyl-6’-methylhydroxy Etoricoxib-β-glucuronide, CAS: 349536-40-9, stock: 3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₃ClN₂O₉S.
Desmethyl Etoricoxib, CAS: 202409-31-2, stock: 3.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₃ClN₂O₂S.
Desmethyl Etoricoxib-d4, CAS: /, stock: 7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₉D₄ClN₂O₂S.
Etoricoxib, CAS: 202409-33-4, stock: 8.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₅ClN₂O₂S.
Etoricoxib (Crystal Form V), CAS: 202409-33-4, stock: 4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₅ClN₂O₂S.
Etoricoxib N-1,1’-Dioxide, CAS: /, stock: 7.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₅ClN₂O₄S.
Etoricoxib N-1-Oxide-d9, CAS: /, stock: 9.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₆D₉ClN₂O₃S.
Etoricoxib N1’-Oxide, CAS: 325855-74-1, stock: 7.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₅ClN₂O₃S.
Etoricoxib-13C,d3, CAS: /, stock: 7.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇¹³CH₁₂D₃ClN2O₂S.
Etoricoxib-d3, CAS: 850896-71-8, stock: 4.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₂D₃ClN₂O₂S.
Etoricoxib-d6, CAS: /, stock: 8.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₉D₆ClN₂O₂S.
Etoricoxib-d9, CAS: /, stock: 6.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₆D₉ClN₂O₂S.
N-[2-Chloro-3-(dimethylamino)-2-propen-1-ylidene]-N-methylmethanaminium Hexafluorophosphate, CAS: 249561-98-6, stock: 7.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₄ClF₆N₂P.
11α-Hydroxyestr-4-ene-3,17-dione, CAS: 6615-00-5, stock: 6.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₄O₃.
17-epi Etonogestrel, CAS: /, stock: 5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₈O₂.
18-Demethyl Etonogestrel, CAS: 54024-10-1, stock: 5.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₆O₂.
Etonogestrel, CAS: 54048-10-1, stock: 8.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₈O₂.
Etonogestrel β-D-Glucuronide, CAS: /, stock: 1.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₆O₈.
Etonogestrel Sulfate Sodium Salt, CAS: /, stock: 8.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₇NaO₅S.
Etonogestrel-d7 (Major), CAS: /, stock: 7.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₁D₇O₂.
2’’,3’’-Bis-O-(Dichloroacetyl) Etoposide, CAS: 260974-95-6, stock: 4.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₃₂Cl₄O₁₅.
3’-O-Desmethyl Etoposide, CAS: 100007-54-3, stock: 6.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₀O₁₃.
3’-O-Desmethyl Etoposide-d4, CAS: /, stock: 3.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₂₆D₄O₁₃.
4,6-O-Ethylidene-D-glucose, CAS: 18465-50-4, stock: 9.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₄O₆.
4’-(O-Podophyllotoxin-9-oxy) Etoposide, CAS: /, stock: 6.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₀H₅₀O₂₀.
4’-O-Benzyl 3’-O-Desmethyl Etoposide, CAS: /, stock: 4.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₅H₃₆O₁₃.
4’-O-Benzyl Etoposide-d3, CAS: /, stock: 2.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₆H₃₅D₃O₁₃.
cis-Etoposide, CAS: 100007-56-5, stock: 5.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₃₂O₁₃.
Decylubiquinone, CAS: 55486-00-5, stock: 9.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₀O₄.
Etoposide, CAS: 33419-42-0, stock: 6.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₃₂O₁₃.
Etoposide 3’,4’-Quinone, CAS: 105016-65-7, stock: 5.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₂₈O₁₃.
Etoposide Hydroxy Acid (Mixture of Diastereomers), CAS: /, stock: 1.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₃₄O₁₄.
Etoposide Phosphate, CAS: 117091-64-2, stock: 7.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₃₃O₁₆P.
Etoposide-d3, CAS: /, stock: 8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₂₉D₃O₁₃.
Etoposide-d4, CAS: /, stock: 4.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₂₈D₄O₁₃.
HAMNO, CAS: 138736-73-9, stock: 3.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₃NO₂.
Heptelidic Acid, CAS: 57710-57-3, stock: 5.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₀O₅.
α-Etoposide, CAS: 100007-53-2, stock: 3.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₃₂O₁₃.
Lignan P, CAS: 23363-35-1, stock: 5.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₀O₁₃.
Lignan P-d3, CAS: /, stock: 7.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₇D₃O₁₃.
N-(9-Fluorenylmethoxycarbonyl) Doxorubicin, CAS: 136582-53-1, stock: 7.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₂H₃₉NO₁₃.
N-(9-Fluorenylmethoxycarbonyl)-4’,6,8,11-tetra-O-benzoyl Doxorubicin, CAS: /, stock: 8.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇₀H₅₅NO₁₇.
Carboetomidate, CAS: 1257067-10-9, stock: 9.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₇NO₂.
Etomidate, CAS: 33125-97-2, stock: 2.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₆N₂O₂.
Etomidate Acid, CAS: 56649-48-0, stock: 7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₂N₂O₂.
Metomidate, CAS: 5377-20-8, stock: 6.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₄N₂O₂.
Metomidate Hydrochloride, CAS: 35944-74-2, stock: 5.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₅ClN₂O₂.
S-(-)-Etomidate, CAS: 56649-47-9, stock: 4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₆N₂O₂.
Etofenamate-d4 Myristate, CAS: /, stock: 3.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₄₀D₄F₃NO₅.
Etofenamate-d4 Palmitate, CAS: /, stock: 2.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₄H₄₄D₄F₃NO₅.
(-)-Desethyl Methyl Etodolac, CAS: 109518-50-5, stock: 3.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₉NO₃.
(R)-(-)-Etodolac, CAS: 87226-41-3, stock: 3.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₁NO₃.
(R)-(-)-Etodolac-d3, CAS: 1246815-33-7, stock: 2.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₈D₃NO₃.
(S)-(+)-Etodolac, CAS: 87249-11-4, stock: 9.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₁NO₃.
(S)-(+)-Etodolac-d3, CAS: 1246818-32-5, stock: 8.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₈D₃NO₃.
(Z)-3-(7-Ethyl-3-(2-hydroxyethyl)-1H-indol-2-yl)pent-2-enoic Acid, CAS: /, stock: 7.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₁NO₃.
1,3,4,9-Tetrahydro-1-ethyl-pyrano[3,4-b]indole-1-acetic Acid Ethyl Ester, CAS: 111962-14-2, stock: 6.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₁NO₃.
1,8-Diethyl-1,3,4,9-tetrahydro-4-oxo-pyrano[3,4-b]indole-1-acetic Acid Methyl Ester, CAS: 111478-84-3, stock: 2.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₁NO₄.
1,8-Diethyl-1,3,4,9-tetrahydro-6-hydroxypyrano[3,4-b]indole-1-acetic Acid Methyl Ester, CAS: 114720-21-7, stock: 6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₃NO₄.
1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indole-1-acetic Acid Methyl Ester, CAS: 122188-02-7, stock: 2.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₃NO₃.
1-Descarboxy Ketorolac, CAS: 113502-55-9, stock: 2.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₃NO.
1-Descarboxy Ketorolac-d4, CAS: /, stock: 8.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₉D₄NO.
1-Ethyl-1,3,4,9-tetrahydro-8-(1-methylethyl)pyrano[3,4-b]indole-1-ethanol, CAS: 849630-33-7, stock: 3.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₅NO₂.
1-Ethyl-1,3,4,9-tetrahydro-8-methyl-pyrano[3,4-b]indole-1-acetic Acid Ethyl Ester, CAS: 849630-60-0, stock: 5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₃NO₃.
1-Isopropyl Etodolac, CAS: 849630-65-5, stock: 3.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₃NO₃.
1-Isopropyl Etodolac-d6, CAS: /, stock: 8.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₇D₆NO₃.
1-Propyl Etodolac, CAS: 57816-83-8, stock: 9.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₃NO₃.
1-Propyl Etodolac-d5, CAS: /, stock: 3.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₈D₅NO₃.
3-(7-Ethyl-1H-indol-3-yl)-3-(7-Ethyl-3-(2-Hydroxyethyl)-1H-indol-2-yl)Pentanoic Acid (Etodolac Impurity), CAS: /, stock: 5.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₂N₂O₃.
3-(7-Ethyl-3-(2-hydroxyethyl)-1H-indol-2-yl)pent-2-enoic Acid, CAS: /, stock: 6.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₁NO₃.
4-Oxo Etodolac, CAS: 111478-86-5, stock: 2.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₉NO₄.
6-Hydroxy Etodolac, CAS: 101901-06-8, stock: 8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₁NO₄.
7-Ethyl-2,3-dihydrotryptophol, CAS: 114737-75-6, stock: 5.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₇NO.
7-Ethyl-4-propyl-2,4,5,5a,6,10b-hexahydro-1H-oxepino[4,5-b]indole-5-carboxylic Acid, CAS: /, stock: 4.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₅NO₃.
7-Ethylindole, CAS: 22867-74-9, stock: 1.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₁N.
7-Ethyltryptophol, CAS: 41340-36-7, stock: 1.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₅NO.
8-Desethyl Etodolac, CAS: 41339-67-7, stock: 6.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₇NO₃.
8-Isopropyl Etodolac, CAS: 57917-63-2, stock: 7.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₃NO₃.
8-Isopropyl Etodolac-d3, CAS: /, stock: 8.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₀D₃NO₃.
8-Methyl Etodolac, CAS: 41340-19-6, stock: 8.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₉NO₃.
8-Propyl Etodolac, CAS: 57817-27-3, stock: 4.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₃NO₃.
8-Propyl Etodolac-d3, CAS: /, stock: 7.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₀D₃NO₃.
Decarboxy Etodolac, CAS: 115066-03-0, stock: 5.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₁NO.
Ethylphenylhydrazine Hydrochloride, CAS: 58711-02-7, stock: 4.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₂N₂•x(HCl).
N-Methyl Etodolac, CAS: 849630-94-0, stock: 5.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₃NO₃.
rac Etodolac Acyl-β-D-glucuronide, CAS: 79541-43-8, stock: 2.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₉NO₉.
rac Etodolac-d3, CAS: 1276197-46-6, stock: 8.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₈D₃NO₃.
rac-Etodolac, CAS: 41340-25-4, stock: 6.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₁NO₃.
11-Oxo Etiocholanolone-d4, CAS: /, stock: 2.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₄D₄O₃.
11β-Hydroxy Etiocholanolone-d4, CAS: /, stock: 6.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₆D₄O₃.
19-Noretiocholanolone-d5, CAS: /, stock: 4.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₃D₅O₂.
1,3,5-Triethynylbenzene, CAS: 7567-63-7, stock: 7.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₆.
1,3-Dichloro-5-Ethynylbenzene, CAS: 99254-90-7, stock: 8.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₄Cl₂.
1,3-Diethynylbenzene, CAS: 1785-61-1, stock: 9.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₆.
1,4-Diethynylbenzene, CAS: 935-14-8, stock: 2.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₆.
1,4-Diidobenzene, CAS: 624-38-4, stock: 5.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄I₂.
1-Butoxy-4-ethynylbenzene, CAS: 79887-15-3, stock: 2.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₄O.
1-Ethyl-4-ethynylbenzene, CAS: 40307-11-7, stock: 4.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₀.
2,4-Dichloro-1-Ethynylbenzene, CAS: 75717-77-0, stock: 7.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₄Cl₂.
2-Bromophenylacetylene, CAS: 766-46-1, stock: 7.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₅Br.
3,4-Difluorophenylacetylene, CAS: 143874-13-9, stock: 4.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₄F₂.
3-Iodo-5-[2-(2-pyridinyl)ethynyl]-benzonitrile, CAS: 1312924-02-9, stock: 4.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₇IN₂.
3-Iodo-5-[2-(2-pyridinyl)ethynyl]-benzonitrile-d4, CAS: /, stock: 8.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₃D₄IN₂.
4-(4-Ethynylbenzenesulfonyl)-piperazine-1-carboxylic acid tert-Butyl Ester, CAS: 1162257-02-4, stock: 8.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₂N₂O₄S.
4-(Dihydroxyborophenyl)acetylene, CAS: 263368-72-5, stock: 2.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₇BO₂.
4-Bromophenylacetylene, CAS: 766-96-1, stock: 6.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₅Br.
4-Ethynylbenzeneboronic Acid Pinacol Ester, CAS: 1034287-04-1, stock: 4.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₇BO₂.
4-Fluorophenylacetylene, CAS: 766-98-3, stock: 2.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₅F.
4-Nitrophenylacetylene, CAS: 937-31-5, stock: 8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₅NO₂.
4’-Dimethylaminophenyl Acetylene, CAS: 17573-94-3, stock: 4.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₁N.
